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Abstract
Sarcopenia, the progressive decline in skeletal muscle mass and strength that occurs with aging, 
contributes substantially to impaired mobility of the elderly and has been associated with an 
increased risk of morbidity, disability, and mortality. Numerous age-associated processes have 
been shown to influence muscle mass and function, but the pathogenic mechanism leading to 
sarcopenia is still poorly understood. We found that destabilization of the neuromuscular junction 
(NMJ) via overexpression of the agrin-cleaving protease neurotrypsin in motoneurons installed 
the full sarcopenia phenotype in juvenile and young adult mice. Characteristic alterations included 
a reduced number of muscle fibers, increased heterogeneity of fiber thickness, angulated fibers, 
centralized nuclei, fiber-type grouping, and an increased proportion of type I fibers. We propose  
the neurotrypsin-overexpressing mouse as an animal model for sarcopenia, providing a well-
defined aging-like neuromuscular environment in an otherwise healthy animal. The induction of 
sarcopenia at young age challenges several hypotheses about its etiology. Age-related endocrine 
changes, physical inactivity, inappropriate food intake, mtitochondrial dysfunction due to life-
long accumulation of oxidative damages, and changes in muscle protein synthesis appear to be 
dispensable for the development of sarcopenia. Similarly, the loss of motoneurons, generally 
thought to be the main sarcopenia-promoting process, may not be a necessary condition for 
sarcopenia, since a reduced number of motoneurons was not found in neurotrypsin-overexpression 
animals. Our results rather suggest NMJ destabilization and fiber denervation at the onset of a 
final common pathway leading to sarcopenia. As in conditions with enhanced agrin cleavage, 
severe fragmentation of the NMJs that eventually lead to the dispersal of the postsynaptic receptor 
clusters was observed with aging. Whether neurotrypsin or agrin cleavage are responsible for age-
related NMJ destabilization and sarcopenia could not be fully elucidated. Neurotrypsin-dependent 
agrin cleavage is ruled out as a single suspect, as absence of neurotrypsin activity does not protect 
mice from developing sarcopenia at old age. Overexpression of a neurotrypsin-resistant form of 
agrin prevented sarcopenia in young neurotrypsin-overexpressing mice, but failed to rescue these 
mice from developing sarcopenia at old age. However, small beneficial effects of transgenic agrin 
on the morphology of aged muscles provide some evidence that the amount of full-length agrin 
may influence the development of sarcopenia. Whether this influence is related to agrin cleavage 
remains unclear. Other processes that affect the stability of the NMJ may adopt a similar pathway 
on the way to NMJ destabilization, muscle fiber denervation, and sarcopenia.

Zusammenfassung
Sarkopenie bezeichnet den kontinuierlichen Muskelschwund mit fortschreitendem Alter, der 
sowohl durch den Verlust an Masse, wie auch an Kraft der Skelettmuskulatur charakterisiert ist. 
Sarkopenie trägt entscheidend zu eingeschränkter Mobilität unter älteren Personen bei und wird 
mit erhöhter Morbidität, Behinderung und Sterblichkeit in Verbindung gebracht. Weil diverse 
altersbedingte Prozesse einen Einfluss auf den Verlauf der Sarkopenie haben können, sind die 
entscheidenden Mechanismen die den Muskelschwund auslösen nach wie vor ungeklärt. In dieser 
Arbeit wird gezeigt, dass die Destabilisierung der neuromuskulären Endplatte, induziert durch 
Überexpression der Agrin-spaltenden Protease Neurotrypsin, Sarkopenie in jungen Mäusen 
verursacht. Charakteristische morphologische Veränderungen der Skelettmuskulatur sind eine 
reduzierte Anzahl Muskelfasern, erhöhte Heterogenität der Faserdicke, abnormal geformte 
Muskelfasern, zentrierte Kerne, Gruppierung der Fasertypen und ein erhöhter Anteil an Typ-I-
Fasern. Die Neurotrypsin-überexprimierende Maus ist ein Tiermodell für Sarkopenie mit einem 
gealterten neuromuskulären System in einem ansonsten gesunden Organismus. Die Induktion 
von Sarkopenie in jungen Mäusen stellt diverse Prozesse, die bisher als Sarkopenie-auslösend 
bezeichnet worden sind, in Frage. Altersbedingte hormonelle Veränderungen, physische 
Inaktivität, mangelhafte Ernährung, Versagen der Mitochondrien durch lebenslange Ansammlung 
von oxidativen Schäden und Veränderungen der Synthese von Muskelproteinen scheinen keine 
essentiellen Voraussetzungen für die Entwicklung von Sarkopenie zu sein. Das gleiche gilt für 
den Verlust von Motoneuronen, der laut vielen Berichten entscheidend zum altersbedingten 
Muskelschwund beiträgt, da kein solcher Verlust in jungen Mäusen mit Sarkopenie gefunden 
wurde. Der Sarkopenie auslösende Prozess scheint eher die Destabilisierung der motorischen 
Endplatte und die Denervierung von Muskelfasern zu beinhalten. Sowohl in Neurotrypsin-
überexprimierenden, wie auch in alten Mäusen wurde eine Fragmentierung der neuromuskulären 
Endplatten gefunden, die mit dem vollständigen Verlust des Kontakts zwischen Nerv und Muskel 
enden kann. Daher könnten Endplatten-stabilisierende (Agrin), wie auch -destabilisierende 
(Neurotrypsin) Proteine eine wichtige Rolle in der Entstehung von altersabhängiger Sarkopenie 
spielen. Experimente mit alten Neurotrypsin-defizienten Mäusen haben aber gezeigt, dass 
Sarkopenie auch in Abwesenheit der Agrin-spaltenden Protease vorkommen kann. Die 
Überexpression einer Neurotrypsin-resistenten Agrin Form konnte zwar Sarkopenie in jungen 
Neurotrypsin-überexprimierenden Mäusen verhindern, nicht aber die Entwicklung der 
altersabhängigen Sarkopenie. Transgenes Agrin beinflusste allerdings die Morphologie von alten 
Muskeln positiv, was auf einen Abhängigkeit des Verlaufs der Sarkopenie von der Menge an 
ungeschnittenem Agrin deuten könnte. Zusammenfassend bleibt unklar ob die Prozessierung 
von Agrin an der Induktion von altersabhängiger Sarkopenie beteiligt ist. Es ist denkbar, dass 
andere Prozesse, die zur Destabilisierung der motorischen Endplatte führen, auf die gleiche Weise 
Sarkopenie verursachen.
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1 INtRoDuCtIoN
1.1 the neuromuscular junction (NMJ)
The vertebrate skeletal neuromuscular junction (NMJ) is the best studied of all synapses, due 
to his size, accessibility and simplicity1,2. It was used as model system for the study of synaptic 
transmission, development and modifications. The first demonstration of synaptic transmission 
was for example accomplished with the NMJ3. Later, the nicotinic acetylcholine receptor (AChR) 
was the first neurotransmitter receptor to be purified and cloned4. Studies of the neuromuscular 
development have spanned a century, with progress determined in large part by the tools available. 
Light microscopic methods were used to elucidate some of the main features of neuromuscular 
synaptogenesis and regenerations. Techniques of intracellular recordings and electron microscopy 
resulted in a sophisticated view of its structure and function. Later, it was realized that synapse 
formation involves elaborate signaling between nerve and muscle5. Molecular biological techniques 
permitted isolation of candidate signaling molecules and demonstration of their bioactivities in 
vitro6. In the last two decades, technical advantages in imaging and molecular genetics have 
permitted the in vivo confirmation of specific hypotheses derived from earlier work.
In this study, we report that destabilization of the NMJs, via enhanced cleavage of the synapse 
stabilizer agrin, leads to severe degeneration of skeletal muscles. This muscle degeneration shares 
numerous characteristics with the age-related loss of skeletal muscle mass and function known 
as sarcopenia. The stability of the NMJ and hence, NMJ protecting or disrupting agents, may be 
essential factors influencing the integrity of the neuromuscular system. We propose that sarcopenia 
results from the deterioration of this system and involves the dispersal of the NMJ that is followed 
by the degeneration of the skeletal muscle.
1.1.1 Structure
The NMJ consists of three cellular components, motoneuron, muscle fiber and Schwann cell7. 
The synaptic portions of all three are highly specialized, containing high concentrations of 
organelles and molecules found at low concentrations extrasynaptically. The motor nerve terminal 
is specialized for neurotransmitter release, bearing a large number of synaptic vesicles containing 
the neurotransmitter acetylcholine (ACh). Many of the vesicles are focused at dense patches on 
the presynaptic membrane, called active zones, at which the vesicles fuse with the membrane and 
release their contents into the synaptic cleft. The postsynaptic membrane is specialized to respond 
rapidly and reliably to neurotransmitter released from the overlying nerve terminal. It bears an 
extremely high concentration of AChRs8, and other signaling molecules9-11. The postsynaptic 
membrane is organized in junctional folds that open directly opposite the active zones. AChRs 
are concentrated at the crests, sodium channels at the depths of folds12. Schwann-cell processes 
cap the nerve terminal and insulate it from the environment. Finally, a basal lamina ensheats each 
muscle fiber, passes through the synaptic cleft and extends into the junctional folds. The major 
components are collagen IV, laminin, entactin, and heparan sulfate proteoglycans. The synaptic 
basal lamina also contains agrin, an important signaling molecule.
1.1.2 Formation
The formation of the NMJ starts with the establishment of rudimentary postsynaptic specializations 
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in the muscle membrane, referred to as prepatterning. A spatially restricted pattern of myonuclear 
AChR expression and the corresponding formation of surface AChR clusters determine the 
region of the prospective endplates without neuronal influence13-15. The prepatterning does not 
depend on agrin but on the function of MuSK, the muscle-specific kinase. Recently, it has been 
shown that these prepatterned clusters can develop to elaborately branched structures without 
neural influence16. These aneural pretzel-like structures share a number of characteristics with 
the mature postsynaptic apparatus, such as colocalization of several postsynaptic markers, 
clustering of subjacent myonuclei, and dependence on MuSK and rapsyn for their formation. 
They develop through a series of steps mirroring those seen in vivo. However, formation of nerve-
muscle contacts, dispersal of ectopic postsynaptic structures, synapse maintenance, intramuscular 
nerve branching, and neuronal survival requires reciprocal signals from nerve and muscle. The 
arriving nerves orchestrate coexisting synapse-stabilizing and synapse-dissolving mechanims to 
generate a well balanced match between pre- and postsynaptic elements. Thereby, prepatterned 
AChR clusters may be recognized by the ingrowing axons and incorporated into synapses17. 
Nerve-derived agrin is released from the presynaptic motoneuron and subsequentially stabilizes 
postsynaptic specialization. Agrin is a heperan sulphate proteoglycan of about 400-600 kDa18,19 
that was initially purified as an activity that induces enhanced clustering of AChRs on myotubes 
in vitro20,21. It is synthesized by motoneurons, released from nerve terminals and incorporated into 
the basal lamina of the synaptic cleft21,22. Gain- and loss-of-function studies indicated that agrin 
is a critical nerve-derived organizer of postsynaptic differentiation. The overexpression of agrin 
in the absence of nerves led to the formation of remarkably complete postsynaptic apparatus on 
muscle fibers23-25. Conversely, postsynaptic differentiation was impaired in agrin-deficient mice. 
The overall levels of AChR were normal, but few nerve-muscle contacts were accompanied by 
detectable AChR clusters or other postsynaptic specializations26. Thus, agrin is necessary and 
sufficient for postsynaptic differentiation. An important discovery was that nerve-, but not muscle 
derived agrin is capable to induce postsynaptic differentiation. Only neurons express the so called 
z/B+ agrin isoform, which results from alternative splicing and posseses an amino acid insert at the 
z/B site27-30 (see below). This agrin form is 1000-fold better at inducing AChR clusters compared 
to the isoform expressed by muscle, and is essential for synaptic development31,32.
1.1.3 Agrin signalling 
Several molecules on the myotube surface are capable of interacting with agrin, including 
dystroglycan, integrins, N-CAM, and laminins33-39. However, none of these essentially contribute 
to postsynaptic differentiation in vivo. In contrast, a transmembrane protein tyrosine kinase, MuSK, 
has emerged as the agrin receptor, even though it does not directly bind agrin40. MuSK is selectively 
expressed by skeletal muscle, where it co-localizes with AChRs in the postsynaptic membrane10. 
MuSK defcient mice displayed the same neuromuscular defects than the agrin deficient mutants41. 
Myoutubes cultered from MuSK deficient mice fail to form AChR clusters, either spontaniously 
or in response to agrin, and this defect can be rescued by reintroduction of MuSK. Furthermore, 
the application of agrin to myotubes results in a rapid phosphorylation of MuSK42. However, a 
direct interaction of agrin and MuSK was never demonstrated. Recently, LRP4, a member of 
the low density lippotein receptor family, has been reported to serve as coreceptor for agrin, 
forming a complex together with MuSK in a manner that is stimulated by agrin43,44. Downstream 
of MuSK, a 43 kDa cytoplasmic protein called rapsyn (receptor-associated protein at the synapse) 
is a critical effector of AChR clustering. AChRs and rapsyn are precisely colocalized at the NMJ 
as soon as clusters form and may interact directly45,46. No AChR clusters form in muscles of 
rapsyn-deficient mice, or in cultured myotubes from the mutants, even following treatment with 
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agrin47. However, MuSK is still clustered at synaptic sites. Therefore, rapsyn is necessary for 
AChR clustering and a downstream target of MuSK. Agrin, via MuSK, may increase the amount 
of rapsyn that associates with AChRs in the muscle membrane to levels that enhance clustering 
during synapse formation and stabilization. The association with rapsyn stabilizes the AChRs in 
the cell membrane by slowing their metabolic degradation. Rapsyn also mediates the attachment of 
AChRs to the utrophin-associated complex required for AChR stabilization and maturation of the 
NMJ48. Proteins within the utrophin-associated complex such as α-dystrobrevin and α-syntrophin 
are also important for signaling events that affect NMJ stability and function. The mechanism by 
which activation of MuSK induces rapsyn and AChR clustering is not yet fully understood but 
may involve the non-receptor tyrosin kinases Abl1 and Abl249,50. In mouse muscles, Abl kinases 
are located at the postsynaptic membrane of the developing NMJ. Their activity is required for 
agrin-induced AChR aggregation and enhancement of MuSK tyrosine phosphorylation. MuSK 
and Abl kinases effect reciprocal tyrosine phosphorylation and form a complex after agrin 
engagement. Abl kinases appear to provide the developing NMJ with the kinase activity that 
is necessary for signal amplification. MuSK activation not only enhances AChR clustering but 
also the synaptic concentration of ErbB receptors, which transduce signals from neuregulin. 
Neuregulin is a synaptic proteoglycan implicated in AChR synthesis in subsynaptic nuclei51,52. 
Synapse-specific gene transcription contributes essentially to the differentiation and stabilization 
of the postsynaptic membrane. However, recently, erbB2 and erbB4 have been conditionally 
deleted from skeletal muscle, rendering muscle fibers insensitive to neuregulin, but preserving 
neuregulin signalling to Schwann cells53. The resulting animals were viable and did not suffer 
from neuromuscular deficits. Structure and function of the NMJs was largely normal, despite a 
small decrease in AChR density. Surprisingly, synapse-specific transcription was maintained with 
only a 20-30% reduction in synaptic AChR transcripts. Thus, neuregulin signaling to muscle is not 
required for at least the principal aspects of postsynaptic development. Instead, defects observed 
in the absence of neuregulin-ErbB signaling are probalbly secondary to aberrant Schwann cell 
development17. Although transcriptional specialization of synaptic nuclei can occur in the absence 
of innervation13,14, its maintanance appears to require agrin and MuSK26,41,47,53. The mechanism 
by which agrin supports synapse-specific gene transcription remains to be elucidated, but it does 
not include autocrine neuregulin-ErbB signaling32. Anchoring of synaptic nuclei to the NMJ 
appears to depend on Syne-1. Syne-1 is a large protein with an N-terminal actin-binding domain, 
spectrin repeats, and a C-terminal domain that mediates association with the nuclear envelope. 
It interacts with MuSK and is concentrated in the envelope of synaptic nuclei at the NMJ54. The 
transgenic expression of a dominant-negative Syne-1 fragment prevented the accumulation of 
subsynaptic nuclei, suggesting that Syne-1 is required for anchoring of synaptic nuclei, perhaps 
through interaction with MuSK55. However, despite the absence of subsynaptic nulcei, there were 
no apparent NMJ defects. Thus, subsynaptic nuclei are dispensable for formation and topological 
maturation of the NMJ, although transcriptional specialization of nuclei in the vicinity of the 
synapses might be required. Extrasynaptically, the AChR synthesis is repressed by electrical 
activity56. Thus, AChRs are negatively regulated by their ligand in extrasynaptic regions, but 
immune for the repressive effects of activity at the synapse (Fig. 1).
1.1.4 Dispersal of unproteced AChR
A similar mechanism is responsible for the dispersal of AChR clusters that are not opposed by 
nerve endings and, thus, not supported by agrin (Fig. 1). ACh negatively regulates neuromuscular 
synapse formation by inducing the dispersal of AChR clusters that have not been stabilized by 
nerve-derived agrin57,58. ACh-mediated dispersion of AChRs may occur by endocytosis causing 
the loss of AChRs and by a redistribution of AChRs in the plane of the membrane. There is 
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evidence for ACh to signal via cyclin-dependent kinase (cdk)-5-dependent mechanism that 
could destablize AChR directly or impair assembly and recycling of AChR clusters. Consistent 
with an ACh-induced dispersal mechanism, denervated endplates develop normally, initiate 
fold formation on schedule and maintain their accumulation of AChRs, acetylcholine esterase 
(AChE) and synaptic nuclei59. Moreover, AChR aggregates persists longer in aneural muscles 
than in innervated muscles of agrin mutants13,14. Finally, double-knockout mice, deficient in both 
agrin and choline acetyl transferase, the sole synthetic enzyme for ACh, were generated57,58. In 
the mutant mice NMJs form, undergo pre- and postsynpatic differentiation, and persist until 
birth when the animals die. Absence of both dispersal (ACh) and protection (agrin) mechanism 
results in persistance of the NMJs. The role of agrin in vivo appears more to relate to synapse 
maintenance than synapse formation. Agrin acts as a protector, preventing the AChR clusters from 
disappearance by counteracting a local dispersal effect of neurotransmission at synaptic sites. 
This mechanism garantuees the perfect alignment of pre- and postsynaptic sites. Nerve-derived 
agrin specifies the innervated postsynaptic specializations as those to be maintained and further 
differentiated, whereas nerve-derived acetylcholine-dependent signals to the muscle fiber shut 
off AChR expression outside of the synaptic area and trigger the “dispersal mechanism” for non-
innervated and, thus, unprotected postsynaptic specializations. As a consequence, postsynaptic 
specialization can be remarkebly stable in the absence of the nerve, since then, not only protective 
but also destructive signals are absent.
1.1.5 Presynaptic differentiation
The agrin-mediated differentiation of the postsynaptic apparatus initiates reciprocal signals to 
the presynaptic nerve, resulting in the cessation of motor axon growth and the maturation of 
the presynaptic terminal60. The phenotype of agrin and MuSK deficient mice provide strong 
evidence that postsynaptic differentiation is necessary for subsequent induction of presynaptic 
development. The motoneuron terminals fail to differentiate, remaining highly dynamic and 
extending processes along the muslce surface26,41. Further evidence that postsynaptic differentiation 
is necessary for the subsequent induction of the presynaptic nerve terminal comes from muscle 
Figure 1 A molecular model of 
postsynaptic development at the 
NMJ. ACh-induced action potentials 
(red flash) disperse AChR clusters 
via endocytosis and repress extra-
synaptic transcription of AChR and 
other synapse-specific mRNAs. 
Neuronally released agrin (blue) 
interacts with MuSK via LRP4 to 
stimulate co-clustering of AChRs and 
rapsyn (red), probably by repressing 
neurotransmission-induced loss of 
AChRs. Synaptic transcriptional 
specialization contributes to synaptic 
AChR accumulation and requires 
agrin and MuSK. Neuregulin signaling 
primarily affects muscle indirectly via 
its effects on perisynaptic Schwann 
cells and may play a modulatory 
role in this process. Syne-1 (cyan) is 
concentrated in the envelopes of synaptic nuclei at the NMJ and may be required for anchoring of synaptic nuclei, 
perhaps through interaction with MuSK. From Kummer et al.17 
rapsyn-AChR
Nerve Schwann cell
MuSK/LRP4
erb
Extra-synaptic nuclei
Muscle
ACh agrin nrg
cdk5
Synaptic nuclei
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transplantation studies in which MuSK or rapsyin deficient muscles are transplanted into wild type 
animals60. Nerve terminals contacting transplanted MuSK or rapsyin deficient muscles remained 
undifferentiated and were observed to remodel continously over the course of several months. 
Initial steps in presynaptic differentiation occurred but wild type nerve terminals were unable to 
mature when postsynaptic differentiation was blocked on MuSK or rapsyin deficient muscles. 
Thus, the presynaptic maturation crucially depends on postsynaptic differentiation. The nature of 
the muscle-derived signal that is necessary to induce presynaptic maturation has not been clealy 
defined. However, it may involve signaling via laminins in the synaptic basal lamina, which is 
necessary for several aspects of presynaptic development61-63. Key signaling molecules that induce 
presynaptic differentiation may be deposited in the synaptic basal lamina by the muscle following 
the activation of MuSK.
1.1.6 Synaptic maturation
During the weeks after initial nerve-muscle contact, the plaque-like early NMJ transforms to the 
typical pretzel-like structure of the mature endplate1,32,64. The plaque perforates as AChRs are lost 
from regions within it. As this process continous, the plaque transforms into a series of branches, 
giving the junction the pretzel-like appearance. The topography of the postsynaptic membrane 
changes from an initially flat and apparently homogenous area to a complicated invaginated, 
pretzel-like structure with a compartmentalized molecular composition. During the same period, 
all but one of the initially multiple nerve terminals projecting on one postsynaptic specialization 
withdraw in a process called synapse elimination65. Polyneuronal innervation originates by the 
convergence of multiple motor axons on individual muscle fibers. Retraction of some terminal 
branches from each muscle fiber leads to the loss of multiple innervation without any changes in 
the total number of motoneurons innervating the muscle66,67. Thus, the size, but not the number 
of motor units decreases during synapse elimination. The elimination process include a stepwise 
loss of terminal branches, which undergo a program of atrophy, detachment, and withdrawal. 
Eventually, the axon forms a retraction bulb and withdraws from the endplate68,69. Serial electron 
microscopy revealed an unusual cellular mechanism that removes axons at the NMJ70. Retracting 
motor axons shed numerous membrane bound remnants (axosomes) that contain a high density of 
synaptic organelles and are formed by engulfment of axon tips by Schwann cells. In most of the 
cases, the remaining nerve then extend axonal processes to takeover the vacated postsynaptic sites. 
When the remaining axon does not reoccupy a site, the postsynaptic receptors rapidly disappear, 
most likely due to active, Ach-induced dispersal. The synapse elimination is competitive and 
activity dependent71, and its dynamics has been analyzed in vivo72 (Fig. 2). Very early it has been 
recognized that activity is involved in synapse elimination, since blockage of activity prevented 
elimination73,74. Moreover, the relative synaptic efficiacy of two competing axons at a single 
NMJ influences the outcome of synaptic competition. This has been demonstrated by genetically 
reducing synaptic efficiacy at one of two axons innervating a target75. This was achieved 
by reducing neurotransmission in a subset of motoneurons by conditional genetic deletion of 
choline acetly transferase. More active inputs were strongly favoured competitors during synapse 
elimination. There are several lines of evidence indicating that the synaptic competition is 
mediated through the muscle cell. Focal blockage of receptor activation within a small region 
of the NMJ induced for example elimination at these sites, indicating that local differences in 
receptor activation can drive elimination76. Postsynaptic activity-dependent mechanisms appears 
to function locally to drive the elimination of neighboring inputs. Consistent with this idea, two 
motoneuron inputs can be maintained on the muscle surface if they are seperated by enough 
distance77. Mainly two models have been formulated to explain activity-dependent competition 
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leading to input elimination at the NMJ1. In the first model, presynaptic inputs compet for access 
to limiting amounts of muscle-derived trophic signals. Less avtive inputs receive less trophic 
support and are subsequentially eliminated. A second model involves signalling mechanisms that 
actively drive the process of elimination of less active inputs. These putative negative signals have 
been termed synaptotoxins or punishment signals. Since activity-dependent competition appears 
to be mediated through the muscle, this model also includes the idea that less active inputs are 
more susceptible to synaptotoxins or that more active inputs are protected, or both. However, 
recently it has been observed that an input could initially begin the process of elimination and then 
subsequentially reverse this process by growing to become the single input that is maintained72. 
Thus, the mechanisms underlying input elimination are reversible and the elimination process 
appears not to progress monotonically but to be continually driven until an entire input is 
eliminated. Moreover, an initially ineffective input can overtake an initially more effective input, 
indicating that the competitive vigor can change dramatically over the time course of the synaptic 
competition. Thus, there must be mechanisms in addition to receptor activation that determine the 
outcome of competition-driven input elimination2. In vivo examination of synaptic competition 
between two motoneurons at each muscle fiber where they converge, led to further insights into 
synaptic competition78. First, one motoneuron loses every competition with the second, suggesting 
that one motoneuron has an intrinsic competitive advantage over the other neuron throughout its 
entire presynaptic arborization. If synaptic efficiacy can be linked to axonal activity, the differences 
in motoneuron activity could be one mean to bias competition throughout the entire arborization 
of a single motoneuron. Second, motoneurons with larger total arboriazation are at disadvantage 
in competitions against motoneurons with smaller total arborization. This observation has been 
explained by a cell-wide finite resource that influences the competitive vigor and becomes diluted 
as a motoneuron gains territories. This finite resource could be neurotransmitter since the depletion 
of ACh by genetic deletion of choline acetyl transferase leads to a competitive disadvantage75. Such 
growth restriction may act to prevent excessive expansion of a single arborization. Interestingly, 
the largest motor units are generally those that are the least active; they are recruited last during 
movements79,80. Motoneurons with larger arborizations may be less active and hence, loss more 
synaptic targets as a result of synaptic competition than smaller, more active motor units. After a 
motoneuronal input has been established, the corresponding muscle fiber becomes unresponsive 
towards further innervation. A foreign nerve, implanted on a muscle, cannot induce the formation 
of new NMJs as long as the muscle is innervated77.
1.1.7 Synapse maintenance
Mature NMJs persists for the life of an animal. Time lapse imaging in mice shows that most NMJs 
Figure 2  In vivo observation of synapse elimination. The same multiply innervated junction is imaged in neonates 
between postnatal day 11 (P11) and 15 (P15). Although in this case the subset CFP axon (blue and insets) has greater 
terminal area (70%) at the first view, it progressively withdraws from the junction (arrows and asterisks). Insets, 70% 
size reduction. Scale bars, 10 µm. From Walsh and Lichtman.72 
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are remarkebly stable, they do not add or lose branches even though they enlarge considerably as 
the animal grows81-83. In vivo visualization of the growth of pre- and postsynaptic elements showed 
that the NMJ primarely grow by expansion of existing motor nerve terminal and postsynaptic 
receptor regions without the addition or loss of synaptic area82,83. Each NMJ grew at the same rate 
that muscle fiber enlarged, suggesting that junctional growth might be a mechanical consequence 
of muscle fiber growth. During this process, the number of AChRs at the synapses increased, but 
AChR density remained constant. Since the alignment between growing motor nerve terminal and 
postsynaptic regions is maintained, nerve terminal growth may be a consequence of its adhesion 
to growing postsynaptic specializations. Synaptic turnover appears not to be a necessary feature of 
synaptic maintenance. Experiments on denervated and damaged muscles showed that postsynaptic 
specialization persist for long periods in the absence of a nerve84-86. Moreover, when myotubes 
regenerate following injury in the absence of the nerve, postsynaptic specialization accumulate 
at the original synaptic sites87-89. Components of the basal lamina remain at synaptic sites after 
removel of the nerve and direct the biochemical and structural organization of the subsynaptic 
membrane. Thus, the synaptic basal lamina, containing agrin, seems to be responsible for the 
maintenance of the postsynaptic apparatus, regardless if the nerve is present or not. However, the 
basal lamina is not sufficient for complete maintenance of the nerve terminal. The degeneration 
of mouse muscle fibers leads to the withdrawal of some terminal branches from endplates within 
two days90. Thus, the nerve terminal may be dependant on an ongoing production of proteins by 
the muscle fiber60. 
Interestingly, silencing of MuSK expression by RNA interference results in dissassembly of 
existing NMJs in adult mice91. Short hairpin RNA (shRNA) were used to enable prolonged and 
stable suppression of gene expression in vivo. The alterations of the postsynaptic structures after 
applying MuSK shRNA ranged from fragmentation to severe disassembly of postsynaptic AChR 
clusters. In response to abrogation of postsynapse integrity, presynaptic nerve endings began to 
sprout. In certain cases, the entire possynaptic structure disappeared and the motoneuron terminal 
was the only evidence that an NMJ had been present before. These results indicate that a continuous 
presence of MuSK is required for the maintainance of the NMJs. Absence of MuSK leads to active 
dispersal of the postsynpatic sites, most likely due to an ACh-induced mechanism. Furthermore, a 
compact postsynaptic structure appears to be required to maintain presynaptic integrity.
The maintenance of the junction seems to be impaired in older age. The number of AChRs per 
junction decreases, extrajunctional recptors appear, and vacated synaptic sites and terminal sprouts 
become more prevalent in old muscles. Branches retract and the number of discrete regions of 
AChR density is increased, leading to a fragmented appearance of the junction82,92-94. These 
changes involve both pre- and postsynaptic disassembly and thus resemble synapse elimination 
rather than denervation1. A progressive loss of synaptic contact in individual NMJs and, finally, 
the loss of entire NMJs with some reinnervation at others has been reported95.
1.2 Agrin is crucial for the maintenance of the NMJ
Agrin was initially purified using basal lamina extracts from the synapse-rich electric organ of 
the pacific electric ray Torpedo californica20. It is a protein of more than 2000 amino acids with 
a predicted molecular mass of 225 kDa. The extensive N- and O-linked glycosylation of the 
amino-terminal half increases the apparent molecular mass of agrin to about 600 kDa. At least 
three of the O-linked carbohydrate attachment sites function as docking sites for heparan sulfate 
glycosaminoglycan side chains and assign agrin to the family of heparan sulfate proteoglycans18,96. 
Agrin is composed of numerous domains that are homologous to motifs found in other basal 
lamina proteins (Fig. 3). It contains 9 FS (follistatin–like), 2 LE (laminin-EGF-like), one SEA 
(sperm protein enterokinase and agrin), 4 EGF (epidermal growth factor-like), and 3 LG (laminin 
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globular) domains. Agrin exists in several isoforms that are generated by alternative splicing96. 
The N-terminus can include a laminin-binding domain or a transmembrane region, which are 
constituents of a secreted or a type II transmembrane form of the protein, respectively. The later 
isoform is predominantly expressed in the brain, whereas the first is expressed by motoneurons. 
It is transported down the motor nerve and released from the nerve ending into the synaptic cleft 
of the NMJ, where it becomes an essential component of the synaptic basal lamina and interacts 
with receptors on the postsynaptic membrane to stabilize postsynaptic membrane specialization 
formation97. The C-terminal moiety of agrin comprises two additional splice sites, called y/A and 
z/B (A and B and y and z are used to denote these sites in chicks and mammels, respectively). 
Splicing at these sites gives rise to protein variants that can contain 0 or 4 amino acids at the y/A 
sites, and 0, 8, 11 or 19 (8 and 11) amino acids at the z/B site. The insert at the y/A site is required 
for heparin binding and modulates the binding of agrin to α-dystroglycan, whereas the insert at 
the z/B site greatly influences agrin signaling at the NMJ38,42,98. In the CNS, in contrast, these 
splice variants seem not to be important for the function of agrin. Agrin contains binding sites for 
several macromolecular interaction partners, including neural cell-adhesion molecule (NCAM), 
heparin-binding growth factors, α-dystroglycan, integrins, heparin, α-dystroglycan, LRP4 and the 
sodium/potassium-ATPase43,44,96,99,100. The AChR aggregation activity of agrin has been mapped to 
the C-terminus. Thereby, a splice insert at the z/B is necessary to exhibit any clustering activity. 
The C-terminal 95 kDa moiety of agrin is required for full activity in AChR aggregation on muscle 
cells, but the most C-terminal LG3 domain, comprising of 20 kDa, is sufficient to induce AChR 
aggregation at low potency101. The main source for the agrin isoforms that can induce aggregation 
is neurons, including motoneurons. Transcripts from all non-neuronal cells, except adult Schwann 
cells, encode z/B- agrin.
In the last years, it has become clear that the activities of agrin are of broader significance than 
NtA
y/A z/B
α cleavage site β cleavage site
agrin-90 agrin-22
α-dystroglycan
Na+/K+-ATPase
AChR aggregation 
heparin, integrins
NCAM
heparin-binding growth factors
laminins
SS
Figure 3 Schematic representation of agrin, showing its structural domains, the binding regions of some of the most 
important partners and the neurotrypsin-specific cleavage sites. The signal sequence (SS) and amino (N)-terminal 
agrin domain (NtA) are present in an agrin isoform that is localized to the NMJ. These two regions are responsible 
for the release of agrin (SS) and the binding to the laminins in basal laminae (NtA). The alternatively spliced type II 
transmembrane segment (TM) of agrin anchors this isoform at places that are devoid of basal laminae such as the brain. 
The amino-terminal half of agrin is highly glycosylated at N-linked glycosylation (circles) and glycosaminoglycan 
(multiple circles) attachment sites. These regions are also involved in binding to neural-cell adhesion molecule 
(NCAM) and heparin-binding growth factors. The carboxy-terminal, 95-kDa part of agrin (starting with the first 
epidermal growth factor (EGF)-like domain (EG)) is fully active in AChR aggregation and contains binding sites 
for α-dystroglycan, heparin, some integrins, and the sodium/potassium-ATPase. Two additional splice sites, y/A and 
z/B, are located in the C-terminal part of agrin.  The most carboxy-terminal, 21-kDa LG domain (LG3) is sufficient 
to induce AChR aggregation at low potency. Agrin can be proteolytically processed by neurotrypsin at the α- and 
β- cleavage sites, generating a C-terminal 22 kDa fragment (agrin-22) and a 90 kDa middle fragment (agrin-90). 
FS, follistatin-like domain; LE, laminin EGF-like domain; S/T, serine/threonine-rich region; LG, laminin globular 
domain; SEA, sperm protein, enterokinase and agrin domain.
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previously anticipated. Agrin is involved in the synapse promotion in the brain, the formation of 
the immunological synapse, the organization of the cytoskeleton and the amelioration of function 
in diseased muscle96. 
Agrin is highly expressed in the developing peripheral and central nervous system during the 
period of synapse formation27,102,103. This expression pattern in the brain and the organizing role 
of agrin at the NMJ indicate that it might orchestrate synaptogenesis in the entire nervous system. 
Indeed, agrin is important in regulating the formation of cholinergic interneuronal synapses in 
the superior cervical ganglion (SCG). Agrin-deficient embryos show a mismatch between pre- 
and postsynaptic structures and have defective synaptic transmission104. Importantly, soluble z+ 
agrin (but not z- agrin) restores the wild type phenotype in cultured agrin-deficient SCG neurons. 
However, synapse deficits have not been observed in the brain of these agrin-deficient mice, and 
cortical and hippocampal neurons derived from these animals still form synapses in culture105,106. 
Other studies showed that the clustering of agrin by antibodies107 and the overexpression of agrin in 
neural cells induce the formation of filopodia108, which in turn provide the basis for the formation 
of new synapses. Dendritic filopodia are thin and usually long membraneous protrusions on 
dendrites that are involved in synapse formation by establishing preliminary contacts with axonal 
boutons that potentially mature into persistent synapses within days109,110. Acute suppression of 
agrin expression by antisense oligonucleotides reduces the number of neuron-neuron synapses 
in cultured hippocampal neurons, which goes in line with decreased filopodia formation111,112. 
Similarly, in adult agrin-deficient mice, when the formation of the NMJ is rescued by transgenic 
expression of z+ agrin in motoneurons, the number of central synapses is significantly lower than 
in wild type mice and dendritic arborization of pyramidal neurons is also impaired113. Recently, it 
has been shown that the cleavage of agrin, generating a C-terminal 22 kDa fragment, is necessary 
for the activity dependent formation of dendritic filopodia in hippocampal neurons114.
The mediator of the response to agrin may be different at the NMJ and in the CNS. MuSK, which 
mediates agrin signaling at the NMJ, was longtime thought not to be expressed in the CNS. 
However, recently, MuSK was found to be expressed in a subpopulation of excitatory synapses 
and could mediate central response to agrin113. Another potential receptor for agrin in the CNS is 
the sodium/potassium-ATPase. A peptide containing the LG-3 domain of agrin, closely resembling 
the 22 kDa fragment, was shown to bind to and inhibit the α3-subunit of the sodium/potassium-
ATPase. Membrane depolarization and increased action potential frequency in cortical neurons 
were a direct result of the inhibitory activity of agrin LG3 on the ATPase100. Thus, agrin has the 
potential to regulate activity-dependent processes in neurons, providing a molecular framework 
for agrin action in the CNS. In addition, the inhibitory effect of agrin on the sodium/potassium-
ATPase also modulates the contraction of cardiac myocytes115.
Recently, a novel role for neuronal agrin in skeletal muscle maturation has been proposed. Agrin 
appears to control the maturation of the excitation-contraction coupling mechanism in human 
muscle116. The fraction of myotubes showing a functional excitation-contraction coupling was 
increased in cocultures of muscle cells with spinal cord explants as well as in aneural muscle cells 
treated with neural agrin. Moreover, the treatment with agrin increased the number of muscle 
cells in which functional ryanodine receptors and dihydropyridine-sensitive L-type Ca2+ channels 
were detected. These two proteins are essential for functional excitation-contraction coupling. 
However, these effects have only been observed in human and not in mouse myotubes.
1.3 Neurotrypsin cleaves agrin and destroys its synapse protecting function
The neuronal serine protease neurotrypsin is a member of the serine peptidase family S1A. The 
murine form of neurotrypsin consists of 761 amino acids with a molecular mass of 84 kDa and a 
theoretical pI of 8.7, the human form of 875 amino acids with a molecular mass of 97 kDa and a 
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pI of 8.4. Neurotrypsin is a secreted multidomain peptidase consisting of a signalpeptide (SP), a 
proline-rich basic (PrB) domain, a kringle (Kri) domain, several scavenger receptor cysteine-rich 
(SRCR) domains, and a serine protease (Prot) domain at the carboxy terminus (Fig. 4). The murine 
neurotrypsin comprises three, the human form four SRCR domains117,118. The peptidase domain 
has 244 amino acids and shows high similarities to trypsin with 40 % amino acid identity. In front 
of the peptidase domain is a zymogen activation site with the furin recognition motif RRQKR. 
Furin is a proprotein converting peptidase, which is widely expressed and processes a broad range 
of substrates. After activation cleavage, 
the protease domain of neurotrypsin 
remains attached to the non-catalytic part 
via a disulfid bond. Murine neurotrypsin 
bears three N-glycosylation motives, one 
in the proline-rich basic and two in the 
peptidase domain, human neurotrypsin 
bears only two, one in PrB and one in the 
peptidase domain118.
Neurotrypsin is predominantly expressed in brain, spinal cord, kidney, lung, and testis118,119. In situ 
hybridization studies on adult mouse brain revealed a highly restricted expression of neurotrypsin 
mRNA in the adult nervous system. In the forebrain, neurotrypsin mRNA signals can exclusively 
be detected in distinct subsets of neurons of the cortex, the hippocampus, the amygdala, and the 
olfactory bulb. In the neocortex, most prominent neurotrypsin mRNA expression can be found 
in layers V and VI. Neurotrypsin mRNA is largely absent from the rest of the CNS, except for a 
strong expression in neurons of the brain stem motor nuclei and the motor columns of the spinal 
cord. Neurotrypsin mRNA is also present in the peripheral nervous system. A subpopulation of 
neurons of the dorsal root ganglia expresses neurotrypsin mRNA. Ultrastructurally, neurotrypsin 
is associated with the presynaptic membrane and the presynaptic active zone of both excitatory 
and inhibitory synapses of the hippocampus and the cerebral cortex120,121. Synaptic recruitment 
and externalization of neurotrypsin is indcued by neuronal activity, and externalized neurotrypsin 
lingers at the synapse for several minutes before disappearing because of diffusion or degradation122. 
These observations suggest an activity-dependent function of neurotrypsin at the synapse, such as 
the activity-dependent remodeling of synaptic circuitries. 
During synapse assembly in pre- and postnatal development, neurotrypsin mRNA is upregulated in 
many brain regions, including hippocampus, neocortex, and midbrain123. The peak of neurotrypsin 
expression, assessed by in situ hybridization and western blotting on mouse brain, is between late 
embryonic and early postnatal phase (embryonic day 12 to postnatal day 10)121. A similar pattern 
for neurotrypsin expression has also been observed in the spinal cord, the peripheral nervous 
system and in non-neuronal tissues. However, neurotrypsin expression remains detectable during 
adulthood and is sustained to senescence. 
Neurotrypsin was recognized to play an indispensable role for cognitive processes in humans 
when a four-nucleotide deletion in the coding region of the neurotrypsin gene, which disabled the 
expression of the proteolytic domain, was identified as the cause of severe mental retardation120. 
The affected children showed normal psychomotor development during the first 18 months but 
exhibited severe deficits in cognitive development thereafter, indicating that neurotrypsin does 
not play a critical role for early neural development or for the formation of synapses. Rather, 
neurotrypsin may be critically involved in the reorganization of synapses and neuronal circuits, 
which are required to establish and maintain higher cognitive functions during later development 
and adult stages.
The analysis of transgenic mice overexpressing neurotrypsin in motoneurons led to further insights 
Figure 4 Domain structure of human neurotrypsin. PB, proline-
rich basic domain; KR, kringle domain; SRCR1 to SRCR4, 
scavenger receptor cysteine-rich domains 1 to 4; ZA, zymogen 
activation region; PROT, serine protease domain; circles, 
putative N-glycosylation sites.
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Figure 5 Neurotrypsin cleaves agrin at two positions and destroys agrin’s synapse protecting function. (a) Over-
production of neurotrypsin in motoneurons causes aberrant innervation of the diaphragm muscle. The neuromuscular 
innervation of the diaphragm was analyzed by indirect immunofluorescence staining of neurofilament protein (Nf), 
synaptophysin (Syn), and acetylcholine receptor (AChR), to visualize the motor axons, the presynaptic terminals, 
and the postsynaptic specializations, respectively. In adult neurotrypsin-overexpressing mice (Tg-Nt), motor axons 
grew out of the endplate band towards the medial and lateral borders of the hemidiaphragm. Normal NMJs in the 
endplate band were virtually absent in transgenic mice. Staining for synaptophysin revealed many small, ectopic 
presynaptic boutons along the trajectories of outgrowing axons. Innervation of muscles from mice overexpressing 
catalytically inactive neurotrypsin (Tg-iNt) was normal. Scale bars, 500 µm (top), 100 µm (bottom). From Bolliger 
et al., in preparation. (b, c) Neurotrypsin cleaves agrin in vitro and in vivo. (b) Western blot analysis of HeLa cells 
cotransfected with combinations of membrane-bound agrin (+), wild type neurotrypsin (wt), inactive neurotrypsin 
(S/A), and empty vector (–). Supernatants (S) and cell lysates (CL) were analyzed with anti-agrin antibodies, directed 
against the C-terminus of agrin. Transfection of agrin alone resulted in a signal above 250 kDa in cell lysate. Upon 
cotransfection with wild type neurotrypsin, full-length agrin was cleaved resulting in fragments running at 22, 90, 
and 110 kDa in supernatant. No cleavage was found after cotransfection with inactive neurotrypsin. (c) Western blot 
analysis of tissue from wild type (wt) and neurotrypsin-deficient (KO) mice. The 90 kDa agrin cleavage product was 
detected in brain, kidney, and lung of wild type mice but was absent in neurotrypsin-deficient. Similar results were 
obtained for the 22 kDa agrin fragment except for lung. ß-Actin was used as a loading control. From Reif et al.119
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into neurotrypsin function. These mice show severe alterations of neuromuscular innervation, 
very similar to the phenotype found in agrin-deficient mice (Fig. 5a). A few days after induction 
of the transgene, most of the previously established NMJs in the endplate band of the diaphragm 
muscle had disappeared. Normally positioned NMJs were rare. Motor nerves had grown diffusely 
over the muscle surface. Along their trajectories they had formed many new, ectopic synapses 
with small weakly stained AChR clusters. The striking similarity of the abnormal neuromuscular 
innervation pattern resulting from neurotrypsin overexpression and agrin deficiency, together with 
the coincident expression of neurotrypsin and agrin in motoneurons suggested agrin as a target of 
neurotrypsin (Bolliger et al., in preparation). 
And indeed, agrin is a proteolytic target of neurotrypsin in vitro and in vivo. Experiments with 
the isolated proteins and in cell culture reveled that agrin is cleaved by neurotrypsin at two 
positions, called α and β cleavage sites (Fig. 5b). The first cleavage site (sequence PIER’ASCY) 
lies in front of the SEA domain, the second (sequence LVEK’SVGD) in front of the third LG 
domain. α cleavage results in a C-terminal 110 kDa fragment, β cleavage in a C-terminal 22 kDa 
fragment and the cleavage at both sites results in a 90 and a 22 kDa fragment, respectively (Fig. 
3). Mutagenesis analysis revealed that neurotrypsin is highly specific due to the unique substrate 
recognition pocket at the active site119. The 90 and the 22 kDa fragments can also be observed in 
vivo, they appear in extracts from brain and spinal cord (Fig. 5c). The fragments are increased 
upon neurotrypsin overexpression in transgenic mice, reflecting an increased agrin cleavage, and 
are completely absent in neurotrypsin deficient mice. Thus, neurotrypsin is responsible for the 
cleavage of agrin in vivo. Thereby, only the glycanated variants of agrin are affected. The analysis 
of agrin cleavage fragments in synaptosomes revealed that the cleavage takes place at or in the 
vicinity of synapses, resulting in increased concentrations of agrin fragments and decreased full-
length agrin at synapses121. 
Neurotrypsin, agrin, and the 90 kDa fragment of agrin, as an indicator of neurotrypsin-dependent 
agrin cleavage, are highest during fetal and early postnatal stages of neural development and 
are found at lower levels throughout adult life. Therefore, the temporal pattern suggests a role 
of neurotrypsin-dependent agrin cleavage in a function occurring with highest activity during 
neuronal development but persisting at lower activity in the adult brain. In particular, a role 
of agrin cleavage in developmental and adult synaptogenesis would be well compatible with 
this expression pattern and with the observation of mental retardation in humans deficient for 
neurotrypsin.
The C-terminal 22 kDa agrin fragment, which is generated by the proteolytic activity of neurotrypsin, 
has been shown to be of involved in several processes: it contains the AChR aggregation activity 
of agrin at the NMJ, inactivates the sodium-potassium ATPase at CNS synpases100, and induces 
filopodia formation in hippocampal neurons114. The activity-dependent formation of dendritic 
filopodia was found to be abolished in hippocampal neurons from neurotrypsin-deficient mice. 
Administration of the neurotrypsin-dependent 22 kDa fragment of agrin rescued the filopodia 
response. Detailed analysis indicated that presynaptic activity is necessary for the release 
of neurotrypsin, whereas postsynaptic activity is necessary for the neurotrypsin-dependent 
agrin-cleavage. Thus, the neurotrypsin-agrin system acts as a coincidence detector of pre-and 
postsynaptic activation. The region covered by the 90 kDa fragment, on the other hand, interacts 
with α-dystroglycan, heparin, and integrins99. The distinct functions associated with the released 
fragments indicate major functional differences between full-length and truncated agrin and 
suggest a role for the proteolytic neurotrypsin-agrin pathway in the regulation of synaptic function 
required for the establishment and the maintenance of cognitive brain function and the NMJ. 
At the NMJ, excessive cleavage of agrin, liberating the diffusible 22 kDa fragment, could 
inactivate agrin signaling and destroy the synapse protecting function of agrin. The unprotected 
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NMJs are prone to be dispersed, most likely by an acetylcholine dependent mechanism. Such 
a process would explain the abnormal innervation pattern seen in neurotrypsin-overexpressing 
mice, which resembles that in agrin mutants. Importantly, the concomitant transgenic expression 
of neurotrypsin and a neurotrypsin-resistant agrin variant, due to mutation of the P1 position at 
both α and β cleavage sites, prevented the expression of the neurotrypsin-dependent phenotype 
(Bolliger et al., in preparation). This finding confirms that the proteolytic processing of agrin at 
the α and β cleavage sites is responsible for the disintegration of neuromuscular innervation. 
Interestingly, the concomitant expression of the cleavage-resistant agrin variant and neurotrypsin 
delayed NMJ transformation from plaque to pretzel, suggesting that agrin cleavage is important 
for normal endplate maturation. The cleavage of agrin may relieve agrin-dependent constraint 
on endplate reorganization during NMJ maturation. Surprisingly, NMJ maturation proceeded 
normally in neurotrypsin deficient mice, although agrin cleavage has not been found in the 
brain114,119,121 and the spinal cord (Bolliger et al.,in preparation) of these mice. Endplate maturation 
is delayed in the absence of agrin processing at the α and β cleavage sites, but normal in the 
absence of neurotrypsin. This observation might be explained most directly by the existence of 
another protease with similar, site-specific activity. This protease should not be expressed in the 
CNS and exhibit very similar enzymatic characteristics as neurotrypsin, because its proteolytic 
function should also depend on the presence of the P1 basic residue at each cleavage site of agrin. 
In summary, the proteolytic processing of agrin at the α and β cleavage sites may regulate the 
maturation of the NMJ by modifying the extent of the synapse stabilizer agrin in the synaptic 
extracellular matrix.
1.4 Sarcopenia
1.4.1 Sarcopenia is a severe health problem in the elderly population
Sarcopenia denotes the progressive decline in skeletal muscle mass and function that is associated 
with aging. It is distinct from wasting, involuntary weight loss due to inadequate energy intake, 
and from cachexia, cytokine-driven loss of lean body mass that cannot be reversed nutritionally 
and occurs despite maintenance of weight. Sarcopenia is a consequence of normal aging, and 
is not necessarily assocated with a disease, although muscle loss can be accelerated by chronic 
illness. Sarcopenia occurs even in fit, athletic elderly adults, who continue to lose lean mass and 
muscle mass despite retaining their functional status124. Body cell mass is systematically lower in 
older adults than in middle-aged or young adults, which is largely attributable to a loss of muscle 
mass125. During aging, humans lose about one-third of the skeletal muscle mass. Sarcopenia 
contributes substantially to impaired mobility and frailty of the elderly and has been associated 
with an increased risk of morbidity, disability and mortality126-131. The prevalence of sarcopenia is 
almost 25% in humans at the age of 65 years and increases to 30 – 50 % at the age of 80 years126,132. 
However, the rate of sarcopenia varies greatly according to health status, physical activity, and 
diet. As a consequence, there is a great difference between biological and chronological age, 
leading to great heterogeneity of elderly subjects and complicating the analysis of sarcopenia. 
Due to the increased longevity of industrialized populations, sarcopenia has emerged a major 
health problem. The estimated direct healthcare costs of sarcopenia in the United States in 2000 
were $ 18.5 billion, which represented about 1.5 % of total healthcare expenditures133.
Sarcopenia not only plays a major role in the loss of muscular strength, but also contributes 
substantially to decreased metabolic rate134-138, gradual reduction of bone density139,140, and 
decreased aerobic capacity141,142. In addition, sarcopenia may also contribute to an increased risk 
for chronic disease such as diabetes and osteoporosis143. 
Speculations about the pathogenic mechanisms of sarcopenia include a variety of candidate 
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mechanisms of neurogenic (impaired innervation), muscle intrinsic (inadequate regeneration), or 
systemic (endocrine failure) origin. Loss of motoneurons and motor unit remodeling144-146, decreased 
capacity among motoneurons to innervate regenerating fibers147, instability of the neuromuscular 
junction (NMJ)148, lack of regenerative drive of the muscle, decreased muscle loading149, physical 
inactivity150,151, mitochondrial dysfunction152,153, oxidative damage154, excitation-contraction 
uncoupling155,156, and decline in satellite cell proliferation and activation157,158 have been suggested 
to contribute to sarcopenia as well as nutritional, hormonal, metabolic and immunological 
factors159-162. These factors include age-related declines in growth hormone and insulin-like 
growth factor-I (IGF-1) production163, sex steroid levels164, insulin action, and muscle protein 
synthesis165,166. In addition, fat gain, subclinical inflammation, increased production of catabolic 
cytokines, and inadequate intake of dietary energy and protein are also potentially influencing the 
development sarcopenia127. Most of these mechanisms may contribute to the pathogenic ensemble 
resulting in sarcopenia. The relative contribution of each of these mechanisms is, however, poorly 
understood.
1.4.2 Age-related loss of muscle mass, strength, and quality
The decline of muscle strength in older adults has been demonstrated in a variety of muscles 
during both voluntary dynamic and isometric contractions167-180. However, the size of this age-
related decline shows considerable variation among different muscle exercise protocols and 
sample characteristics. On average, by the seventh and eighth decade of life, maximal voluntary 
contractile strength is decreased by 20-40% for both men and women in proximal and distal 
muscles. A longitudinal study of older men (initially 65 years) showed a rate of decline in 
isokinetic muscle strength of the knee and elbow extensors and flexors of 20 to 30% in 12 years181. 
Vandervoort and McComas182 showed a pronounced decline of up to 50% for maximum voluntary 
strength of the ankle dorsiflexor and plantarflexor muscles in 111 men and women, starting in 
the 6th decade (Fig. 6). Stimulation of motor nerves during maximum voluntary effort produced 
no additional force in the majority of the elderly men and women, indicating that these subjects 
remained able to utilize their descending motor pathways for optimal muscle activation. Therefore, 
a decrease in excitable muscle mass appeared to be entirely responsible for the lower strength in 
the elderly, a hypothesis that will be discussed below. Recently, McNeil et al.183 demonstrated 
that not only static muscle strength but also velocity-dependent muscle power (work over time) is 
substantially reduced with age. Age-associated decreases in velocity induced reductions in power 
that were two to three times the magnitude of 
losses in strength. In a large study including 
1030 subjects in the age range of 20-102 years, 
an age-related decline in knee-extension torque, 
handgrip strength, muscle power, and muscle 
thickness was found184. Reductions of strength 
were between 50 and 60% in the oldest (older 
than 85 years) compared to the youngest (20-29 
years old) age group for both men and women. 
Muscle power, however, dropped by about 75%, 
whereas calf muscle area was only 15 and 31% 
lower in the aged women and men, respectively. 
Low muscle strength and power were strongly 
associated with poor mobility, whereas a small 
calf muscle cross-sectional area (CSA) was a 
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Figure 6 Age-associated change of maximum voluntary 
dorsiflexor and plantarflexor torques, expressed as 
percentage of mean values for youngest group (20-30 
years). From Vandervoort and McComas182.
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weak predictor of mobility limitations.
The contractile properties of muscles from aged rodents for the most part parallel the findings 
of human muscle. Here, the contractile properties can be analyzed ex situ, in single muscle 
preparations. Arabadjis et al.185 showed that the peak twitch tension, rates of force development 
and relaxation are significantly lower in old than in young rat plantaris muscle. Brooks and 
Faulkner186 demonstrated that the maximum titanic force of m. soleus and m. extensor digitorum 
longus (EDL) of 26 months old mice were 78 and 73%, respectively, of the values for 9 months 
old mice. 
The majority of muscle strength loss in age can be accounted for by decreased muscle mass. 
Muscle volume and muscle cross-sectional area of humans have been measured by various 
indirect and direct methods. A number of ultrasound, computed tomography, magnetic resonance 
imaging (MRI), and direct cross-sectional studies have quantified the decline in skeletal muscle 
mass with age170,171,177,180,182,187-189. Muscle mass has been demonstrated to decrease by up to 40% 
between the ages of 20 and 70 years. Young et al.170,171 reported for example 25-35% reductions 
in the CSAs of the quadriceps muscles of older men and women compared with young controls 
using ultrasonographic imaging. Isometric strength of the quadriceps muscle was also reduced 
and a clear correlation of muscle thickness and strength has been found in the old subjects. 
Computed tomography scanning has shown similar results for the quadriceps and the biceps 
brachii muscles180,190. More recently, two studies used larger sample sizes and measured whole 
skeletal muscle mass instead of only some individual muscles. Gallagher et al.191 measured total 
appendicular skeletal muscle mass using dual-energy X-ray absorptiometry in 148 women and 
136 men between 20 and 90 years of age and found an age-related decrease in total appendicular 
skeletal muscle mass of 10-15%. Janssen et al.192 determined skeletal muscle mass in 468 men 
and women between 18 and 88 years of age using whole body magnetic resonance and found 
an age-related decrease in muscle mass of up to 20% after the end of the fifth decade. Frontera 
et al.181 accomplished a 12-yr longitudinal study on men initially 64 years old and measured the 
CSA of all thigh muscles, the quadriceps femoris muscle and flexor muscles by computerized 
tomography. A reduction of about 15 % in muscle CSA was found over the 12 years. Furthermore, 
this and other studies have shown a correlation between reduction in muscle mass and strength16
7,170,171,177,179,193,194.
Age-associated reduction in muscle mass has not only been observed in humans but also in rodents, 
although there has been considerable variability in this response between different studies. In an 
early report, Tauchi et al.195 showed a weight reduction of about 50% of the tibialis anterior muscle 
of 24 months old compared to 12 months old rats. Similar results were obtained from Tucek and 
Gutmann196. Muscle masses of EDL, soleus and diaphragm in 28 months old rats were reduced 
47, 56 and 19%, respectively compared to 9 months old animals. Soleus and EDL muscles of the 
rat have been extensively analyzed for age-related loss of mass in a number of studies. A decline 
in muscle mass of 10-30% in aged (24-30 months) compared to adult (8-12 months) animals has 
been observed197-201. However, the extent of the age-associated loss of muscle mass and the age of 
onset varies considerably between the different studies. This effect is due in part to the very wide 
range of ages used to represent old animals, and perhaps the confounding influence of pathology 
in the inbred strains typically studied in the past. More recently, survival curves for specific rodent 
strains have been used to more accurately describe the relative ages of the animals studied. In this 
respect, the Fischer 344xBrown Norway F1-hybrid rat has been shown to demonstrate progressive 
skeletal muscle atrophy with aging on a consistent basis202-205. The observed decline in muscle 
mass is very similar to the effects in humans in the analogical age-range.
Interestingly, the decrease in muscle strength in older subjects appears to be greater than the decrease 
in muscle CSA, suggesting that the quality of skeletal muscle or efficiency of muscle strength per 
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muscle mass is reduced with age166,180,183,186,194,206-208. Kallman et al.179 measured grip strength and 
muscle mass in 847 healthy humans, aged 20-100 years. Both cross-sectional and longitudinal 
results indicated that grip strength increases into the thirties and declines at an accelerating rate 
after 40. Grip strength was strongly correlated with muscle mass, but multiple regression analysis 
showed that grip strength is more strongly correlated with age than with muscle mass. Further 
analysis demonstrated that younger subjects were stronger and older subjects were weaker than 
predicted based on their muscular size. Thus, decline in muscle mass does only partially explain 
the loss of force seen with aging. This finding is supported by the study of Vandervoort and 
McComas182, reporting a significant decline of plantarflexor muscle strength relative to CSA in old 
(82-100 yr) compared to young (23-31 yr) men and women. The authors suggested that muscle 
denervation and increased amounts of connective tissue in the muscles of elderly subjects could be 
responsible for a specific decrease in excitable muscle mass. However, age-associated decline in 
specific force (force per muscle CSA) was also observed after correction of the CSA for increased 
amounts of non-contractile tissue in older subjects209. The change in muscle CSA accounted for 
only about half of the change seen in force production, suggesting a loss of contractile muscle 
quality. In another study, maximum voluntary force and CSA of the adductor pollicis muscle were 
compared in 53 young (19-55 years) and 39 elderly (72-90 years) subjects210. Despite both young 
and elderly subjects were able to fully activate their muscles, the specific force (voluntary force 
per muscle CSA) was 26% lower in the old group. Thus, the muscle weakness of old age did not 
appear to be due to reduced activation of the muscles. Findings from rodent studies resemble those 
from humans. Brooks and Faulkner186 found a specific force deficit of 22% for the EDL muscle 
of aged animals, suggesting a decline in muscle quality. However, the specific force of the soleus 
muscle did not change significantly in the observed age range, although the same tendency was 
noticed. An age-associated decrease in peak absolute force and specific tension (peak absolute force 
per CSA) was even demonstrated for single muscle fibers of aged (24-37 months) compared to 
adult (12 months) rats204. This finding was confirmed in more recent studies, reporting a reduction 
of specific force generated by single muscle fibers of the EDL, the soleus and the flexor digitorum 
brevis muscles of 26%, 19% and 37%, respectively in old (20-24 months) compared to young adult 
(2-6 months) mice211,212. However, these findings are challenged by a number of studies. Brooks 
and Faulkner213 did not find reduced specific force in single muscle fibers from EDL muscles of 
aged (27 months old) compared to adult (12 months old) mice. Thus, the age-associated decrease 
in muscle strength was not the result of an impairment of the intrinsic force-generating capacity 
of single muscle fibers. Similarly, age-related force deficits were not found in living fiber bundles 
and skinned fibers from EDL and soleus muscle of rats214. Changes in the muscle itself, either 
in the contractile proteins or in excitation-contraction coupling, appeared not to be responsible 
for the weakness in old age, which instead was likely due to changes in structures or processes 
external to the muscle, such as alterations in neuromuscular transmission. Together, a decline in 
absolute and specific force with aging is generally accepted, but the contribution of reduced force 
generation of single muscle fibers is still conversely discussed. The age-associated loss of specific 
force may not be simply explained by reduced force generation of single muscle fibers, although 
this may be a contributing factor. 
There have been extensive discussions about the mechanisms underlying specific force losses with 
aging. Contraction-induced injury215,216, appearance of denervated muscle fibers208 (see below), 
infiltration of fat and connective tissue (see below), decreased muscle protein synthesis rate166 (see 
below), age-related posttranslational modifications of contractile proteins217,218, and excitation-
contraction uncoupling (ECU)155,219 have been suggested to contribute to age-associated loss of 
muscle quality. 
Recent evidence supports ECU as a key factor explaining the discrepancy between age-related loss 
2
Introduction
of muscle mass and muscle strength. The uncoupling between excitation of the muscle and increase 
in myoplasmic Ca2+ concentration is thought to be responsible for ECU. It has been demonstrated 
that the peak intracellular Ca2+ evoked by sarcolemmal depolarization under voltage-clamp 
conditions in muscle fibers from old mice is significantly smaller than that recorded in fibers from 
middle-aged or young mice219. This substantial reduction in intracellular Ca2+ accumulation upon 
fiber activation leads to ECU, because the level of free cytosolic Ca2+ regulates muscle tension. 
Gonzalez et al.212 measured intracellular Ca2+ concentration and contractility simultaneously, and 
found a direct relationship between the decreases of both. Impaired Ca2+ mobilization following 
muscle excitation results in decreased muscle contraction. Two key molecules involved in 
intracellular Ca2+ handling and muscle contractility are the dihydropyridine (DHPR) and ryanodine 
(RyR1) receptors. The DHPR is a dihydropyridine-sensitive voltage-gated L-type Ca2+ channel that 
induces Ca2+ release from the sarcoplasmatic reticulum (ST) through the activation of ryanodine-
sensitive Ca2+ release channel (RyR1)220,221. The transduction of the trans-sarcolemmal potential 
into elevations in intracellular Ca2+ is a key event that induces muscle contractions. Absolute 
reductions in the number and/or function of the DHPR and/or RyR1 are potentially causing the age-
related impairment in intracellular Ca2+ mobilization in skeletal muscle. The number of DHPR and 
RyR1 expressed in mouse EDL and soleus muscles indeed decreases with age222,223. IGF-1 could 
play an important role in this process by modulating the expression of DHPR in skeletal muscle224. 
Transgenic overexpression of IGF-1 in skeletal muscles of mice resulted in increases in DHPR 
and RyR1 mRNA in young and old mice and prevented age-dependent decrease in intracellular 
Ca2+ in skeletal muscle fibers. Thus, specific force of single muscle fibers and the whole muscle 
could be maintained at older age at a level similar to young muscles212. Alternatively, reduced 
homoestatic capacity for intracellular Ca2+ movement may underlie ECU225. The dynamic nature 
of Ca2+ sparks seems to disappear in aged skeletal muscle, most likely due to the uncoupling of 
a segregated Ca2+ reserve from the normal EC process. A similar phenotype can be observed 
in mitsugumin-29 (MG29) mutant adult muscles. MG29 is involved in maintenance of muscle 
membrane ultrastructure and Ca2+ signaling and its expression is decreased in aged muscles, 
suggesting that MG29 is important in maintaining skeletal muscle Ca2+ homoestasis during aging. 
In summary, ECU may explain the decrease in skeletal muscle force, which can’t be attributed to 
muscle atrophy. ECU is most likely caused by age-dependent reduction in charge movement and 
peak cytosolic Ca2+, which are associated with decreased DHPR and RyR1 gene expression, and 
can be prevented by skeletal muscle IGF-1 overexpression. 
The loss of muscle quantity and quality is associated with a loss of function in task performances 
of daily living, such as basal movement in the upper extremities in hygiene and dressing activities, 
ability to rise from a stool, and stair climbing226. Bassey et al.227 demonstrated that leg extensor 
power correlated with multiple functional parameters, including stair climbing speed and walking 
speed. In agreement with this finding, there is a close correlation between loss of quadriceps 
muscle strength, loss of skeletal muscle mass, and slowing gait speed in frail institutionalized men 
and women over 86 years of age193. Similarly, Lauretani et al.184 found sarcopenia to be associated 
with low walking speed and the inability to walk at least 1 km without difficulty in a large study 
including 1030 persons. These functional impairments mean a loss of independence for many 
individuals suffering from sarcopenia.
1.4.3 Age-related morphological changes in skeletal muscles
Each skeletal muscle contains many contractile cells (myocytes) that are commonly referred to as 
muscle fibers. Skeletal muscle fibers can be categorized into several types on the basis of which 
isoform of the myosin heavy chain is expressed. Type I fibers, slow-twitch fibers, develop force 
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relatively slowly in response to activation and are characterized by an ability to sustain tension 
development over prolonged period of times. They are characterized by high oxidative capacity 
that is mediated by high mitochondrial density and by low glyocolytic capacity. Type II fibers, fast 
twitch fibers, are capable of faster contraction in response to activation. In humans, they can be 
further categorized into two types. Type IIx fibers contract very fast and produce high power but 
show low resistance to fatigue and low mitochondrial density. Type IIa fibers exhibit intermediate 
characteristics between type I and type IIx. Many other animals express a third subclass of type 
II fibers: type IIb fibers, which usually exhibit the fastest development of force in response to 
activation and exhibit the least resistance to fatigue during repetitive activation. Different fiber 
types express distinct myosin heavy chain isoforms. The ATPase of these myosin isoforms 
exhibit different stability towards acid- or alkali treatment, a characteristic that has been used for 
histological discrimination of the fiber types228,229. Cross-reinnervation experiments demonstrated 
that the fiber type is determined by the innervating motoneuron and that all fibers are principally 
capable of expressing all myosin isoforms230.
1.4.3.1 Loss of muscle fibers is a major pathologic characterstic of sarcopenia
Over the past three decades, it has become generally accepted that loss of muscle fibers is probably 
a major pathologic feature of sarcopenia231. The marked decrease in muscle fibers with advanced 
age has extensively been documented. Lexell et al.232 showed an age-related loss of muscle fibers 
in a comprehensive study of the whole m. vastus lateralis in 43 male cadavers at age between 15 
and 83 years. The number of fibers was reduced by about 50% over this age range. The decline 
in fiber number was already evident at the 
age of 30 years and increased progressively. 
After the age of 50 years, an average annual 
fiber loss of over 1% was registered (Fig. 7). 
All studies in humans indicate that muscle 
mass is well maintained throughout the fifth 
decade, but considerably and progressively 
diminishes thereafter.
Most of the knowledge about fiber numbers 
comes, however, from animal studies. In rats, 
two muscles of the lower extremities, the slow-
twitch soleus and the fast-twitch EDL muscle, 
have been extensively analyzed in regard to 
age-associated change in fiber numbers. 
Decreased number of fibers in the senescent 
soleus muscle has been constantly found in 
a large number of reports146,196,197,199,201,233-235, 
although the extent of fiber loss varied greatly 
between the studies. Overall, a reduction of about 10% in the number of fibers at the age of 24 
months and more than 30% at the age of 30 months has been reported. This appears to be less than 
in humans, which has been attributed to the reinnervation process that could be more effective 
in the smaller muscle of rats236. A minority of studies did not reveal a significant age-related 
decrease in fiber number of the soleus muscle, although such a tendency was noticed200,237. Age-
related decrease in the number of muscle fibers has also been reported to occur in the rat EDL 
muscle196,199 and has again be challenged by studies that have found a constant number of fibers 
during aging146,200,235,237. Finally, Wanagat et al.152 reported an age-related loss of 30 % of the fibers of 
the rat rectus femoris muscle and Tauchi et al.195 observed such a loss in tibialis anterior and psoas 
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Figure 7 Relationship between the total number of fibers 
in the vastus lateralis muscle and the age of men between 
18 and 82 years of age. The number of fibers does not 
change between 18 and 50 years of age, but decreases 
thereafter. By age of 80 years, the mean number of fibers 
drops to 50% of the number for younger men. Modified 
by Faulkner et al.236 from Lexell et al.232
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major muscles. Conflicting results and discrepancies are probably ascribable to variations between 
different strains and ages of the animals, as well as to methodological differences. Together, the 
vast majority of the studies indicate an age-related loss of fibers in different rat muscles. However, 
the extent of this fiber loss and muscle specific differences are not fully understood.
There are still ongoing discussions about the relative contribution of muscle fiber loss and atrophy 
to age-related decline in muscle mass. Both the number and thickness of individual muscle fibers 
can be reduced with age. However, individual muscle fibers have also been shown to undergo 
compensatory hypertrophy with aging, suggesting that a part of the muscle fibers have the abilities 
to grow in age. Hepple et al.238 reported that the mean fiber CSA of the soleus muscle was actually 
increased in aged compared to adult rats. Hypertrophy of muscle fibers can also be induced with 
physical exercises in young and aged people (see below). Even when age-related fiber atrophy 
is diminished after physical exercises, age-associated loss of muscular strength can be observed. 
Thus, the strength decline in age may not primarily be due to muscle fiber atrophy but due to 
muscle fiber loss. Fiber atrophy could be introduced by non-functional, degenerating fibers or 
could be secondary to age-related decrease in activity, potentially caused by developing sarcopenia. 
Nevertheless, the impact of fiber atrophy may be quite severe, especially without exercising. Daw 
et al.199 analyzed soleus and EDL muscles of 27 months old rats and found that the fiber numbers 
declined with age only by 5.6 and 4.2%, respectively. Muscle masses, however, were decreased 
17 and 30%, respectively. The authors concluded that the loss of muscle fibers could account at 
most for about 25% of the observed skeletal muscle atrophy.
1.4.3.2 Fiber type specific alterations in aged skeletal muscles
It is generally agreed that the averaged size of type II fibers is considerable reduced with increasing 
age in humans, while the size of type I fibers remains more or less unaffected232,239-245. Coggan 
et al.240 reported for example a reduction of 13-31% in type IIa and type IIb fiber areas in the 
gastrocnemius muscle of older men and women compared to young adults, whereas the area of 
type I fibers remained constant.
The proportion of type I and II fibers was extensively analyzed for age-related change. Here, the 
situation is less clear. Based on early studies of muscle biopsies from humans, a preferential loss 
of type II fiber with aging was postulated242,243,246,247. These findings have been challenged in other 
biopsy studies that have not found a type I preference in senescent muscles239,248,249. However, a 
muscle biopsy sample consists of, at most, several hundred out of thousands muscle fibers that form 
a muscle, and the sample-to-sample variability of fiber type with this method of analysis is well 
established and may explain the conflicting results. Therefore, a single biopsy is a poor estimator 
of the fiber type proportion of a whole muscle250. Finally, an exhaustive analysis of cross-sections, 
using whole muscle taken from human cadavers, did not reveal a preferential loss of type II fibers, 
although such a tendency was observed232. However, there is considerable variability between 
individuals of similar ages; for example, some individuals have large type II fibers, while others 
have a high proportion of type II fibers. Together, both type I and type II fibers may be equally lost 
in humans. However, the relative type I area is increased, due to selective type II fiber atrophy.
In animal studies, predominant reduction of type II fiber thickness has also been observed. Alnaqeeb 
and Goldspink237 found a significant decline in the CSA of type II fibers in soleus between rats aged 
10 months and 24 months, but no reduction in size of type I fibers. In the rat plantaris muscle the 
CSA of type II fibers declined 37% and the type I fibers only by 21% between ages of 9-10 months 
and 28-30 months251. In contrast to humans, an increase in the relative number of type I fibers in 
aged rodents is generally accepted. Several studies reported an increase in type I fiber proportion in 
the soleus muscle of aged rats146,201,234,235,252-255. Thereby, studies using myofibrillar ATPase staining 
or type specific MHC antibodies were in close agreements. Larsson and Ansved256 showed that the 
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mean percentage of type I fibers in the soleus muscle increased from 71 in 2-month old rats to 98 in 
those 12 months old or older, based on myofibrillar ATPase staining characteristics. Consequently, 
a clear age-associated reduction in the number and proportion of type II fibers was noticed. Age-
associated type I fiber preference was also observed in the diaphragm, tibialis anterior, rectus 
femoris muscles, but not in the EDL muscle, which contains only a very low number of type I 
fibers200,234. Recently, age-related increase in the proportion of type I fibers has also been found 
in the medial gastrocnemius muscle of rats257. Together, the majority of studies about a variety of 
rodent muscles reports the accumulation of type I fibers in senescence. However, the extent of the 
fiber type rearrangement is poorly understood. Conflicting results between different studies do 
not allow a clear readout. Eddinger et al.200 summarized the fiber type composition of different rat 
muscles, which had been presented in a large number of distinct studies. The percentage of type I 
fibers in the soleus muscle of adult male rats, for example, varies between 66 and 90%, depending 
on the strain and the experimental method. With this differences in mind, it is not surprising that 
the results concerning age-related changes in fiber type composition vary considerably. 
Several ideas have been proposed to explain the apparent reduction in the proportion and 
thickness of type II muscle fibers with aging. Central to these ideas is the hypothesis that some 
characteristics of type II fibers render them more susceptible to aging-induced processes, resulting 
in their preferential loss or atrophy. For example, mitochondrial dysfunction, which arises from 
the accumulation, over time, of mitochondrial DNA damage as a result of oxidative stress, leads 
to fiber atrophy in rats152. The lower mitochondrial volume of type II fibers could render such 
a cell more susceptible to death via mitochondrial dysfunction mechanisms153. Another aspect 
is the transformation of type II to type I fibers, which could contribute to the increase in the 
proportion of type I fibers. This process includes the denervation and subsequent reinnervation and 
reprogramming of muscle fibers and results in fiber type grouping, processes that can be observed 
in aged muscles (see below). Reinnervation by type I motoneurons may occur more often than 
reinnervation by type II motoneurons, resulting in an increase in type I fibers. Different stabilities 
of the motoneurons as well as the corresponding NMJs towards age-associated degeneration 
processes could be the reason. An alternative hypothesis is independent of innervation: Vaughan 
et al.258 speculated about an influence of androgens on the percentage of type I fibers, since this 
percentage was higher in female than in male mice, but was similar between castrate males and 
females. Interestingly, even castration at an age of 4 month, an age by which the “male” pattern 
of fiber types should have been fully established, resulted in a significant increase in type I fibers. 
It therefore appeared that continuously high androgen levels are required to maintain the low 
proportion of alkali-labile type I fibers. With age, levels of androgens are decreased in both males 
and females259-261, potentially inducing an increase in type I fibers. 
1.4.3.3 Age-associated fiber type grouping implies neuropathological processes
The light microscopical observation of groups of histochemically similar muscle fibers, 
referred to as fiber-type grouping, is commonly considered to be evidence of a denervation and 
reinnervation process affecting the spinal motor neurons or the peripheral nerves (Fig. 8a). In 
healthy muscles, the two fiber types are randomly arranged, and the term mosaic is commonly 
used. The occurrence of large groups of fibers with the same histochemical properties provides 
evidence of a neuropathological process (Fig. 8b).
Muscle fibers belonging to one motor unit have similar structural and functional properties and 
intermingle with fibers of other motor units. Denervation of muscle fibers, resulting from motor 
neuron death, from irreparable damage to peripheral nerve axons, or eventually from deterioration 
of the NMJ, is followed by the growth of fine sprouts from nearby axons. When these sprouts 
establish new contacts with the denervated fibers (reinnervation), the size of the remaining motor 
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units can increase more than tenfold. When reinnervation occurs, muscle fibers completely adapt 
to the functional demands mediated through the new nerve. For example, if denervated type II 
fibers are reinnervated by type I neurons, they are transformed to type I fibers. A progressive 
denervation and reinnervation process may in this way ultimately change the arrangement of fiber 
types and so cause the clustering referred to as fiber type grouping. Thus, fiber type grouping is 
used with other histological features (angulated fibers, grouped atrophy, etc.) as evidence of an 
underlying continuous neurogenic disorder. 
Early studies suggested that aging is associated with fiber type grouping198,241,245,247,262-264. However 
a statistical method to analyze fiber type grouping was not available. Lexell and colleagues adopted 
the measure of counting the number of enclosed fibers262 and developed a statistical method to 
assess fiber type grouping using a model based upon hexagonal-shaped fibers265. They found 
increased type grouping with age in three groups of men at the age of 24, 52 and 77 years266. For 
the old group, the proportion of fascicles with a significant number of enclosed fibers (21%) was 
greater than the proportion for the middle (6%) and the young group (6%). Increasing age affects 
the fiber type arrangement, leading to an increased occurrence of enclosed fibers. This finding 
was confirmed, using an improved statistical and analytical method267. This method allowed the 
calculation of the expected number of enclosed fiber, when a random distribution was assumed. 
Thereby the influence of the fiber type proportions and positions were considered. Comparison of 
Figure 8 (a) Schematic illustration of the process of fiber type grouping. Muscle 
fiber denervation (arrow) and reinnervation, with the subsequent fiber-type 
transformation leads to the change in the arrangement of fiber types known as 
fiber-type grouping. From Lexell et al.640 (b) Small parts of whole cross-sectioned 
autopsied vastus lateralis muscle from a healthy young man showing the two fiber 
types, type 1 (lightly stained) and type 2 (heavily stained), in a mosaic pattern 
(top), and a young man with spinal muscular atrophy, showing excessive grouping 
of both fiber types (bottom). Stainings for myofibrillar ATPase at pH 9.4. From 
Lexell and Downham267. (c) The measures T1 and T2 of the arrangement of type 
1 and type 2 fibers for the vastus lateralis muscle from 24 men plotted against age with the cubic regression line 
(continuous line) and 95 % prediction interval (dashed lines). Fiber type grouping, represented by positive T values, 
can be observed beyond 60 years of age. From Lexell and Downham267.
a b c
2
Introduction
the expected and the counted number of enclosed fibers gave the possibility to make a statement 
about the randomness of the fiber type distribution. Using this method, it has been shown that in 
the vastus lateralis muscle of persons up to 25 years of age, the fiber types are segregated. From 
the ages of 30 to 60 years, fiber types are randomly arranged and above the age of 60 years, fibers 
of both types are grouped (Fig. 8c).
Edström and Larsson146 used another method to determine muscle fiber rearrangements in the old 
motor units of the rat. Soleus muscle fibers belonging to a motor unit were identified using the 
glycogen depletion. The principle of this method is to repeatedly stimulate a single motor unit 
until the fibers are depleted of glycogen. These fibers are then mapped as unstained fibers in PAS 
(periodic acid-Schiff reagent)-stained sections. To assess the randomness of the fiber arrangement 
the muscle was divided into eight territories, which should contain equal numbers of depleted 
fibers. The mean difference between measured and predicted numbers of fibers in the eight 
sectors of the motor unit territory was calculated in young (3-6 months) and old (20-24 months) 
rats. In the fast-twitch units, these differences were not affected by age, whereas in the slow-
twitch unit the differences were increased in the old compared to the young animals, indicating 
a rearrangement of the muscle fibers in the old slow-twitch motor units. These findings confirm 
previous morphological studies of muscles from old individuals in which indirect or direct signs 
of a neurogenic process have been presented. Type grouping does not occur in aged long-term 
denervated muscle, confirming that the grouping in old skeletal muscle is a sign indicative of 
denervation and reinnervation processes under control of the nervous system268.
The collected evidence strongly indicates that the muscle fiber population undergoes continuous 
denervation and reinnervation with increasing age. The etiology of denervation is considered 
to involve motor neuron death, irreparable damage to peripheral nerve axons, or, eventually, 
deterioration of the NMJ. This age-related progressive neurogenic process must be a major 
contributor to the gradual loss of fibers with increasing age.
1.4.3.4 Increase in heterogeneity of fiber thickness indicates coincidental hypertrophy and 
atrophy in sarcopenic muscles
As early as 1968 an abnormal degree of variation in fiber CSA has been observed in muscle biopsies 
of elderly subjects263. Later, an age-associated increase in the heterogeneity of fiber thickness 
was confirmed in numerous studies in humans, rats, and mice175,198,237,244,269,270. The proportion of 
both, severely atrophied and hypertrophied muscle fibers is increased in senescent muscles and 
contributes to the picture of increased heterogeneity of fiber thickness. Recently, Hepple et al.238 
showed differences in the age-related alterations of fiber sizes between individual skeletal muscles 
of aged rats. Atrophied muscles were found both in the gastrocnemius, a locomotor muscle, and 
in the soleus, a postural muscle. Hypertrophied fibers, however, were only observed in the slow 
region of the gastrocnemius and in the soleus muscle. Frequency histograms underscored the 
increase of heterogeneity with aging, as they demonstrated the presence of both atrophied and 
hypertrophied fibers in soleus muscle, and atrophied fibers in gastrocnemius muscle in aged 
compared to young animals. Interestingly, the atrophied fibers of the soleus muscle exhibited a 
reduction of subsarcolemmal mitochondrial staining, an observation suggesting the denervation 
of these fibers. Denervation may result in atrophy of the corresponding fibers due to the loss of 
neuronal input. Functionally innervated fibers, on the other hand, may undergo hypertrophy to 
compensate for the loss of contractile area. This compensatory effect is likely to correlate to the 
load on the muscle. The use of a locomotor muscle, such as the gastrocnemius, might be reduced 
in age, as reduced physical activity is a common and often observed consequence of aging. 
Decreased physical activity does not reduce loading on a postural muscle, such as the soleus, to 
the same extent. Therefore, compensatory hypertrophy may be more pronounced in soleus than in 
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gastrocnemius muscle.
1.4.3.5 Accumulation of angular and central nucleated muscle fibers and infiltration of 
non-contractile tissue in aged muscles
Further histological features of skeletal muscles in old age have been described in a number of 
early papers262-264. Grouped atrophy, fiber splitting, centrally located nuclei, areas of focal necrosis 
with infiltration of macrophages, and replacement of muscle fibers by connective tissue or by fat 
has been observed in muscle biopsies of aged subjects. Tomonaga245 described several neuropathic 
and myopathic changes in senile human skeletal muscle. Neuropathic changes included small, 
angulated fibers, type grouping, grouped atrophy, target fibers, and nuclear clumps, whereas 
myopathic changes included central nuclei, necrosis, phagocytosis, and interstitial fibrosis. The 
neuropathic changes were found to predominate, and thus, denervation processes were suggested. 
Increased occurrence of angulated atrophic fibers was found in both aged EDL and soleus muscle 
of the rat, together with central nucleation of muscle fibers and fiber splitting197,198. Angular fibers 
are considered to be evidence for denervation158,197, suggesting the denervation of muscle fibers as 
pathogenic mechanism underlying age-related fiber loss. Myopathic changes, such as centralized 
nuclei, could be reactions of the muscle to the denervation induced muscle degeneration. In human 
anterior tibial muscle, the frequency of central nucleated fibers increased form 1.1% to 10.3% in 
elderly compared to young subjects242. In rat soleus muscle, the number of centrally located nuclei 
per 100 fibers increased from about 2 in 6-month-old animals to more than 12 in 32-months-old 
animals271. Centrally nucleated fibers are commonly recognized as regenerated fibers, since newly 
formed muscle fibers have central nuclei272. Thus, a regeneration reaction of the muscles to the 
aging-induced loss of fibers can be assumed. The infiltration of fat and connective tissue, replacing 
muscle tissues might be a result of fiber atrophy and the ongoing degeneration and regeneration 
process167,190,197,273. Kent-Braun et al.274 quantified contractile and noncontractile contents of the 
leg anterior compartment. Young adults had larger contractile areas and smaller absolute and 
relative noncontractile areas than older subjects. The content of noncontractile tissue increased 
from 6% in both young women and men to 13.9 and 15.9% in older women and men, respectively. 
A 2- to 3-fold increase in intramuscular noncontractile content in older adults was also found in 
the quadriceps190,209,275, in the hamstrings190 and in the elbow extensors and flexors189. Age-related 
increase in endomysial connective tissue of the soleus and EDL muscles has also been observed 
in rats198,276. Perimysial connective tissue, in contrast, remained constant throughout life. 
In summary, different neuropathic and myopathic changes can be observed in aged skeletal 
muscles. Predomination of neuropathic changes suggest that degenerative changes of muscle fiber 
innervation could induce the pathogenic process resulting in sarcopenia. Myopathic changes might 
represent muscle intrinsic reactions to the neurogenically induced atrophy or loss of myofibers.
1.4.4 Fiber regeneration and de novo generation in adult and aging skeletal muscle
The number of muscle fibers an adult will have is largely determined during prenatal development 
by the process of myogenesis. Mesodermal germ cells differentiate into myoblasts, which fuse 
and form myotubes. Myotubes then differentiate into mature muscle fibers. This process is largely 
complete before birth. Muscle growth between early childhood and adulthood occurs exclusively 
by increase in thickness of the individual muscle fibers. Skeletal muscle fibers are postmitotic, 
thus loss of fibers, for example due to aging, should result in a permanent reduction in the number 
of fibers. However, it is now well established that skeletal muscle contains mitotically competent 
cells that contribute not only to muscle fiber hypertrophy in response to physiological overload but 
also to the regeneration of muscle fibers after other types of damage. These mitotically competent 
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cells are referred to as satellite cells277. They are mononucleated and located between sarcolemma 
and basement membrane of terminally-differentiated muscle fibers. Satellite cells determine 
the regenerative capacity of skeletal muscle after injury, surgery or in neuromuscular diseases 
involving muscle degeneration such as muscular dystrophies. Among the parameters involved 
in muscle regeneration, the number of satellite cells, their proliferative capacity, and the speed at 
which the general response to injury is induced all influences the recovery. 
Whereas fiber number is known to decrease with aging, the extent to which fibers are regenerated 
after age-related loss is unclear. Obviously, if regeneration occurs, it is not enough to keep up with 
the loss. In adult mammels, induced myocyte necrosis, for example by injection of bupivacaine, is 
followed by regeneration. Bupivacaine injection causes dissolution of the sarcolemma that leads 
to rapid fiber necrosis but does not affect basal laminae, satellite cells, intramuscular nerves and 
blood vessels. Interestingly, regeneration after injury restores a very similar number of muscle 
fibers as were present before necrosis, suggesting that myocyte number is tightly regulated278. 
Thus, with aging, the regulation of myocyte number itself or the capacity for regeneration becomes 
compromised. The later could for example be caused by reduced number or reduced proliferative 
potential of satellite cells as well as impaired activation and incorporation of satellite cells into 
myotubes, or unsuccessful innervation of newly generated myotubes.
Satellite cells proportion were estimated at 15 % of all myonuclei at birth, 6-10% at 2 years of 
age, and only 4% in the adult157,279,280. For aged subjects, this value varied between 0.6 and 3.4% 
in independent studies157,280,281. Decreased number of satellite cells was accompanied by increased 
number of myonuclei per muscle fiber in elderly subjects282. This finding suggests increased 
incorporation of satellite cells into myofibers without adequate restorage of the reserve pool. 
However, telomere lengths, an indicator of the regenerative history, were not changed, suggesting 
that there is only a limited incorporation of new myonuclei originating from satellite cells during 
normal aging157. The decrease in numbers of satellite cells could be due to a continued low level 
turnover of the satellite cells, which occurs during normal growth and repair, and which exhaust 
the proliferative capacity of some of these cells. Consequently, they can no longer be activated 
and the size of the reserve pool would decrease. An exhausted pool of satellite cells was also been 
demonstrated in long–term denervated muscles. The percentage of satellite cells increased at 2 
month of denervation, but substantially decreased thereafter268,283. 
Therefore, in concert with reduction in number of satellite cells with age, decreased proliferative 
potential has been expected. Indeed, age-related decline in satellite cell proliferative potential has 
been reported284,285. Under identical in vitro conditions, the ability of satellite cells to proliferate and 
form colonies was inversely proportional to the age of the donor animals. Thus, a possible limited 
proliferative capacity of satellite cells of senile animals must be considered as a contributory factor 
to atrophic changes in the skeletal muscle. However, the main difference in proliferative potential 
was seen between cells from young (6-30 days) and adult (3 months) and not between cells from 
adult (3 months) and aged (30 months) rats. Moreover, a decline of the proliferative potential 
of satellite cells isolated from donors of increasing age has not been found in other studies286,287. 
Satellite cells isolated from adult human quadriceps muscles independent of age were always able 
to make between 15 and 20 divisions157. However, satellite cells from older donors took longer to 
grow out from the explants. Dodson and Allen288 reported that the rate of proliferation in satellite 
cells did not appear to be depressed with advancing age, and they suggested that cells from old 
animals rather differ in the length of the lag phase of growth in culture and might therefore be 
less response to agents that activate them. Together, if there is a reduced proliferative potential in 
aged compared to adult satellite cells, it may be rather small. Nevertheless, reparative processes 
in severely injured muscles are markedly impaired in old rats compared to adult animals in regard 
to both the rate of regeneration and the amount of muscle replaced. Recovery after bupivacaine 
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injection or hindlimb unloading is slower and markedly impaired in aged rats284,289. However, a 
slight depletion of the satellite cell population combined with a minor reduction in its proliferative 
activity may not or not alone be accountable for the insufficiency of the reparative response in 
skeletal muscle of senescent animals.
Activation of satellite cells and differentiation into myotubes could also have an effect on 
the regeneration ability of aged muscles. Myoblasts derived from old satellite cells might not 
differentiate and fuse as well as those from young adult satellite cells290. Recently, it has been 
demonstrated that satellite cells isolated from skeletal muscle of aged rats exhibit decreased 
differentiation into myotubes compared with those isolated from young rats291. Conboy et al.292 
reported that the impaired regenerative potential in response to injury in aged mice is due to an 
impairment of activation rather than a decline in number of satellite cells. Quantification of the 
number of purified satellite cells isolated from hindlimb muscles of young (2-4 months) and 
old (23-24 months) mice by FACS (fluorescence-activated cell sorting) didn’t reveal significant 
differences. Experimental modulation of Notch signaling, which plays a critical role in satellite cell 
activation and adult muscle regeneration293 dramatically affected muscle regeneration in young and 
aged muscle. Inhibition of Notch signaling reduced the regenerative potential in response to injury 
in adult mouse muscles. Bromodeoxyuridine (BrdU) incorporation into nascent myotubes and 
formation of myotubes was reduced. Activation of Notch signaling, on the other hand, promoted 
BrdU incorporation and regeneration in old muscle to a level observed in adult muscle. Thus, the 
impaired regenerative potential of old muscles can be, at least partially, attributed to an impaired 
activation of satellite cells. More recently, this effect was confirmed in a model of parabiosis 
where young and old mice had a shared circulation294. Exposure of old muscle to the blood supply 
of a young mouse restored the regenerative potential that was normally impaired in senescence. 
The efficacy of muscle regeneration was increased without recruitment of young cells from the 
shared circulation. The authors concluded that the parabiosis restored the activation of Notch 
signaling and sequentially the activation of satellite cells in aged muscles. In summary, impaired 
activation of satellite cell in response to introduced injury appears to be partially accountable for 
the decreased reparative reaction of aged muscles.
Results obtained in cross-age transplantation experiments also demonstrated that there are 
sufficient cellular reserves to allow old muscles to regenerate as well as young ones if they are 
both placed in comparable environments. EDL muscles from 24-months-old rats were grafted 
into the bed of EDL muscles from 4-months-old hosts, and the EDL muscles from the young 
rats were transplanted into the EDL beds of the old rats. Measurements of in vitro contractile 
properties on the cross-age grafts as well as the same-age controls on the collateral limbs showed 
that the old-into-young grafts regenerated almost as well as young muscle autografts, whereas the 
young-into-old grafts regenerated no better than the old-into-old controls. Moreover, muscle mass 
and histological appearance was similar between old-into-young grafts and young autografts and 
between young-into-old grafts and old autografts, respectively295,296. Even the muscle of an old rat 
showing evidence of hind-limb neuropathy regenerated to almost control level after transplantation 
into a young host. These results suggest that old muscles have the intrinsic capacity to regenerate 
well and that the host environment in which the graft develops is the major determinant of the 
success of regeneration. Among the factors in the host environment that could account for the 
level of muscle fiber regeneration, innervation is important, because muscle grafts must become 
innervated by motor nerve fibers regenerating from host nerves. Further experiments have shown 
little difference in the success of muscle regeneration between young and old rats in either 
absence of innervation or the presence of full innervation297. Thus, it is likely that the success 
of skeletal muscle regeneration in old animals is, to a large extent, determined by the success of 
axonal regeneration of the nerve fibers that will ultimately supply the transplanted muscles or, 
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eventually, by the formation of the nerve–muscle contact. Even a reduced satellite cell population 
in aged animals is sufficient to repair a damaged muscle to near control levels of mass and force if 
conditions for regeneration are favorable, like for example muscle fiber damage without damage 
to the motor nerve supply or cross-age transplantation into young hosts295. Advanced age itself 
does not appear to limit the regenerative potential of skeletal muscle. Grounds298 concluded that 
the overall regenerative capacity of satellite cells is not impaired in old muscles, despite the fact 
that the proliferative response of these cells becomes retarded with aging. However, the success 
of muscle fiber regeneration depends not only on adequate satellite cell population, but also on 
adequate innervation to complete the regenerative process299.
Moreover, impaired regenerative response to introduced injury in aged animals does not necessarily 
mean that impaired regeneration is responsible for sarcopenia. In contrast, it has been recently shown 
that sarcopenia is not due to lack of regenerative drive300. The initial drive to regenerate myofibers, 
based on density of cell nuclei, occurrence of aberrant fibers, fibers expressing embryonic myosin, 
expression of myogenic regulatory factors, and level of IGF-1, is mostly marked in cases with the 
most advanced loss of muscle mass. Thus, the regenerative drive is not decreased, but increased 
in sarcopenia. This striking regenerative phenotype in sarcopenic skeletal muscle reflects a tissue 
in a state of continuous repair. BrdU incorporation experiments showed that age-associated loss of 
muscle mass is accompanied by increased myonuclear density that involves fusion of proliferative 
satellite cells271. This clearly implicates ongoing regeneration in aged muscles. The reaction to 
hindlimb suspension and consecutive reloading then showed an impaired regeneration in old 
compared with young animals. An increase in proliferative myofiber nuclei (incorporated satellite 
cells) was only observed in young animals, indicating impaired regeneration after unloading in 
aged animals. The aged muscle appears to already be in a state of regeneration and hence, does 
not react to injury cues that induce regeneration. However, that does not necessarily emphasize 
that impaired regeneration induces sarcopenia. Important may rather be the events that induce the 
regenerative phenotype in aged animals and prevent the regeneration from being successful.
Furthermore, it has been demonstrated that the difference in satellite cell number between 
young and old rats disappears after activation of the satellite cell by 2-month of denervation. 
The number of satellite cell was significantly increased and reached similar levels in both young 
and old animals after denervation301. Thus, aging does not repress the capacity of satellite cells 
to become activated and grow in response to denervation. In contrast to experiments in which 
the reparative response of satellite cells in aged muscle was initiated by the death of associated 
muscle fibers by, for example, bupivacaine injection, the response of satellite cells to denervation 
appears not to be reduced in age. Stimulation of satellite cell response by denervation may be 
more relevant for sarcopenia than introduced injury. Advanced age itself does not appear to be 
a key factor that limits the regeneration potential of satellite cells in senescent muscle under 
a condition in which reparative processes are triggered by muscle fiber denervation. Multiple 
lines of evidences suggest that sarcopenia represents such a condition (see below). Furthermore, 
sarcopenia is associated with an increase in muscle fiber heterogeneity, which depends on atrophy 
and hypertrophy of fibers238. Induction of skeletal muscle hypertrophy involves the addition of 
newly formed myonuclei via the fusion of satellite cells to the adult myofiber302. Irridation that 
causes reproductive death of satellite cells prevents compensatory hypertrophy in response to 
increased skeletal muscle loading303,304. Therefore, skeletal muscle hypertrophy in aged muscles 
exclude a general failure of satellite cell metabolism.
In summary, aging may influence the number of satellite cells and probably their initial response to 
an activating stimulus, but the intrinsic overall growth potential of the entire satellite cell population 
in response to denervation appears to remain similar in young and old skeletal muscle, regardless 
of their local and systemic environment. However, regeneration is not successful in aged skeletal 
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muscles, as the age-related loss of muscle mass can’t be prevented. Impaired final maturation of 
regenerated myofibers into fully functional fibers could be responsible for the unsuccessful pattern 
of regeneration. Sarcopenic muscle seems not to be in a state of poor responsivness, but the aged 
motoneurons are less successful than adult motoneurons in innervating denervated muscle fibers147. 
In agreement with this hypothesis, myogenesis in long-term denervated muscle is abortive and 
does not lead to the formation of normal muscle fibers, despite activation of satellite cells305. Thus, 
innervation is of essential importance to form muscle fibers from activated satellite cells. Satellite 
cells from denervated muscles have been shown to undergo phenotypic modulation, including 
resistance to recruitment into the mitotic cycle and a robust extension of the nonproliferative 
compartment306. These characteristics of satellite cells deprived of neural influence may account 
for the inability of denervated muscle to fully regenerate.
1.4.5 Disruption or deterioration of the neuromuscular connection
Multiple lines of evidence indicate that changes in the neural activation of muscle significantly 
contribute to the progressive muscle weakness that is a hallmark of advancing age. Changes in 
the structural integrity of neuromuscular innervation, functional changes such as decreases in 
neurotransmitter release, and changes in motor unit size and other properties have been observed 
in many skeletal muscles in several animal species with advancing age. The cellular mechanisms 
underlying progressive structural and functional changes in neuromuscular innervation have 
remained elusive. Disruption of the neuromuscular connection can be caused either by loss of the 
innervating motoneuron or by deterioration of the NMJ. The loss of a motoneuron results in the 
denervation of the muscle fibers of the entire motor unit, whereas the deterioration of the NMJ 
only denervates an individual muscle fiber and may leave the other muscle fibers innervated by the 
same motoneuron intact. Investigations on motoneurons and NMJs indicate that both degeneration 
of motoneurons and deterioration of NMJs might contribute to age-associated denervation and 
subsequent muscle atrophy.
1.4.5.1 Age-related increase of denervated muscle fibers
The loss of muscle mass may be secondary to age-related denervation of muscle fibers. Denervation 
removes the trophic influence on the fiber and leads to atrophy. The mass of a muscle declines 
rapidly, falling to less than half its original weight within a month of denervation307. Experimental 
studies of total sciatic section in the rat have essentially contributed to the knowledge of the 
effects of long-term denervation of mammalian skeletal muscle283,308,309. The mass of the affected 
muscles falls rapidly within 5 to 7 days of denervation and declines further to 30-50% of control 
weight in succeeding weeks310-312. After several months, muscle weight remains constant at 5-20% 
of control268,313. Individual fibers show reduction of 70% in CSA over a period of months, and over 
90% in the longer term314,315. Initially type II fibers are more susceptible to atrophy than type I fibers, 
but over prolonged periods the fibers atrophy to a similar extent316-318. This reduction in fiber CSA 
is accompanied by a progressive increase in interstitial collagen and fat. The number of myonuclei 
per muscle fiber is also declining in respond to denervation and may contribute to the shrinkage in 
thickness of the multinucleated muscle fiber. Interestingly, the number of muscle fibers appears not 
to be changed even after prolonged time of denervation of up to 7 months283. Contradictory to this 
finding, a decrease in the number of fibers after 9 month of denervation has also been reported319. 
However, the authors suggested that the fiber count was an underestimate due to the small size 
of many fibers, which made it difficult to identify them under the light microscope. Interestingly, 
electrical stimulation of denervated fibers restored the initial number of fibers. In several studies, 
necrosis and evidence of regeneration has been found after prolonged time of denervation up to 
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several months268,313,319. Thereby, newly formed fibers appear not to undergo complete maturation, 
possibly due to the absence of innervation. Ultrastructurally, atrophic muscle fibers exhbit evidence 
of disorganization, including loss or misalignment of sarcomeres, dissociation of the T system and 
sarcoplasmic reticulum, and alterations in the sarcomeric location of mitochondria320,321. Effects 
of denervation on the NMJ include a complete disappearance of nerve terminals in 24 hours85. 
Postsynaptic AChR aggregates, however, persists over a long period of time. After 10 weeks of 
denervation of the rat thyroarytenoid muscle 70.5% of AChR clusters were preserved. Moreover, 
denervation does not prevent the normal growth-related increase in AChR number, at least for 
short periods322. A number of studies reported a spread of AChRs over the muscle membrane after 
several days of denervation that resulted in an increase of the sensitivity of the muscle to ACh323. 
This denervation supersensitivity is due to an increase in extrajunctional receptors following 
increased AChR synthesis and not due to a relocation or dispersal of junctional receptors, since 
a decline in junctional AChRs has not been found86. Consequentially, electrical stimulation of 
denervated muscle can suppress the denervation-induced synthesis of extrajunctional AChRs323,324. 
Ultrastructurally, denervation changes included shallowing of the synaptic cleft and decrease in 
number of secondary folds, alterations that were completely reversible after reinnervation325. 
Corresponding to these morphological changes force-generating capacity diminishes in respond 
to denervation. Long-term denervated rat muscles develop only 10% of tetanic force of a normally 
innervated muscle. This loss is usually accompanied by a reduction in specific force that may 
reflect the disorganization at the ultrastructural level. In humans, chronic denervation of muscles 
as a result of injuries to spinal cord or peripheral nerves induced marked loss of muscle mass and 
CSA and increase in overlying fat326. Recently, the effect of denervation of the tibialis anterior 
muscle has been studied in rabbits327. Muscle morphology was examined at 10, 36 and 51 weeks 
after denervation by selective section of motor branches of the common peroneal nerve. Muscle 
mass and CSA were reduced by 50-60% and tetanic force by 75%, with no apparent reduction 
in specific force. The loss of mass was associated with atrophy of type II fibers and increase in 
fibrous and adipose connective tissue. The muscles denervated for 10, 36, or 51 weeks showed no 
significant differences. Evidence of necrosis or regeneration was not found and the total number 
of fibers stayed constant. In agreement with this observation, reinnervation of denervated muscles 
after nerve crush reconstitute to initial morphology of the muscle in regard to mass and fiber 
diameter328. The atrophied fibers are able to extend to their initial size after regaining motoneuronal 
input.
Together, denervation introduced muscle atrophy shares some features with sarcopenia, including 
loss of mass, strength and CSA, increase in intramuscular noncontractile tissues, selective type II 
atrophy and, eventually, regeneration. Thus, the pathogenic mechanism leading to sarcopenia may 
include denervation of muscle fibers. Interestingly, partial denervation more closely resembles 
the aging phenotype. Partial denervation of rat plantaris muscle resulted in precocious aging-
like changes329. Compensatory hypertrophy, angulated fibers, type grouping and grouped atrophy, 
increased level of axonal sprouting and degenerating NMJs have been observed 6-12 months 
postsurgery. The possibility of reinnervation in partial denervated muscles appears to be essential to 
induce a sarcopenia-like phenotype. Therefore, reinnervation of denervated muscle fibers appears 
to be a process that essentially contributes to the characteristic histophathological phenotype of 
sarcopenia. In agreement with this finding, extensive denervation accelerates the development of 
sarcopenia.
Corresponding to a role of denervation in sarcopenia, the proportion of muscle fibers that are 
denervated at a given time has been demonstrated to be considerably increased in old skeletal 
muscles. The expression of the neural cell adhesion molecule (NCAM), a marker for denervated 
muscle fibers, was anlayzed on skeletal muscle cross-sections208. 8% of the muscle fibers of old 
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rats were in a denervated state. In contrast, young rats exhibited only 1% of the fibers of the same 
muscle to be denervated. These observations indicate that muscle denervation and reinnervation 
is a lifelong process that is enhanced at old age. About 15% of the observed deficit in specific 
force can be explained by the presence of non-innervated muscle fibers. Larkin et al.257 similarly 
found an increase of NCAM positive fibers from 2% in 12-month old to 4% in 24-month-old rats. 
Additionally, they found a relative increase in type I fibers and fiber type grouping, indicatives of 
reinnervation processes. Interestingly, nerve-repair grafting resulted in similar changes than aging 
in regard to fiber type composition, grouping, and denervation. These similarities suggest that 
denervation and/or diminished reinnervation may be important factors in aging effects on muscle. 
Recently, Delbono and colleagues330 assessed age-related denervation using a combination of 
electrophysiological and immunohistochemical methods to detect tetrodotoxin (TTX)-resistant 
sodium channels (Na
v
1.5) in the flexor digitorum brevis muscles of young and old mice. The TTX 
dose-response curve showed three populations of fibers in senescent mice, one similar to fibers of 
young mice (TTX sensitive), another similar to fibers of experimentally denervated muscles (TTX 
resistant) and a third group characterized by an intermediate state between the former two. The 
three categories represented fully innervated, fully denervated and partially denervated muscle 
fibers respectively. Partially and fully denervated fibers added up to approximately 50 % of all 
fibers tested, a number that concurs with the percentage of fibers positive for the Na
v
1.5 channel 
by specific immunostaining. The extent of denervated fibers is surprisingly high and suggests that 
age-dependent denervation has been underestimated in previous studies. 
In summary, denervation of muscle fibers is clearly increased in senescence and contributes to 
the etiology of sarcopenia. However, the extent to which fibers are denervated and the time a 
fiber stays denervated until it’s reinnervated or lost are poorly understood. Nevertheless, atrophy 
and loss of muscle fibers following loss of motoneuronal input in combination with impaired 
reinnervation is considered to be an important mechanism underlying sarcopenia. There are mainly 
three possibilities for a muscle fiber to get denervated: motor neuron death, irreparable damage to 
peripheral nerve axons, or deterioration of the NMJ.
1.4.5.2 Age-dependent reinnervation of denervated muscle fibers
The aging neuromuscular system is thought to undergo a continual process of reorganization as 
fibers become denervated and eventually reinnervated by adjacent motor nerves. Since motor unit 
innervation rations may increase five- to tenfold, this is a powerful compensatory mechanism331,332. 
Thompson and Jansen333 for example partially denervated the soleus muscle of rats and found 
that the remaining motor units sprouted to about four times their average normal size. Sprouting 
occurs either from the nerve terminals (terminal sprouting) or from the first node of Ranvier 
(nodal sprouting) and is rapid, with significant recovery of function within weeks. Several studies 
addressed the extent to which collateral reinnervation is able to compensate for age-associated 
neural deficits. Einsiedel and Luff334 demonstrated that senescent motoneurons are not able to 
substantially increase the size of their peripheral fields by extensive collateral reinnervation. Partial 
denervation of the gastrocnemius muscle of old rats followed by reinnervation in a recovery period 
did not result in the change of motor unit size. Furthermore, Pestronk et al.335, using botulinum 
toxin to denervate fibers in the rat soleus muscle, found that although this resulted in significant 
terminal sprouting in the muscles of young rats, there was no significant change in aged rats. 
However, this does not reflect an age-associated inability to sustain neuronal growth. Sprouting 
was significantly increased in aged compared to young rats prior to any denervation procedure336. 
Although the sprouting response after partial denervation was decreased in aged animals, the 
total extent of sprouting was still higher in the aged group. Explanations for the reduced response 
in aged animals are a maximum limit to the amount of sprout growth for each motoneuron or, 
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alternatively, the latency of axonal sprouting that may be greater in aged than in younger animals. 
In agreement with the later explanation, myelinated fiber regeneration after sciatic nerve crush was 
substantially retarded in aged compared to adult mice337. The number and diameter of myelinated 
fibers, myelin area and thickness and Schwann cell cytoplasm area was significantly reduced after 
2 and 4 weeks of regeneration in aged animals. At 8 weeks, however, most of the differences 
disappeared, although some deficiencies were maintained in myelin architecture and Schwann cell 
cytoplasm. A comparison of muscle endplate reinnervation that followed crush injury of the sciatic 
nerve between young adult and aged rats demonstrated that the re-establishment of normal single 
motor innervation was impaired in age338. Abnormal nerve bundles, immature nerve terminals, 
and multiple innervation were substantially increased in aged compared to young adult animals. 
Jacob and Robbins339 showed that after partial denervation of mouse soleus muscle, postsynaptic 
sites were nearly or completely reoccupied at 60 days after denervation in young muscle. In 
old muscle, about 22% of former junctions remained denervated. At the same time, motor unit 
size expanded about 2.5 times in young and 2 times in old muscle. Nerve terminal volume per 
motoneuron increased 60-100% compared to control in young but only 20-25% in old muscle. 
These findings indicate the inability of the aged motoneurons to expand their field of innervation. 
The same authors340 found that forced expansion of the motor unit in old mice, in contrast to 
young mice, resulted in physiological deficits in both regenerated and nondenervated NMJs of 
the expanded motor unit, and a persistent increase in latency of newly regenerated junctions. 
This finding indicates that the formation of new NMJs is impaired in age and could play a critical 
role in age-related difficulties to innervate regenerated fibers and to maintain large motor units. 
Later, impaired neuromuscular regeneration in senescence after sciatic nerve-crushing injury has 
been confirmed in rats341,342. Delayed arrival of Schwann cells and axons at the NMJ, drastic and 
long-lasting decline in the dimensions of terminal Schwann cells and AChR sites, low degree 
in spatial overlap between terminal Schwann cells and AChR sites, persistent aberrant changes, 
such as multiple innervation and terminal axon sprouting, together with poorly formed collateral 
innervation, nerve bundles, and NMJs were observed in aged animals. Also here, age-dependant 
regeneration inabilities have been attributed to impairments in the later regeneration phase, in 
which the regenerating axon extended into the NMJ. Recently, the influence of age on the response 
of the NMJ to nerve transection and repair was assessed343. After nerve injury, regeneration was 
delayed and incomplete in aged animals. At 4 weeks, 67% of the young animals had measurable 
compound motor action potentials (CMAPs), whereas none of the aged animals showed electrical 
evidence of regeneration. At 16 weeks, amplitude recovery was 65% of the contralateral reference 
in young, but only 36% in aged animals. Moreover, aged animals did not improve from 8 to 
16 weeks post injury. The aged NMJs showed significant fragmentation and loss of area while 
the young NMJs remained relatively stable. Concomitantly, age impaired peak upregulation of 
AChRs and muscle regulatory factors. This impaired response of the NMJ to denervation may 
contribute to age-related neuromuscular degeneration by impairing full neuromuscular recovery 
after microdenervation.
In summary, the capacity of reinnervation is markedly diminished in aged subjects, resulting in 
an increasing number of permanently denervated muscle fibers. Impaired reinnervation in age has 
been attributed to sprouting deficits, reduced axon growth, impaired Schwann cell-axon interaction, 
reduced axonal transport or difficulties to establish functional NMJs. The fact that sprouting is 
frequent in aged animals and that aged animals can obviously sustain a substantial amount of 
neuronal growth does not speak in favor of sprouting or axonal growth deficits. The reason why 
sprouting finally does not lead to an increase in motor unit size in aged animals may rather reflect 
the inability to build functional NMJs. Alternatively, differences in size between aged and adult 
motor units may also explain the inability of aged motoneurons to react to nerve injury. It has been 
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shown that aged motor units consist of clearly more muscle fibers than adult motor units, most 
likely due to compensatory innervation of denervated muscle fibers (see below).  There might be 
an overall limit of muscle fiber that a motoneuron can support. Aged units may be close to the 
limit, whereas, in adult motor units, there are still resources to support an enlargement.
1.4.5.3 Age-dependent loss of motor units
The concept of the motor unit was defined by Liddell and Sherrington344 and consists of the 
motoneuron and all the muscle fibers innervated by that motoneuron. The number of fibers 
innervated by a particular motoneuron is referred to as innervation ratio, which can vary greatly 
within a single muscle and between different muscles. A motor unit innervating the soleus muscle 
of rats, for example, contains 58 muscle fibers, whereas a motor unit of the tibialis anterior muscle 
contains 127 muscle fibers256. Essentially, if a motoneuron is lost, a motor unit is lost. Both animal 
and human studies suggest that motor units are lost with age.
Very early electromyographic methods were applied on human muscles to estimate the number 
of motor units. The principle of these method is to measure the amplitudes of the muscle action 
potentials generated, firstly, by a single motor unit of average size and, secondly, by the whole 
muscle. Then, the number of motor units within the muscle can be determined by division. McComas 
et al.345 found a constant number of motor units innervating the extensor digitorum brevis muscle 
of 41 subjects between 4 and 58 years of age. At this age, muscle fiber number had already begun 
to fall. Thus, factors other than denervation of entire motor units might be implicated in the initial 
loss of muscle fibers. After the age of 60, an 
age-related decrease in the number of active 
motor units was observed in several studies346-
349 (Fig. 9). Proband over 70 years of age had 
a motor unit count less than half that of the 
subjects under 40 years. Interestingly, the 
size of the remaining motor unit potential 
was often enlarged in the elderly subjects. 
However, the electromyographic studies 
may be influenced by age-related alteration 
of the signal transmission from nerve to 
muscle due to structural or functional 
changes of the NMJ. On morphological 
basis, Tomlinson and Irving350 studied, 
postmortem, the lumbosacral spinal cords of 
47 subjects between 13 and 95 years of age, 
and found that, although individual counts 
varied considerably in all age groups, there was no evidence of reduced number of motoneurons 
up to 60 years of age. Beyond 60 years, there were significant reductions in motoneuron numbers, 
with several cases exhibiting counts of only 50% of those found in young subjects, confirming the 
findings from electrophysiological studies. Based on a later electromyographic study using spike-
triggered averaging, the estimated number of motor units in old (60 to 81 years) subjects was on 
average reduced to 53% of the number recorded in young (22 to 38 years) adults in the biceps 
brachii and brachialis muscles145. The motor units of the old subjects had, however, larger action 
potentials (23%). The association of a 23% increase in motor unit size and a 47% decrease in motor 
unit number indicates that motor unit loss is followed by incomplete compensatory reinnervation 
of denervated muscle fibers by adjacent motor units. Denervated muscle fibers not receiving 
compensatory reinnervation within a given time are atrophied and lost. An age-related increase in 
No
 o
f m
ot
or
 u
nit
s 
Age (years)
20 40 60 800
50
250
300
0
100
150
200
350
100
Figure 9  Relationship between the number of motor units 
in the extensor digitorum brevis muscle and the age of 
men between 5 and 88 years of age. The number of motor 
units remains constant from 5 to 50 years of age, but then 
decreases linearly with a zero intercept at 95 years of age. 
Modified by Faulkner et al.236 from Campbell et al.347
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motor unit size has also been found in the human thenar motor unit pool and was accompanied by 
a slowing of contraction speed. Such adaption may help to overcome age-related losses of motor 
units351,352. Recently, age-related decline in the motor unit number estimate (MUNE) has been 
confirmed in the tibialis anterior353. The MUNE was reduced from 150 in young (25 years) to 91 
in old (65 years) and to 59 in very old (over 80 years) men. Despite the smaller MUNE at age 
65, strength was not reduced in this age group, suggesting that age-related motor unit loss does 
not limit function until a critical threshold is reached. Compensatory enlargement of motor units 
could compensate the loss of motoneurons. 
The muscles in the rat hindlimb have been studied extensively with regard to age-related 
changes in their motor unit populations334. Although some discrepancies are apparent in the 
findings, there is a general agreement among studies that substantial age related degeneration 
of the motoneurons is present in the senescent rat. Physiologic and morphometric studies have 
shown significant reductions of 40 to 75% in the estimated number of motor units in the hindlimb 
muscles146,252,354,355. However, direct determinations of the motoneuron number using retrograde 
labeling of motoneurons with horseradish peroxidase (HRP) revealed only a small decline in HRP- 
labeled alpha-motoneurons in the tibialis anterior but not in the soleus muscle of 135-weeks-old 
rats234. Burke and colleagues144 counted motoneurons in an individual motor nucleus, the medial 
gastrocnemius (MG) motor nucleus. They found an age-associated reduction in the total number 
of motoneurons, which was due mainly to the loss of large-sized motoneurons, a finding that was 
confirmed in other studies356,357. The number of large motoneurons was reduced by 13% in the old 
(26 months) and by 30% in the very old (31 months) group and consequently, the mean average 
soma diameter was smaller in the older animals. Interestingly, a negative correlation between 
soma size and oxidative enzyme activity of motoneurons has been found358, suggesting that the 
age-associated loss of large motoneurons may reflect a predominant loss of fast motoneurons with 
a low oxidative capacity. This could be an explanation for the predominant loss of fast, type II 
muscle fibers. Later, Hashizume and Kanda359 reassessed the MG muscle motoneurons and found 
a significant decrease from an average of 132 in middle-aged rats to 121 in old rats (27 months), 
accompanied by a reduction in soma CSA of about 10%. Interestingly, there was no change in 
the number of motoneurons supplying the ulnar nerve in the rat forelimb. These findings suggest 
that the effects of aging on motoneurons and peripheral nerves innervating the MG muscle in 
the hindlimb are greater than those innervating forelimb muscles. The underlying mechanisms 
causing the differential extent and/or rate of progress of aging among different motor nuclei and 
peripheral nerves are not yet clear. 
Morphological studies not only included the count of motoneuron cell bodies, but also the 
enumeration of myelinated fibers (MFs) in ventral spinal roots and peripheral nerves. An age-related 
decline has been shown in numerous reports in humans and rodents252,354,360-365, but conflicting 
results exist357,366-369. In the soleus motor nerve of rats, the number of MFs decreased for example 
by 9 % with age356. In aged MG nerve a reduction in number (10%) and density (47%) of MFs 
has been found that was accompanied by increased fascicular area and fiber diameter, and myelin 
sheath irregularities359. Degenerative changes in myelin sheath structure, such as demyelination 
and remyelination, increase in amount of endoneuronal connective tissue, myelin infolding, and 
myelin reduplication have been found frequently both in ventral roots and peripheral nerve in aged 
humans and animals, regardless whether the actual number of MFs was reduced or not357,360,367,370-
373. Degenerative changes in myelin sheath structure may reduce the conduction velocity in the 
peripheral nerves374,375 and the spinal cord376. 
In concert with a reduced number of motor units with age, an enlargement of these motor units 
has been proposed from electrophysiological studies. Single motor unit action potentials were 
clearly increased in age, suggesting greater innervation ratios of aged motoneurons145,346,347,377,378. 
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An age-related enlargement of motor units was confirmed on morphological basis using the 
glycogen depletion method146. Larsson and Ansved256 reported that the motor units of the soleus 
muscle contained 58 and 84 muscle fibers in young (2 months) and old (20 months and older) rats, 
respectively. A motor unit of the tibialis anterior muscle consisted of 127 and 178 muscle fibers, 
in young and old animals, respectively, indicating a significant enlargement of motor units in age. 
Consequently, motor unit areas in the old animals were increased from 3.9 to 6.4 and from 8.8 to 
12.5 mm2 in soleus and tibialis anterior muscle, respectively. The loss of motor units may partially 
be compensated by the reinnervation of denervated muscle fibers by adjacent motor nerves, 
thereby increasing the number of innervated fibers per motor unit. The enlargement predominantly 
affected the low-threshold motor units in which the innervated muscle fibers belong to type I and 
was attributed to the sprouting of new collaterals from nerves innervating type I fibers in order 
to innervate part of the denervated type II fibers. This could be an explanation for the relative 
increase in type I fibers seen in aging rodents, since type II fibers which become reinnervated by 
type I motor unit axons actually become type I fibers with respect to biochemical and physiological 
properties379. Similarly, Kanda and Hashizume380 reported a significant age-associated reduction 
in the mean tetanic tension of fast motor units, while the mean tension of slow motor units was 
substantially increased. An increase in the innervation ratio of slow motor units was the likely 
mechanism for the age-associated increases in their tetanic tensions. The reason for altered motor 
unit remodeling, in favor to slow motor units, is unclear; it might result from their superiority in 
establishing permanent connections with both type I and II muscle fibers, or from predominant 
loss of fast motoneurons. Whether motor units with specific physiological properties are lost in 
humans, as appears to be true for the rat, remains unclear. 
The loss of large motoneurons, the associated remodeling of the motor unit, and the resulting 
electrophysiological changes were recently reexamined on the motor unit of the gastrocnemius 
muscle of aged compared to young and adult rats381. The decline in motoneuron number, 
preferentially among type II units, and associated evidence for motor unit remodeling started after 
21/22 months of life and accelerated with advancing age. Important changes were found in the 
whole muscle tension, the specific tension (whole muscle tension per CSA), axonal conduction 
velocity and the CSA of type II fibers, which were all significantly reduced. Individual tension 
of type II motor units decreased, whereas tension of type I motor units continuously increased 
until the age of 36 months. Interestingly, the age-related change in tension produced by individual 
motor units was marginal compared to the decline in whole muscle tension. The maintenance of 
the motor unit tension indicated that the motor units had acquired additional muscle fibers, most 
likely recruited from those that were denervated due to death of their motoneuron. In some of these 
units, this process reduced or even exceeded a decrease in tension due to muscle fiber atrophy and 
a decrease in the specific tension. These observations, thus confirm that remodeling of the motor 
units in the aged individuals by recapturing of denervated fibers contributes substantially to the 
compensatory mechanism for age-related motoneuron loss. 
Taken together, these results point towards an age associated reorganization of the motor unit 
pool, whereby selective losses or degradation of the fastest motor units are accompanied by 
increases in the proportion of slow motor units. The greater success of slow motor units in 
partially reinnervating muscle fibers, that have become denervated following the loss of their 
parent motoneurons, may possibly explain the apparent shifts in the fiber type composition in 
rat muscles. Previously described histological changes in the skeletal muscle, such as angular 
fibers and fiber-type grouping support the conclusion of ongoing remodeling of neuromuscular 
innervation in aged individuals203. 
In contrast to these findings, a couple of studies are available which do not confirm an age-related 
decrease in motor unit or motoneuron numbers. In an early report the number of cells in the 
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nucleus of the trochlear nerve in humans was determined in a total of 20 brains from newborn 
to 87 years of age. The cell count was 1830 in newborn, 2010 in the 87-year-old and 2115 in 
average over all the specimens examined382. The normal aging process was not accompanied 
by neural cell loss in this nucleus, which is in accordance with findings in five other brain stem 
nuclei examined by various investigators. Johnson et al.383 did not find a significant decrease in 
the number of large motoneurons innervating the hindlimb muscles in aged (30 months old) rats 
with symptoms of hindlimb incapacities compared with adult (3 months old) rats. Nevertheless, 
a non-significant loss of about 15% of the motoneurons on cresyl violet-stained cross-sections 
was detected. An electromyographic assessment of the soleus motor units did not show a change 
in the estimated motor unit number between young (5-8 month) and old (25-30 month) mice340, 
correlating with studies from rats234 and humans384 both finding the age-related change in soleus 
motor unit number to be minimal. Dalton et al.384 explained the obvious discrepancy to earlier 
studies with the specific muscle and with methodological differences. The soleus muscle is a 
postural muscle, which is frequently activated. Since long-term physical exercises slow the age-
related changes in motoneurons and peripheral nerves in rats385, frequent activation of the soleus 
muscle could maintain motor axons and motor unit health. The contradiction to a further study, 
reporting 70% decrease in the MUNE of the soleus muscle182 was attributed to the incremental 
stimulation technique, which is based on assumptions that may overestimates a MUNE, to the 
smaller sample size, and to the higher mean age of the subjects (about 90 years compared to 75 
years). The dependence of age-related changes in motor unit estimates on the analyzed muscle 
was confirmed in a study on 79 human subjects between 20 and 98 years of age386. Motor unit 
populations were noted to decrease significantly with age in two distal muscles (thenar, extensor 
digitorum brevis) but appeared to remain constant in the biceps brachii. The excitable muscle mass, 
however, was diminished in all three muscles. The author concluded that muscle deterioration in 
the elderly is due to a combination of changes in the muscle fibers and in their nerve supply and 
that the extent may differ between proximal and distal muscles. In another study, the number, 
size, density and pathologic alterations of MF of ventral and dorsal roots and of peroneal and 
sural nerves in rats at 10, 20 and 30 months of age were analyzed357. Neither the number of 
MF per nerve nor the fascicular area were changed according to age. However, striking changes 
in MF size distribution, pathologic alterations of fibers and presence of regeneration clusters 
suggested age-related degenerative and regenerative events. These changes were most dramatic 
in the ventral root, where myelin infolding, myelin separation from axon and ballooning, as well 
as macrophagia and hyperplasia of Schwann cell nuclei were prominent. Importantly, axonal 
atrophy was observed in MF of the ventral root at old age. Morphometric changes of nerve fibers 
may complicate the counting of their number, and could lead to inexact or misinterpreted results. 
This might be a factor explaining the large discrepancies between MF estimates from different 
studies (see above). An extensive study on the total number of neurons in the fifth cervical and 
fourth lumbar dorsal root ganglion (containing afferent, sensory neurons) of 2- and 30-month old 
rats using stereological techniques and confocal microscopy revealed only a small decrease (12 
%) in the number of neurons in the aged animals387. Moreover, a correlation between the degree 
of neuron loss and the extent of behavioral deficits among the aged individuals was not found. 
The authors concluded that loss of primary sensory neurons could not exclusively explain the 
functional deficits in sensory perception among senescent individuals. Although this study was 
not performed on motoneurons but on sensory neurons, the growing evidence that aging is not 
accompanied by a substantial loss of neurons388-392 exclude a general instability and degeneration 
of neurons as an explanation for age-related motoneuron loss. A substantial loss of motoneurons (if 
it actually takes place) would have to be explained by different stabilities of afferent and efferent 
nerves. Furthermore, aging was not accompanied by neuron loss in most of the subcortical nuclei, 
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including the motor nucleus of the facial nerve, and the nuclei of the trochlear and abducens 
nerves389.
It’s important to keep in mind that several factors may limit the interpretation of studies on 
aging nervous system, including secular trends, species and strain differences, effects of tissue 
processing, and bias which may be introduced at many levels of an experimental design. 
Hippocampal cell death with aging has for example been generally accepted. Death of nerve cell 
in the hippocampus, a brain structure known to be critical to learning and memory, is a simple 
explanation for forgetfulness observed with aging and has been supported by a large number 
of studies. However, the development of more sophisticated and powerful methods of counting 
neurons have contradicted much of the early work392,393. It becomes now evident that neuron death 
is not an inevitable result of normal aging. A similar situation could also account for the impact 
and extent of age-related loss of motoneurons.
In summary, age-associated loss of motoneurons has been found in numerous studies, using a 
variety of morphological and physiological methods. Therefore, denervation because of neuronal 
death is one of the mechanisms that could account for atrophy and loss of some populations 
of muscle fibers. However, a subset of studies reported only small or no age-related change in 
motoneuron number. Especially motor units innervating the soleus may be less affected by age-
related degeneration. Despite a minimal loss of motoneurons, age-associated muscle fiber loss has 
been found in a large number of reports on rat soleus muscle146,196,197,199,201,233-235. Therefore, the age-
associated loss of muscle fibers may not be simply explainable by loss of motoneurons, at least not 
for all skeletal muscles. Generally, motor unit populations innervating different muscles undergo 
different age-related changes. Dramatic morphological alterations in the nerve fibers in regard 
to myelination or size complicate the analysis of nerve fibers and could influence the results. 
Furthermore, the variety of methods, subjects, and age-ranges makes it difficult to interpret the 
results. Especially indirect methods, like for example glycogen depletion or electromyographic 
studies could also be influenced by age-related changes at the NMJ or by age-associated events 
disconnecting excitation and muscle contraction, such as contraction-induced injury, age-related 
posttranslational modifications of contractile proteins, and excitation-contraction uncoupling (see 
above). Together, there is clear evidence for an age-related loss of motoneurons. However, the 
age of onset, the extent, and the influence on different muscles are unclear, making it difficult to 
estimate the impact of these motoneuron losses on muscle architecture and sarcopenia. There is 
increasing evidence that the loss of motoneurons is not the sole cause of the age-related muscle 
fiber loss. The loss of muscle fibers seems to exceed the loss of motoneurons. Moreover, the start 
of motoneuron loss occurs at high ages and may not precede the loss of muscle fibers (Fig. 7, 
9). If senile muscle atrophy would be caused purely by death of motoneurons, it is difficult to 
explain why aging motoneuron have preserved cholinergic phenotype, and why they display no 
signs of cell-body atrophy394,395. It is also unclear whether the loss of motoneurons, if it actually 
takes place, is due to an inherent failure of the motoneuron or due to the inability or incapability 
of the muscle fiber to support the motoneuron, for example following deterioration of the NMJ. 
If there is an impairment of motoneuron function, the nature and origin of that impairment is 
largely unknown. Decline in neurotrophic factors and impairment of mitochondrial function due 
to oxidative damages396 and increase in mitochondrial DNA mutations397 have for example been 
suggested, but clear evidence has not been found.
Very early, it has alternatively been suggested that a slow loss of neuromuscular contact could 
be caused by degeneration of the endplate region, rather than by the loss of entire motoneurons. 
Gutmann and Hanzlikova233 concluded that age-related fiber loss in rat soleus muscle, between 
adult (4 months) and old (24 months) animals, was secondary to a degeneration of motor endplates, 
which was found to cause a 33% decrease in motor unit innervation ratio but no change in the 
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number of motor units. Similarly the remodeling of motor units, i.e., the lifting of axon terminals 
of viable neurons from muscle fibers could be a mechanism that could account for the denervation 
of muscle fibers95,398. The amount of instability of the NMJ increases dramatically with advancing 
age, and muscle fibers that are rendered totally denervated during the remodeling process will 
undergo denervation atrophy until or unless they become reinnervated.
1.4.5.4 Age-related deterioration of the NMJ: cause or consequence of motoneuron loss? 
The NMJ is the crucial link between motoneuron and muscle. Not alone signals for muscle 
contraction, but also trophic factors from nerve to muscle (anterograde signals) and vice versa 
(retrograde signals) pass via the NMJ. Therefore, the state of the NMJ is of outmost importance 
for the state of the motor unit. Deterioration of the NMJ could result via lacking or insufficient 
transmission of anterograde trophic signals in muscular deterioration and, conversely, via lacking 
or insufficient transmission of retrograde trophic signals in motoneuron deterioration. However, 
if not all NMJs of a motor unit are affected, deterioration of the motoneuron may not necessarily 
take place. Normally, the NMJ has a high safety factor, so that the arrival of an action potential at 
the motoneuron almost invariably results in an action potential in the muscle fiber. Consequently, 
any change in the security of synaptic transmission at the NMJ may profoundly affect the extent 
to which individual muscle fibers are recruited for normal function.
The endplate undergoes continual growth and degeneration in normal muscle of healthy adult 
mammels with gradual changes in pre- and postsynaptic components through adult life399. With 
advancing age the NMJ undergoes degenerative structural and functional changes. The Pretzel-
like shape of the NMJ typically found in the young adult is remodeled and becomes increasingly 
fragmented and dispersed with advancing age, resulting in more distinct synaptic regions. 
The fragmentation occurs on both the presynaptic and the postsynaptic side. It is reflected by 
the distribution of AChR clusters233 and AChE399, and by the structure of presynaptic nerve 
terminals400,401. Courtney and Steinbach92 labeled postsynaptic AchRs with a fluorescent derivative 
of α-bungarotoxin and found an increase in the number of discrete regions of high AChR density 
in junctions from older rats. In another study, the percentage of fragmented NMJs, visulaized 
by cholinesterase stainings, gradually increased with age. NMJs classified as normal completely 
disappeared in rats older than 15 months. The gradual and progressive loss of synaptic contacts 
resulted in the loss of entire NMJs95. Prakash and Sieck402 counted the number of nerve terminal 
and motor endplate branches on type-identified diaphragm muscle fibers and found a significant 
increase between 6-month-old and 24-month-old rats on all fiber types, indicating age-related 
fragmentation of pre- and postsynaptic sites. Thereby, the aging associated fragmentation was 
found to be more severe on type II than on type I muscle fibers. This finding could be an explanation 
for the age-associated increase in proportion of type I fibers seen in rodents. The capability to 
support the associated fibers may be greater among the less fragmented and thus, more stable 
NMJs on type I fibers. In an electron microscopy based morphological comparison of NMJs on the 
gastrocnemius muscle of the mouse, only 40% of the NMJ in old mice were classified as normal, 
compared to 85% in young mice403. In several studies presynaptic nerve endings were analyzed 
by zinc iodide-osmium stainings in adult and aged mice. Increased numbers of nerve terminal 
regions were found on soleus, EDL401 and masseter muscles400 of old (30 months) compared to 
adult (5-6 months) mice. The increase in the number of presynaptic regions was associated with a 
decrease in size per region, reflecting an ongoing dispersal of the nerve terminal with age. It has 
been speculated that this redistribution is due to constriction and retractions of nerve terminals 
in old mice, which may result from loss of adhesion of nerve terminals to the synaptic matrix or 
surrounding Schwann cells404. It is possible that a component of the adhesion complex could be 
defective in old mice, resulting in diminished integrity of the entire complex. For instance, in old 
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mice the complex might be affected by reduced axonal transport of cytoskeletal or membrane 
components, altered synaptic matrix due to proteases, or primary changes in muscle or Schwann 
cell.
A number of studies tried to analyze age-related alterations in the size of both pre- and postsynaptic 
parts of the NMJ. Deschenes and Wilson405 found a drop of 12 and 14% in the stained area of 
antisynapsin labeled presynapses and α-bungarotoxin labeled postsynapses, respectively, in aged 
compared to young adult rats. Apel et al.343, in contrast, did not detect any significant differences 
between α-bungarotoxin labeled postsynaptic areas of young compared to aged NMJs, a finding 
that was confirmed in another study using cholinesterase staining406. Robbins and Fahim401, finally, 
found a tendency for age-related increase in zinc-iodide stained nerve terminal area. Analysis 
of nerve terminal area on type-identified diaphragm muscle fiber revealed fiber type specific 
differences. The area of aged endplates was increased on type IIx and type IIb but not on type I and 
type IIa fibers402. Moreover, extensive analysis of endplate areas on different rat muscles revealed 
substantial muscle specific differences93. Together, fiber type and muscle dependent variations 
as well as methodological distinctions may be explanations for the diversity of results obtained 
in different studies. Methodological difficulties include the analysis of NMJs on single muscle 
fibers, where it is not always positioned on top but can be wrapped around the fiber. Quantification 
of tilted NMJs leads to underestimation of the areas. NMJ size is also dependent on fiber size and 
has been shown to progressively increase over an animal’s life83. Thus, to judge age-dependent 
differences, not only the age of the animals categorized as “old” but also the age of the “young” 
animals may be important. The progressive growth of the NMJ was substantial in the first months 
of a mouse life and slowed down during later adulthood. Whether this trend is reversed at a certain 
age or just slowly continues is not fully clear, but if there are changes in senescence, they may be 
rather small. 
Further structural alterations of the NMJs of old mice included degenerative features such as partially 
innervated and vacated endplates, abnormalities of junctional folds, degenerations of Schwann cells, 
extra-junctional AChR, and increased length and complexity of the endplate92,399,403. Furthermore, 
decline in synaptic vesicle density403,407,408 has been reported. The final stage of the disturbance of 
the NMJ is the appearance of “silent” axons, characterized by retraction of axonal terminals and 
disruption of the postsynaptic membrane409. At the same time, evidence for regenerative processes, 
such as terminal sprouting and multiple innervation have also been observed336,410,411. It has been 
suggested that two major processes account for morphological alterations in NMJs of mature 
rodents: changes that are simple continuations of normal development and late changes that 
reflect newly arising age-dependent extrinsic or intrinsic factors. Interestingly, it has been shown 
that aged NMJs underwent significant remodeling of both pre- and postsynaptic parts following 
muscle unloading, whereas adult NMJs maintained normal morphological characteristics405. 
Similarly, aged NMJ exhibited significant fragmentation and loss of motor endplate area after 
nerve injury and repair while the young NMJ remained relatively stable343. Aged NMJs may be 
generally less stable than young ones, rendering them more susceptible to disturbances such as 
unloading or denervation.
Only few studies on NMJ morphology in age were performed on human muscles. However, the 
situation appears to be similar. Oda399 used human intercostal muscle fibers and showed a greater 
number of smaller AChR conglomerates per endplate in older subjects. Additionally, perijunctional 
AChRs were observed and the number of preterminal axons entering an endplate was increased.
In recent years, Lichtman and others have developed vital stainings and video microscopy 
techniques that have allowed the same NMJ to be monitored over time in living animals81. This 
method generates direct information about the life history of NMJs and sheds light on structural 
changes in the development and aging of synapses. The pre- and postsynaptic components can be 
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vitally stained with fluorescent dyes and imaged, without inducing damage. Using these in vivo 
imaging approaches, the growth, maintenance and aging of NMJs in the sternomastoid muscle 
of mice has been studied. Following the developmental period of synapse elimination, NMJs are 
remarkably stable in the pattern of presynaptic motor nerve terminals and postsynaptic receptor 
rich areas. For the most part, the NMJs grow by expansion of existing elements without the addition 
or loss of synaptic regions83. In mice older than 12-15 months of age, however, the stability of 
neuromuscular innervation decreases, a process becoming more marked beyond 18-20 months of 
age. The aging process has extensively been studied by Balice-Gordon148 using the sternomastoid 
muscle of rats (Fig. 10). The same NMJs were continuously imaged between 10 and 36 months of 
age. At early times (12-14 months of age), only a small percentage of the NMJs undergo loss of 
motor nerve terminal branches and underlying receptor rich areas. The loss of postsynaptic AChR 
areas occurs via the gradual loss of receptors from a region, followed by loss of the overlying 
nerve terminal. Pre- and postsynaptic loss occurs one region at a time rather than all at once. 
This sequence of events is strikingly similar to that observed during naturally occurring synapse 
elimination during development412 and synapse elimination following reinnervation90. Thus, it is 
possible that the cellular mechanisms underlying synaptic loss may be similar in development, 
reinnervation and aging. At 12-18 months of age, in some junctions, motor neurons appear to 
compensate for small losses of synaptic area by sprouting and adding new sites. The proportion of 
NMJs undergoing loss and addition of synaptic sites increases over time. However, the incidence 
of compensatory addition decreases dramatically with age. Moreover, the newly formed synaptic 
sites also appear to be unstable, with many disappearing within several weeks of their formation, 
which is a marked contrast to the stability of NMJs at earlier ages. By 24-36 months of age, 
Figure 10 Age-related changes in the stability of the NMJs. Vital fluorescent dyes and video microscopy were used to 
follow NMJs in the mouse sternomastoid muscle over time. Motor nerve terminals (top row) and postsynaptic AChRs 
(bottom row) were stained. After digital images were obtained, the animal was allowed to recover. Several months 
later, the experiment was repeated and the same junctions were re-located and re-imaged. Three junctions viewed at 
10, 14, 18 and 20 months of age are shown. Age-related changes include loss of existing synaptic areas (compare 10 
m and 14 m panels), compensatory addition of new synaptic sites (arrow in 14 m panel), further loss and addition in 
these areas (18 m panel) followed by almost complete disintegration of the junction (20 m panel). Scale bar, 20 µm. 
From Balice-Gordon148.
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the vast majority of NMJs have undergone significant losses of pre- and postsynaptic sites. In 
some cases these structural alterations were associated with degenerative changes of postsynaptic 
muscle fibers themselves. At 36 months loss of existing synaptic areas and compensatory addition 
of new synaptic sites is followed by almost complete disintegration of the junction.
Beside structural alterations with age, there is also evidence for functional impairment. The ability 
to sustain synaptic transmission at the NMJ is diminished with advancing age413-415. Banker at 
al.407 analyzed neuromuscular transmission in different muscles of young (8-12 months) and old 
(29-33 months) mice. The frequency of spontaneous miniature endplate potentials was decreased 
with age in the majority of the muscles but their amplitudes were unchanged. Evoked endplate 
potential amplitudes, however, were increased by about 100%. This suggested that the number of 
quanta released per nerve impulse is increased with age, a finding that was confirmed by direct 
measurements414,416. This may rather reflect a compensatory than a degenerative response. Motor 
inactivity is an obvious candidate for the stimulus for this compensation, especially since synaptic 
efficacy increases after experimental disuse in young animals417,418. Lower level of AChRs may be 
partially compensated by increased transmitter release. The age-related increase in quantal content 
could be accounted for by an increase in numbers of synaptic vesicles per terminal, active zones 
per terminal or terminals per endplate. Utrastructural morphometric analysis showed age-related 
loss of synaptic vesicles in the majority of reports403,407,408, but the opposite situation has also been 
found406. Increase in the number of nerve terminals per endplate, and by inference the number 
of release sites, has been observed constantly93,401,415. Total neurotransmitter level at the NMJ, 
however, has been shown to decrease with age, probably due to increased quantal content after 
nerve stimulation and increased leakage in the resting state414. Thus, the fraction of transmitter that 
is released per action potential must increase in age, leading to an enhanced synaptic depression 
in aged animals. Consequentially, the rate of transmitter turnover in old mice is increased419. 
However, in more advanced ages the demands of increased transmitter turnover might become 
overwhelming and the ability to sustain synaptic transmission is decreased. Observations of 
NMJ function evaluated with intracellular recordings of nerve evoked endplate potentials in 
muscle fibers of aged mice (24-36 months of age) in vitro suggest that at most junctions, synaptic 
transmission fails more than half of the time to activate muscle fibers when the muscle nerve is 
stimulated at relatively low frequencies (10 to 20 Hz). At these and higher frequencies, endplate 
potentials fall below threshold for initiation of a muscle fiber action potential and thus activation 
of muscle fiber contraction. 
Progressive changes in the presynaptic populations of motoneurons, in the postsynaptic population 
of muscle fibers, or at the NMJ itself are likely to contribute to the synaptic instability observed 
as animal age. Additionally, Schwann cells have been shown to play an important role in axon 
outgrowth and synaptic repair420 and clearly show age-related abnormalities341,342. Together, age-
related changes in synaptic maintenance may be an adaption to changes in the number and viability 
of motoneurons, muscle fibers and Schwann cells or in the interactions among them. Loss of 
presynaptic motoneurons may lead to transient denervation of muscle fiber in aging animals, with 
subsequent reinnervation by sprouts from remaining motor axons that may become compromised 
in their ability to maintain excess synapses. In very aged animals decline in motoneuron number has 
been well documented, but there are conflicting reports about the onset and extent of motoneuron 
death (see above). As motor neurons die, NMJs might be expected to be dismantled abruptly 
rather than gradually. Contradictory, changes in synaptic maintenance occurred via a protracted 
time course148. Alternatively, before the final event of cell death, motoneurons may gradually 
lose their ability to maintain all their endings, resulting in the loss of one synaptic site after 
another. However, the sequence of events, gradual loss of postsynaptic receptors followed by loss 
of overlying nerve terminals, does not speak in favor of a denervation due to motoneuronal death. 
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On the other hand, a number of observations argue that the postsynaptic muscle fiber also plays 
an important role in synaptic maintenance. Muscle fibers in aged animals become progressively 
atrophic, and may become more susceptible to damage during normal behavior than muscle from 
young adult animals. Increased muscle degeneration in aging animals may induce synaptic loss on 
compromised fibers in advance of their removal from the muscle. Death of postsynaptic muscle 
fibers has been shown to lead to the loss of synaptic sites on residual basal lamina ghosts in young 
adult mice90  and to cause the sprouting of motor nerve terminals innervating adjacent intact 
muscle fibers. This and other work suggest that healthy postsynaptic muscle fibers provide essential 
factors for normal synaptic maintenance. Trophic factors have been shown to play key roles in 
motoneuron survival, nerve –muscle maturation and in synaptic maintenance421. Muscle derived 
trophic factors acting on motoneurons (neurotrophic factors) mediate developmental events such 
as naturally occurring cell death and promote maturation of NMJs. Similarly, motoneuron derived 
trophic factor acting on muscle fibers (myotrophic factors) may play a role in the generation of 
secondary myotubes and the maturation of fiber type characteristics in developing muscle. The 
identity of trophic factors has not been determined with certainty, although a number of candidate 
molecules have been proposed. Deterioration of the NMJ prevents the exchange of trophic factors, 
and hence, may induce degeneration of both motor axon and muscle fiber.
Together, an age-associated deterioration of the structure and the function of the NMJ takes place, 
ultimately causing structural and functional denervation. Denervated muscle fibers not receiving 
compensatory reinnervation within weeks become progressively atrophic and eventually disappear. 
Difficulties to establish functional NMJs could have influence on the regeneration of the muscle 
by reinnervation of denervated fibers. Newly formed muscle fibers can’t be maintained if the 
formation of a stable NMJ is not possible. Regeneration has clearly been shown to be impaired in 
senescence and failure of reinnervation is one of the most convincing explanations. Whether a loss 
of motoneurons or muscle fibers induces the NMJ deterioration or whether a deterioration of the 
NMJ leads to the absence of trophic factor supply and consequentially death of the motoneuron 
and muscle fiber is currently not known. 
1.4.6 oxidative damages to mitochondria compromise mitochondrial function in age 
One of the most popular mechanisms thought to cause aging in skeletal muscle and other highly 
metabolic active cells, such as neurons and cardiac myocytes, is oxidative stress. Reactive oxygen 
species (ROS), normally produced by mitochondria, may cause oxidative damage to organelles, 
lipids, proteins, and DNA (in particular mitochondrial DNA (mtDNA))422. Over a lifetime, the 
accumulated damage becomes sufficient to compromise cellular function and may result in 
permanent removal of the cell by apoptosis. This mechanism is consistent with the distribution of 
aging effects in skeletal muscle. Within the same muscle, myofibers can be differentially affected, 
suggesting a mechanism that distinguishes between distinct fibers and does not damage the whole 
muscle423. Mitochondrial production of ROS significantly increases in skeletal muscle over the 
course of aging424. ROS production was 1.7 fold greater in mitochondria isolated from 36-month 
compared to 6-month rats, and was accompanied by an increase in a DNA repair enzyme (8-
oxoguanine glycosylase 1). ROS induced oxidative damage leads, over time, to mtDNA mutation 
deletions that result in dysfunctional mitochondria425. There are several characteristics of mtDNA 
that suggest it could be involved in the decline of mitochondrial function with age426. It codes for 
13 subunits of the respiratory chain and oxidative phosphorylation system, 2 rRNAs and all the 
tRNAs necessary for translation. In detail, 7 subunits of complex I, 1 subunit of complex III, 3 
subunits of complex IV, and 2 subunits of the ATP synthase are encoded by mtDNA. MtDNA is 
situated in the mitochondrial matrix where it may be vulnerable to damage from ROS generated 
1
Introduction
by the mitochondrial electron transport chain (ETC). The absence of DNA-protecting proteins 
like histones and some of the repair mechanisms associated with nuclear DNA renders mtDNA 
particularly susceptible to damage. Moreover, mtDNA undergoes a continuous turnover both in 
mitotic and post-mitotic cells and the DNA polimerase that is involved in mtDNA replication is 
believed to have a high error rate. This vulnerability of mtDNA has led to the suggestion that the 
accumulation of somatic mtDNA mutations might play a role in the aging process, especially 
in highly metabolic cells such as skeletal muscle. The preferential accumulation of deleterious 
mitochondrial mutations in a restricted subset of aging tissues may correlate with age-related 
deficiencies of function in those tissues.
Age-related decline in whole muscle oxidative capacity is well established427-430, and was partially 
accounted for by reduced mitochondrial volume. Reduced volume of each mitochondria rather 
than a reduced number of mitochondria seems to be responsible for this age-associated loss of 
mitochondrial volume. Several studies constantly reported a loss of volume per mitochondria in 
the range of about 30%, whereas the results about the number of mitochondria are conflicting431-433. 
Reduced mitochondrial volume is also reflected by a decline in the number of copies of mtDNA 
and the concentration of mtDNA transcripts in older muscles434,435.
Interestingly, Conley et al.428 found that not only reduced mitochondrial volume density but also 
reduced oxidative capacity per mitochondrial volume were responsible for the loss of oxidative 
capacity per volume of vastus lateralis muscle seen in elderly compared to adult human subjects. 
Reduced capacity of the mitochondria themselves implies mitochondrial dysfunction with 
age. Indeed, a number of studies found a progressive age-associated decline in mitochondrial 
respiratory chain function in skeletal muscle mitochondria422,426,436-442. Especially complexes I and 
IV of the ETC and the ATP synthase are susceptible to age-related alterations, whereas complexes 
II and III are largely unaffected. This reflects the extent to which these complexes are encoded 
by mtDNA, indicating an influence of age-associated mitochondrial DNA mutations on ETC 
function. Cooper et al.426, using human skeletal muscle mitochondria, showed that the activities 
of complexes I and IV decreased by 59% and 47%, respectively between 20-30 years and 60-90 
years of age. Substantial reductions in ETC functions occurred also in mitochondria harvested 
from the gastrocnemius muscle of old mice (20 months) compared to those from adult mice (10 
months)437. Most notable were reductions in the activities of complexes I, III, and IV, kinetic 
alterations for complexes III and IV, and loss of high-affinity sites for complex IV. Complex II, 
the one complex without mtDNA-coded component, was not affected. Another indication for age-
associated mitochondrial dysfunction is the disproportionate change in one enzyme versus another 
that can be observed in aged skeletal muscle. Hagen et al.425 demonstrated that the reduction in flux 
through ETS complexes I-III was greater than the reduction in citrate synthase activity in older 
rats. Moreover, it has been shown that mitochondrial abnormalities are more frequent in muscles 
undergoing sarcopenia153. The number of muscle fibers with ETC abnormalities, represented by 
complex IV (cytochrome-c oxidase, COX) deficiencies and increase in complex II (succinate 
dehydrogenase, SDH) activity, was increased with age in vastus lateralis and soleus muscles of 
rats. Fiber reconstructions showed that the cross-sectional area of ETC-abnormal fibers decreased 
in the abnormal region (region displaying COX-/SDH+ phenotype), whereas control fibers did 
not. Muscles undergoing high degree of sarcopenia in regard to fiber loss, exhibited more ETC 
abnormalities, suggesting a direct association between ETC abnormalities and fiber loss. Wanagat 
et al.152 found that ETC abnormalities are increased from 289 in 5-months-old rats to 1094 in 
38-months-old rats in the entire rectus femoris muscle. Additionally, segmental mitochondrial 
abnormalities contained mitochondrial DNA mutations as revealed by laser capture microdissection 
and whole mitochondrial genome amplification. Muscle fibers harboring mitochondria deletions 
often displayed atrophy and splitting. It has been concluded that age-associated mitochondrial 
2
Introduction
DNA mutations play a causal role in sarcopenia. 
Mitochondrial DNA mutations have long been thought to compromise mitochondrial function443. 
Small deletions and insertions444,445, as well as large deletions446,447 and specific point mutations448 
have been observed in mtDNA of diverse tissues with aging. Cortopassi and Arnheim449 probed 
mtDNA from older humans for a specific 5 kb deletion previously found only in patients 
affected with the rare neuromuscular diseases Kearns-Sayre syndrome and progressive external 
opthalmoplegia. They found this deletion in heart and brain of older adults, but failed to detect 
it in fetal tissues, suggesting that this pathogenic deletion could accumulate with age. Indeed, 
in old skeletal muscle, accumulation of this 5kb deletion of mtDNA was found in several 
studies426,440,450,451. The age-associated accumulation of this mutation and ETC deficiency appear to 
be chronologically and quantitatively correlated. However, the low absolute level of this mutation 
on older subjects is unlikely to contribute significantly to the observed mitochondrial dysfunction. 
The increased incidence of the 5kb deletion could rather be indicative of multiple accompanying 
mtDNA mutations, and the decrease in ETC activities could be the result of an age-associated 
increase in random mtDNA mutations. Torii et al.452, examining diaphragm muscle from 34 
humans, detected multiple mtDNA deletions particularly among the elderly. A 3.4 kb deletion of 
mtDNA was found in 0% of the subjects under age 30, in 28.6% of those in their sixties, in 72.7 
% of those in their seventies and in all of those over age 80. This deletion included the genes for 
four subunits of complexes I and IV. The activities of these two complexes have been shown to 
decrease most dramatically in relation to age, suggesting a direct connection between mutation and 
functional deficits. Hayakawa et al.453,454 more directly showed that ROS were responsible for the 
age-associated accumulations of mtDNA mutations. A hydroxyl-radical adduct of deoxyguanosine 
(dG), 8-Hydroxy-deoxyguanosine (8-OH-dG), accumulated in mtDNA from human diaphragm 
and heart muscles. In subjects below 55 years of age, the level of 8-OH-dG in diaphragm mtDNA 
was below 0.05% of the total dG, whereas, in subjects over 65 years of age, the level of 8-OH-
dG increased with age at a rate of 0.25% per 10 years, reaching 0.51% at age 85. In addition, a 
concomitant increase in multiple deletions was detected with increasing age. Accumulations of 
8-OH-dG in mtDNA could trigger double-strand separation that favors DNA deletions.
The percentage of mtDNA mutations accumulating with age varies substantially from tissue to 
tissue. Selective amplification of the common 5kb deletion of the mitochondrial genome has been 
used to quantify the extent of the deletion’s accumulation in a variety of human tissues, including 
heart, brainstem, brain cortex, psoas and diaphragm muscle, liver, kidney, skin, spleen, testis, and 
lung450,455,456. The deletion occurred at much higher level in nervous and muscle tissues than in all 
other tissues studied. Skeletal muscle and nervous tissue are especially susceptible for mtDNA 
mutations with age, a finding that could be accounted for by the high metabolic rate of these 
tissues, producing high amounts of ROS.
Not only mtDNA but also mitochondrial proteins and lipids are a target for oxidation by ROS. 
Oxidative modifications of proteins increase with age and lead to protein cross-linking, proteolysis 
and loss of functional activity457. Choksi et al.458 found for example that a dramatic age-related 
decline in almost all ETC complex activities correlates with increased oxidative modification of 
the ETC subunits, whereas the overall protein amount was not changed. Oxidative damages to 
ETC subunits by mitochondrial ROS may lead to further mitochondrial dysfunction. Enhanced 
lipid peroxidation, on the other hand, leads to decreased fluidity of cell membranes459. Oxidative 
damage of cardiolipin, a crucial component of the inner mitochondrial membrane, is particularly 
deleterious as this phospholipid is required for the activity of mitochondrial enzymes.
Very recently, it has been shown that mice lacking the antioxidant enzyme CuZnSOD (Sod1) are 
characterized by high levels of oxidative damage and an acceleration of sarcopenia460. Muscle 
atrophy in Sod1 deficient mice was accompanied by a progressive decline in bioenergetic function 
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and an elevation of mitochondrial ROS generation. As a consequence, more rapid induction of 
mitochondrial-mediated apoptosis and loss of myonuclei have been observed. Interestingly, aged 
Sod1-deficient mice showed increased NMJ fragmentation and denervation and the contractile 
force in these mice was greatly diminished. These findings demonstrate that increased ROS levels 
can lead to oxidative damage, mitochondrial dysfunction, muscle atrophy and even denervation 
and fragmentation of the NMJ.
Together, oxidative damages caused by ROS have an influence on aging skeletal muscle. The 
susceptibility of skeletal muscle and nervous tissue to ROS induced mtDNA damage and the 
prevalence of mitochondrial dysfunction in aged muscle provide evidence that this process 
contributes to the pathogenic ensemble resulting in sarcopenia. It is well-established that oxidative 
damages comprise the oxidative capacity of skeletal muscle. However, it is not fully understood 
whether and how oxidative damages can lead to muscle fiber atrophy and loss. There is increasing 
evidence that cell death by apoptosis could be involved. 
1.4.7 Role of apoptosis in sarcopenia
Apoptosis denotes a form of cell death that is highly regulated and characterized by specific 
morphological, biochemical, and molecular events. It is essential to normal development of 
multicellular organisms and is involved in cell turnover and remodeling in healthy and diseased 
tissue. During apoptotic cell death, cells successively shrink without detectable release of their 
constituents. The shrunken apoptotic remnants are then phagocytosed by macrophages and their 
constituents recycled. Apoptosis is promoted by death-inducing signals, such as ROS and the 
cytokine tumor necrosis factor (TNF)-α, imbalances in calcium regulation, and alteration in the 
composition and abundance of Bcl-2 family proteins (Bax, Bad, Bcal-2, Bcl-xl, etc.). After this 
induction phase, nuclear activators, activation of cell surface receptors, or mitochondrial pathways, 
such as the release of cytochrome c and/or apoptosis inducing factor (AIF), contribute to the 
commitment to cellular death461. Cytoplasmic and nuclear events are involved in the execution 
of cell death. A cascade of protein-cleaving enzymes called caspases is activated in the cytosol 
and is responsible for the breakdown of a broad spectrum of cellular targets. In the nucleus, DNA 
fragmentation caused by activated endonucleases, chromatin condensation, and breakdown of the 
nuclear envelope occurs. There are also caspase-independent pathways, such as the release of AIF 
and endonuclease G (EndoG) from mitochondria, which induce large scale DNA fragmentation 
and apoptosis after translocation in the nucleus.
Accelerated apoptosis with aging has been found in several mitotic tissues, like for example 
liver and white blood cells, and may serve to prevent age-associated tumorgenesis. Apoptosis in 
post-mitotic tissues, such as skeletal muscle, in contrast, may result in diminished tissue function 
with normal aging. There is some evidence indicating a role of apoptosis in pathophysiological 
skeletal muscle cell loss. However, with respect to apoptosis, skeletal muscle is a unique tissue, 
because muscle cells are multinucleated. Within the individual muscle fiber, not all nuclei are 
transcriptionally equivalent, and each nucleus governs the surrounding cytoplasmic area, called 
the myonuclear domain302. Although muscle size can vary considerably under different conditions, 
the size of the myonuclear domain remains relatively stable, implying a fairly strict regulation of 
myonuclear number at least in muscles from young adults. This regulation is governed by two 
opposing processes: the gain of myonuclei by fusion of satellite cells into hypertrophying muscle 
fibers and the loss of nuclei in atrophying muscle fiber461. A decline in myonuclear number has been 
found in muscles undergoing atrophy in a variety of experimental conditions, such as spinal cord 
isolation and transection, microgravity, hind limb suspension and chronic denervation271,462-469. The 
process by which nuclei are eliminated from multinucleated muscle fibers shares similarities with 
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apoptosis, since it involves chromatin condensation and DNA fragmentation, which are considered 
to be hallmarks of apoptosis. However, apoptosis in a multinucleated myofiber should actually 
be termed apoptotic nuclear death because destruction of the entire cell does not necessarily 
follow elimination of the nucleus as in mononucleated cells461. There is some evidence that one 
or more myonuclei can be eliminated by apoptosis without affecting the other nuclei within the 
same cytoplasm. Therefore, the mechanisms by which nuclear cell death occurs in muscle fibers 
may be distinct from those involved in apoptosis in mononucleated cells where nuclear as well 
as cytoplasmic contents are cleared. Nevertheless, apoptosis plays an important role in skeletal 
muscle atrophy since it is increased in a number of pathological and physiological conditions. 
Motoneuron diseases, skeletal muscle denervation, spinal cord injury, muscular dystrophy, 
hindlimb suspension or immobilization, and acute exercise are all associated with an increase in 
DNA fragmentation that is usually associated with apoptosis462,463,466,469-473.
The incidence of apoptosis in skeletal muscle with age has not been well investigated. Dirks 
and Leeuwenburgh474 quantified apoptosis in 6-month-old and 24-month-old rats and found a 
50% increase in cytosolic mononucleosomes and olignucleosomes in the aged compared with 
the young animals. Other apoptotic markers, such as cytosolic cytochrome c, caspase-3 activity, 
and mitochondrial Bcl-2 and Bax, were not altered with age. This finding does not favor the 
hypothesis that, with aging, mitochondrial dysfunction and oxidant stress to mitochondria could 
induce the mitochondrial permeability transition, the release of cytochrome-c, and subsequent 
initiation of apoptosis475. More recently, myocyte expression of procaspase-3, cleaved caspase-3 
and the extent of DNA fragmentation were reported to be elevated in the gastrocnemius muscle 
of aged rats, suggesting an involvement of apoptosis-like processes in sarcopenia. However, 
activity of caspase-3 and levels of cytochrome c and caspase-9 were not changed with age476. The 
protein levels of XIAP, an inhibitor of caspase-3 were increased in the aged muscle, suggesting 
that a compensatory mechanism opposing the increase in caspase-3 protein content may dampen 
caspase-3 activity. Later, Leeuwenburgh et al.477 found that EndoG co-localized with nuclei in 
soleus muscle of old rats, indicating that this caspase-independent pathway could play a role in 
sarcopenia. Very recently, Marzetti et al.478 analyzed the gastrocnemius muscle of 8-, 18-, 29-, 
and 37-month old rats for the occurrence of apoptosis. Apoptotic DNA fragmentation, as well 
as cytosolic and nuclear levels of the caspase-independent apoptotic mediators AIF and EndoG 
increased progressively with age, paralleling the loss of muscle mass. On the contrary, cytosolic 
content of cytochrome c remained unchanged over the course of aging and levels of active caspase-
9 were slightly elevated in old (29-month) but not in senescent (37-month) rats. Mitochondrial 
levels of both anti-apoptotic Bcl-2 and pro-apoptotic Bax were significantly increased in the very 
old (37-month) but not in the old (28-month) animals. The balance between these two mediators, 
which is believed to regulate mitochondrial membrane stability, was not changed. According to 
these findings, the authors concluded that mitochondrial caspase-independent apoptotic signaling 
might play a more prominent role in age-related muscle wasting compared to the caspase-
dependent pathway. As a potential apoptosis inducing mechanism they suggested age-associated 
deletion mutations in the mitochondrial genome.
Oxidative stress has been claimed to lead to the activation of apoptosis via its effect on 
mitochondria479. Age-related increase in ROS may lead to an increase in apoptosis and hence, 
atrophy and eventually loss of muscle fibers. Another potential mechanism for age-related fiber 
atrophy or loss is the activation of apoptosis in denervated muscle fibers. Cell death in denervated 
skeletal muscle is distinct from, but related to classical apoptosis. Hypercondensed chromatin and 
fragmented nuclei typical of apoptotic cells can be observed in muscle tissue 2, 4 and to a lesser extent 
7 months after denervation469. Electron microscopy revealed clear morphological manifestations 
of muscle cell death, with ultrastructural characteristics very similar to those considered as nuclear 
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and cytoplasmic markers of apoptosis. Another marker of apoptosis, the presence of nuclear DNA 
fragmentation, was analyzed by the TUNEL (terminal deoxyribonucleotidyl transferase mediated 
dUTP nick end labeling) method. The number of nuclei with abnormal morphology exceeded by 
over 30 times the number of TUNEL positive nuclei, indicating that genomic DNA fragmentation 
is not an obligatory event during atrophy and cell death of muscle cells, or, alternatively, it may 
occur only for a short time period during this process. In contrast to classical apoptosis, non-
inflammatory death of muscle fibers in denervated muscle occurs a long time after removal of 
myotrophic influence. 
Since apoptosis is increased in aged muscles and muscle fibers decrease in size with aging, it 
was expected that myonuclear number would decrease and a constant myonuclear domain would 
be maintained. However, studies in humans and rats have indicated that there is no decrease in 
myonuclear number with age, but rather aged muscles exhibit a smaller myonuclear domain477,480,481. 
Because increased amounts of centrally nucleated fibers have constantly been observed in aged 
muscles (see above), fusion of satellite cells to replace the nuclei lost by apoptotic nuclear death 
is a probable scenario271. Smaller myonuclear domain in aged subjects may be attributable to 
impaired function and lower efficiency of aged nuclei, which could be the consequence of 
oxidative damages.
Together, apoptosis, most likely via the mitochondrial caspase-independent pathway, appears to 
be elevated in aged skeletal muscle. Both oxidative damages to mitochondria and denervation 
of muscle fibers are potentially inducing apoptosis. If other signals, such as elevated levels of 
calcium, could induce apoptosis in age has to be determined. However, it is unclear whether 
apoptosis contribute to age-associated muscle fiber atrophy or loss. Apoptotic loss of myonuclei in 
aged muscle is counteracted by fusion of satellite cells. Finally, it is not the loss of myonuclei but 
rather the decreased myonuclear domain that contributes to fiber atrophy. Alternatively, apoptotic 
nuclear cell death following denervation or oxidative damage may lead to the death of the entire 
muscle cell and contribute to the age-related loss of muscle fibers. In such a scenario, a lower 
myonuclear number would not be found.
1.4.8 The influence of physical activity on sarcopenia 
The neuromuscular degeneration observed in aging animals has also been proposed to be due to 
changes in motoneuronal activity rather than aging per se423. Generally, senescence is associated 
with reduced physical activity in humans482, although some older people maintain a high level of 
activity. The tendency to be less active in old age appears to be a universal phenomenon, occurring in 
different species, such as fruitflies, rodents, monkeys and humans. However, contradictory reports 
demonstrate the difficulty of the assessment of physical activity. Physical activity, quantitated by 
three-dimensional accelerometer worn about the waist for one weak, was for example not found 
to be decreased in old (65-83 years) compared to young (26-44 years) adults274. Robbins and 
Fahim401 analyzed the locomotor activity in adult (5-9 months) and aged (27-31 months) mice. 
The daily activity, continuously monitored over 24 hours, was averaged over a 20-day-period and 
varied greatly between individual mice, with about twofold difference between the least and the 
most active mice. The mean average daily activity and the mean lowest and highest activity of the 
two age groups were not significantly different. This result was in contrast with most studies of 
rats and other mice, in which a decline in locomotor activity of 57-64% was noted between 6 and 
30 months483. However, previous studies entailed only single or multiple trials over a few minutes 
duration, which may lead to a less accurate picture of overall activity. Thus, decline in physical 
activity is not necessarily associated with aging. It may depend on species and environment, and 
certainly varies greatly between individuals.
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Decrease in activity results in general muscle atrophy and a decline in muscle strength. Patrick 
et al.151 analyzed body fat and muscle in 73 manual workers at and 1 year after retirement and 
found an increase in body fat and a decrease in body muscle. The decline in muscle was more 
pronounced in a subgroup of 22 men who reported that their activity was less after the retirement. 
Because the assessment of physical activity over a long time period bears a lot of difficulties, bed 
rest or immobilization is often used as short-term model for decreased physical activity. Data 
form human studies of experimental bed rest, lower limb unloading, or spaceflight ranging from 
2 to 6 weeks reported strength losses in range of 12-25% for knee and ankle extensors484-492. 
Thereby, type specificity was not detected485,493. Strength losses have mainly been accounted for 
by decreased skeletal muscle mass. A 2-3% weekly rate of atrophy has been found in the majority 
of studies examining healthy individuals after 1-6 weeks of unloading or bed rest484,485,487,491-497. 
However, the decline in strength could not entirely be attributed to the decrease in muscle CSA. 
Therefore, it has been suggested that the strength loss could also be due to factors resulting in 
decreased neural input to muscle or decreased specific tension of muscle. Recently, Suetta et al.498 
showed that 2 weeks of immobilization caused decreases in strength, quadriceps volume and 
specific force in both young and old men. After 4 weeks of retrain initial values of strength and 
quadriceps volume were reached in both groups, indicating that the changes to immobilization do 
not include irreversible loss of muscle function or mass. Most likely, fibers were atrophied, but 
not lost during immobilization.
Data obtained in animal studies are in close agreement with the findings in humans. Reductions in 
muscle weight and strength were between 20 and 50% after 1-6 weeks of hindlimb immobilization 
or suspension in adult rats499-503. Similar atrophy was observed after unloading in weightlessness 
during spaceflight in rats504 and monkeys505. In a number of studies a decrease in proportion of 
type I fibers during unloading has been detected in rats501,506-510. However, alterations in fiber type 
composition were not associated with a change in fiber number511,512. 
Interestingly, an increase in intramuscular connective tissue, regularly observed in sarcopenia, 
has been found in several studies of hindlimb immobilization in rats508,513,514 and lower limb 
suspension in humans515. Moreover, a significant linear relationship between physical activity 
and percent noncontractile content of muscle was found in old, but not in young subjects274. Thus, 
physical activity can modulate the age-related increase in noncontractile muscle components, 
but appears not to influence the amount of connective tissues in young subjects. Experimentally 
induced muscle disuse in rats has also been reported to lead to denervation-like alterations501 and to 
changes in motor nerve terminals such as increased turnover and sprouting516. However, functional 
parameters, such as miniature endplate potential frequency, specific membrane resistance or resting 
membrane potential were unaffected by periods of disuse as long as 6 weeks417,517. On the other 
hand, increase in synaptic efficiency (increased fractional release of ACh and faster recovery) 
and a small spread of extrajunctional ACh sensitivity was observed, indicating that the level of 
conducted neural activity affected postsynaptic receptor distribution. However, the magnitude 
of the changes suggest that subtle decreases in normal cage activity with advancing age may not 
have significant effects on the morphology of the NMJs518. The motoneurons seem also not to be 
affected by decreased physical activity. No changes in morphological or metabolic properties of 
spinal motoneurons innervating soleus muscle have been observed following 2 weeks of hindlimb 
unloading in young adult rats, although muscle atrophy was observed510. Importantly, all studies 
concur that immobilization induced changes are to a great extent reversible phenomena, especially 
if remobilization is intensified by physical training. 
Together, decrease in physical activity results in muscle atrophy that shares features with sarcopenia 
but fails to explain typical characteristics of sarcopenia. Fiber atrophy, loss of strength, increase 
in intramuscular connective tissue, and remodeling events at the NMJ can be observed in both 
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immobilization atrophy and sarcopenia. However, loss of muscle fibers has not been observed 
in models of muscle disuse and increased heterogeneity of fiber thickness, involving atrophy 
and hypertrophy within the same muscle, is clearly not a result of decreased physical activity. 
Thus, although a reduction in the amount of physical activity with aging undoubtedly contributes 
to atrophy, it can’t account for sarcopenia. Alteration in physical activity may rather modulate 
than induce age-related muscular changes. Furthermore, models of immobilization simulate an 
extreme situation, in which movement is completely abolished. Aging is associated with, at most, 
a slight decrease in physical activity, and not with complete immobilization. Immobilization may 
result in effects that are by far more severe than those upon slight reduction of activity. On the 
other hand, although immobilization does induce a decrease or cessation of muscle activity, the 
immobilized muscle never become inactivated completely, since the structural continuity of the 
neuromuscular apparatus is maintained519. Similarly, decreased physical activity does not lead 
to complete blockage of neuromuscular activation. Thus, it does not induce situations where a 
complete absence of neural activation can occur, which is certainly the case in individual fibers 
from sarcopenic muscles. Moreover, individuals maintaining a high physical activity also suffer 
from sarcopenia, indicating that reduced physical activity alone does not account for sarcopenia. 
Decreased physical activity may rather be a consequence than a cause of age-related neuromuscular 
deterioration. Sarcopenia, by making physical activity more difficult, may be one of the reasons 
for being inactive.
Increasing physical activity, on the other hand, can induce muscle growth in young adults520,521. 
However, these adaptations to changes in muscle activation involve modifications in the CSAs 
of individual muscle fibers rather than in fiber number. There appears to be little, if any, increase 
in fiber number in response to exercise training in young subjects. Gollnick et al.522 demonstrated 
for example that muscular enlargement by synergistic ablation and/or treadmill exercises resulted 
in increase in muscle weight from 10 to over 100%. Muscle fiber hypertrophy, increase in CSA, 
but not hyperplasia, increase in fiber number, was detected in soleus, plantaris and EDL muscles 
of rats. Similarly, overloading of chicken anterior latissimus dorsi muscle, which might be more 
similar to weight-lifting activities as practiced by man, resulted in enlargement of skeletal muscle 
that was entirely due to hypertrophy of preexisting fibers and not due to formation of new ones523. 
These findings suggest that exercise training in the elderly probably does also not restore the 
number of fibers lost to aging. Daw et al.199 demonstrated that exercise training did not affect the 
soleus fiber number in aged rats, although muscle mass was 113% of sedentary controls. Although 
regular exercises can avoid, or at least delay, disability caused by sarcopenia, they cannot prevent 
a relative decline in muscle mass and performance174,524-529. It remains unclear whether the increase 
in whole muscle size in aged people after resistance training530-533 results from the hypertrophy 
of only healthy fibers or whether it also benefits the severely atrophied fibers: the answer to 
this question will be critical to understand whether exercise training actually affects fundamental 
aging processes in skeletal muscle or merely slows the consequences of fiber loss and selective 
atrophy by promoting compensation by healthy fibers. 
1.4.9 Biochemical changes in the aging muscle
1.4.9.1 Age-associated changes in protein synthesis
Proteins represent the most important muscle constituents and accounts for about 20% of muscle 
weight. An imbalance between removal of old and damaged muscle proteins and synthesis of new 
ones could potentially contribute to the age-associated loss of muscle mass534. To understand the 
biochemical basis for sarcopenia, protein synthesis and breakdown rates have been compared 
in subjects of different ages. Since muscle contributes less than 30% to the whole body protein 
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turnover, whole body measurements are inappropriate for determining small alterations in muscle 
protein synthesis and breakdown. Thus, fractional synthesis rates of mixed or myofibrillar proteins 
from muscle biopsy samples have been measured. A number of studies demonstrated a progressive 
decline in fractional muscle protein synthesis with age, indicating that aging is associated with 
a reduced capacity of skeletal muscle to synthesize new proteins165,166,535,536. A decrease of 28% 
in the synthesis rate of myofibrillar proteins in the elderly has been reported, measured by in 
vivo incorporation of 13C labeled leucine into myofibrillar proteins obtained by muscle biopsy165. 
Whole body protein synthesis, in contrast, was only marginally slower. However, these results 
have been challenged by other studies537,538. Volpi et al.538 did not find an age-related change in the 
fractional synthesis or breakdown rate of skeletal muscle protein. The contrast to previous studies 
was explained by a combination of factors. Any dietary manipulations prior to the study were 
avoided and only healthy and active people were intentionally selected. Importantly, in contrast to 
previous studies, not only muscle protein synthesis rate, but also the breakdown and net balance 
of muscle proteins was measured. Quantification of breakdown is absolutely required to draw any 
conclusions on the mechanisms leading to the loss of skeletal muscle mass. The authors calculated 
that, without a change in protein breakdown rate, a 30% reduction in the myofibrillar and mixed 
muscle protein synthesis rate would have resulted in a net loss of approximately 60% of the 
muscle mass within one year. This reduction is inconsistent with the natural history of sarcopenia 
that develops over decades and suggests that the measurements of that large decrease in muscle 
protein synthesis rate may reflect an acute response to the experimental design. Differences in 
basal muscle protein turnover between old and young subjects do not appear to explain age-
related muscle mass loss.
Importantly, the synthesis rate of mixed muscle or myofibrillar protein represent an average 
measure of the synthesis rate of several proteins. Different muscle proteins are synthesized at 
different rates and regulated by different genes. An insight into the pathophysiology of sarcopenia 
at the molecular level requires measurement of the synthesis rate of smaller groups of proteins 
or even individual proteins. Rooyackers et al.142 found for example a substantial age-associated 
decline in the rate of mitochondrial protein synthesis in skeletal muscle. From young (24 yr) to 
middle age (54 yr), there was a decrease in mitochondrial protein synthesis rate of on average 
40%, whereas no further decrease was observed in individuals at older age (73 yr). In agreement 
with this finding, a reduction in muscle respiratory capacity with aging has been observed (see 
above). Balagopal et al.166 found that myosin heavy-chain synthesis rate declined progressively 
with advancing age, whereas sarcoplasmic protein synthesis remained constant. A decline in the 
rate of myosin heavy-chain synthesis could contribute to diminishing contractile function in the 
elderly. Welle et al.435 used serial analysis of gene expression (SAGE) to perform a broad search 
for transcripts expressed at quantitatively different levels in vastus lateralis muscle of young (21-
24 yr) and older (66-77 yr) individuals. The mRNAs encoding several mitochondrial proteins 
involved in electron transport, including several subunits of complexes I and IV, and subunits 
of ATPsynthase were about 30% less abundant in older muscle, a finding that may be partially 
explained by the lower mitochondrial volume of aged muscles (see above). Furthermore, the 
expression of several genes encoding enzymes involved in glucose metabolism was also decreased 
in older muscle. Beside synthesis, also spatially expression of muscle proteins could be changed 
with aging. The expression pattern of myosin heavy-chain was altered with aging, resulting in 
an increased occurrence of single fibers expressing two or more isoforms180. Marked alterations 
occurred in the concentrations of proteins in the sarcoplasmic reticulum. The concentration of the 
Ca2+-ATPase was reduced in older subjects, whereas the concentration of the Ca2+-channel release 
protein was actually increased. These age-related alterations in protein expression may contribute 
to the slowing of muscle contraction with age.
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Recently, gene expression in aged skeletal muscle has been analyzed using high-density 
oligonucleotide microarrays. Differential gene expression pattern indicative of a marked stress 
response and lower expression of metabolic and biosynthetic genes have been observed with 
aging in the gastrocnemius muscle of mice539-541. Mediators of stress responses, such as oxidative 
damage inducible and DNA damage inducible genes, increased in expression with age, whereas 
the expression of genes associated with mitochondrial function and turnover was decreased. 
Furthermore, aging was characterized by inductions of genes involved in neuronal growth. 
These findings imply accumulation of oxidative damage, reduction in energy metabolism and 
nerve sprouting in aged skeletal muscles. A similar transcriptional profiling on the soleus muscle 
of young compared to old rats revealed an extensive downregulation of extracellular matrix 
genes542. 24% of the downregulated genes have a biological role in the extracellular matrix and 
cell adhesion. The genes with increased expression with age were involved in immune response, 
proteolysis, ubiquitin-dependent degradation and stress response. Interestingly, the expression 
of the mRNA of several subunits of AChR was increased in the old compared to young soleus 
muscle, probably reflecting the appearance of extrajunctional receptors and denervated muscle 
fibers in aged muscles. Kayo et al.543 examined mRNA from vastus lateralis muscles of young 
adult, middle-aged and old rhesus monkeys. Aging was associated with reduced expression of 
genes involved in mitochondrial electron transport and oxidative phosphorylation, and with 
upregulation of transcripts involved in oxidative stress responses, reinnervation of muscle fibers, 
and inflammatory or immune responses. Later, the gene expression profile of aging in human 
vastus lateralis muscle was established544. In accordance with previous findings, the expression of 
genes with a function in energy metabolism and mitochondrial protein synthesis was decreased 
in older muscle, whereas the expression of components of the ubiquitin-proteasome proteolytic 
pathway was increased. Expression of numerous genes involved in stress responses, hormone/
cytokine/growth factor signaling, control of cell cycle and apoptosis, and transcriptional regulation 
appeared to be affected by aging. However, these changes tended to be of low magnitude and the 
analysis is complicated by the heterogeneity of human muscle samples. Therefore, the so-called 
molecular signature, the smallest number of gene expressions that is required to identify aged 
muscle, was established545. The molecular signature of sarcopenia among 10 young and 12 older 
male subjects included 45 genes. Interestingly, genes involved in mediating cellular response to 
inflammation and apoptosis were expressed at higher levels in aged skeletal muscle, suggesting 
an involvement of these processes in sarcopenia. More information about genes that show age-
related differences in expression are important for the understanding of the molecular events 
underlying sarcopenia and may lead to novel treatment strategies.
1.4.9.2 Influence of age-associated endocrine changes on sarcopenia
The growth and maintenance of muscles is regulated by a number of hormones and growth factors. 
Some of these are produced in remote organs and are transported to muscle in the blood (endocrine 
signals), while others are produced locally in the muscle (autocrine and paracrine signals). There 
is an age-associated decline of the circulating levels of several hormones, such as testosterone, 
estradiol, growth hormone (GH), and insulin-like growth factor-1 (IGF-1). Serum Tumor necrosis 
factor-alpha (TNF-α), interleukin-6 (IL-6), and cortisol levels, in contrast, are increased in old 
age529. All these age-associated hormonal changes might potentially contribute to sarcopenia.
1.4.9.2.1 Steroids
Androgens, such as testosterone, regulate muscle mass in humans546. Testosterone administration 
has been shown to increase muscle size and strength, and fat-free mass in normal men in a dose 
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dependent manner547. Testosterone binds to androgen receptors, which are predominantly expressed 
in satellite cells and myonuclei548,549. It increases satellite cell number by potentially regulating 
their proliferation and differentiation549,550, and leads to greater numbers of myonuclei in larger 
myofibers551. There is increasing evidence that androgens interact with IGF-1 in skeletal muscle552. 
In rat diaphragm muscle, a dose dependent increase in IGF-1 mRNA expression occurred following 
exposure to androgen553. When harvested bovine male satellite cells were treated with various 
androgen concentrations, a dose dependent increase in IGF-1 mRNA expression occurred554. 
Similarly, increase in serum IGF-1 levels has been positively correlated with concentrations of 
testosterone administrated to young men547.
Between the ages of 25 and 86 years, testosterone levels decrease by 60% and 28% in healthy 
males and females, respectively259-261. In about 60% of men over the age of 65, testosterone levels 
decrease to below the normal values in young men163. Due to the anabolic effects of testosterone 
on skeletal muscle, it has been proposed that its decline could result in a loss of muscle mass555. 
Indeed, a relationship between serum testosterone levels and muscle strength in older man has 
been demonstrated by several studies. In contrast, a decrease in testosterone has not been linked 
to a decline in muscle mass or strength in women132,556,557. Several studies have examined the 
effect of testosterone replacement therapies and found a significant increase in muscle mass and 
strength, fat-free mass, protein synthesis and bone density in elderly men following testosterone 
application558-560. Like in young men, increase in muscle mass and strength and fat-free mass 
has been shown to correlate with the amount of testosterone administrated561. Older men are 
as responsive as young men to the anabolic effects of graded doses of testosterone on skeletal 
muscle. However, doses greater than 100 mg applied by weekly injections are needed to induce 
significant anabolic effects. Low doses of testosterone appear not to increase muscle mass and 
strength in the elderly562. Furthermore, increase in muscle mass may not always result in improved 
strength563. Together, decreasing testosterone level may not play a prominent role in the etiology 
of sarcopenia, since it fails to explain most of the sarcopenic phenotype. Moreover, a correlation 
of decreasing testosterone concentrations and muscle mass in aging women is missing, despite 
women also suffer from sarcopenia. It’s not very likely that fundamental sarcopenia promoting 
processes are different between men and women. Decreasing estradiol levels in women do also 
not mimick the effects of decreasing testosterone levels. Estradiol levels abruptly decrease during 
menopause. The decline in muscle mass, in contrast, progresses gradually over decades, suggesting 
only marginal, if any, role of decreased estradiol levels on sarcopenia. 
1.4.9.2.2 The growth hormone/insulin-like growth factor-1 axis
Many of the responses regulated by GH are primarily mediated by IGF-1 in tissues throughout 
the body564. IGF-1 is produced by the liver, but also by the skeletal muscle and is important for 
the pre- and postnatal development of skeletal muscle. There are local as well as systemic forms 
of IGF-1 that have different functions. The IGF-1 gene is subject to alternative splicing, resulting 
in at least two variants that are expressed from skeletal muscle including the so-called mechano 
growth factor (MGF)565.
It is generally accepted that serum IGF-1 concentrations decrease gradually with age163,566,567. 
However, it was for a longtime unknown whether skeletal muscle IGF-1 expression change during 
aging. Hamilton et al.568, using a ribonuclease protection assay, found that skeletal muscle IGF-
1 mRNA levels changed during maturation (decrease of 39-49% between 3 and 12 month old 
rats) but not during aging (12-24 month old rats) in the gastrocnemius muscles of rats. Recently, 
using quantitative RT-PCR on human muscle tissue, it has been demonstrated that older men 
tend to have lower IGF-1 mRNA levels in muscle569. In older muscle (62-77 yr) IGF-1 mRNA 
concentration was about 25% less, per ng total RNA, than in young adult muscle (21-31 yr). One 
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third of the older men had IGF-1 mRNA levels below the lowest concentration detected in young 
men. Thus, IGF-1, as an important regulator of muscle mass, could influence the development of 
sarcopenia. 
IGF-1 production is sensitive to increases in loading state of the muscles. Overloading of skeletal 
muscle produces hypertrophy and is associated with increase in IGF-1 mRNA and peptide level570, 
whereas unloading-induced atrophy is associated with decreased IGF-1 mRNA expression571. 
Especially one of the skeletal muscle isoforms of IGF-1, MGF, is expressed in response to physical 
activity and is responsible for the hypertrophy of a muscle in response to physical exercise. 
Consequentially, injection of MGF cDNA into skeletal muscle of mice results in a 25% increase 
in the mean muscle size within 3 weeks with a similar increase in muscle strength572. Similarly, 
Barton-davis et al.573 demonstrated that virus-mediated overexpression of IGF-1 in differentiated 
skeletal muscle fibers promoted an increase of 15% in muscle mass and 14% in muscle strength in 
young adult mice. Interestingly the ability to increase IGF-1 expression in response to mechanical 
overload is reduced in older muscles of rats160 and humans574. The increase in IGF-1 expression 
following muscle overloading is an adaption mechanism that is impaired in senescence.
Age-dependent decrease in IGF-1 concentrations, together with the ability of IGF-1 to induce 
hypertrophy in young muscles, suggests that low level of IGF-1 or unsuccessful increases of IGF-
1 level after induction may contribute to the etiology of sarcopenia. Several studies assessed the 
influence of sustained or even increased IGF-1 expression or application in old muscles. In old 
mice, viral mediated IGF-1 overexpression in skeletal muscle prevented age-related loss of skeletal 
muscle function, resulting in a 27% increase in strength compared with untreated muscle573. Muscle 
mass and fiber type distribution were maintained at levels similar to those in young adults. The 
authors proposed that these effects are primarily due to stimulation of muscle regeneration via the 
activation of satellite cells by IGF-1. There is evidence that IGF-1 is involved in the replication of 
satellite cells which is important for the continuing maintenance of muscle mass and function. The 
application of IGF-1 onto immobilized old skeletal muscle restores the proliferative potential of 
satellite cells and partially rescues the lost muscle mass284. Localized IGF-1 transgene expression 
in skeletal muscle of the mouse preserved muscle architecture and regenerative capacity in aged 
muscles575 and partially rescued age-dependent alterations in neuromuscular innervation576. Age-
related alterations of nerve terminal branching, of number, length, area and density of postsynaptic 
folds, and of postsynaptic α-bungarotoxin stained area were partially or completely rescued by 
sustained overexpression of IGF-1 in skeletal muscle. IGF-1 appears to enhance the reinnervation 
of muscle fibers and could be relevant to the repair and preservation of muscle function in more than 
one way. Evidence for different roles of IGF-1 in preservation of muscle function also comes from 
denervation studies in transgenic mice, which overexpresses IGF-1 specifically in differentiated 
myofibers317. The rate of denervation-induced atrophy was reduced by approximately 30% in 
these mice and myofibers with larger CSA were preserved. Here, innervation was not involved 
and the beneficial influence of IGF-1 was attributed to reduced protein breakdown. IGF-1 is also 
involved in age-related ECU by regulating transcription of DHPR224,577, which plays a key role in 
intracellular Ca2+ handling and muscle contractility (see above).
The cellular actions of IGF-1 are modulated by the actions of a family of six IGF binding proteins 
(IGFBP1-6). Although the precise role of these IGFBPs is poorly understood, the disruption 
of IGFBP expression has been found to impair myoblast proliferation, differentiation and 
maturation578-581. The circulating level of the IGFBP undergoes age-related alterations, thereby 
influencing the availability or the action of IGF-1. What effect this may have on skeletal muscle 
in detail has yet to be fully elucidated582.
The level circulating GH is also subject to age-related alterations. It is reduced to about one-third in 
aged (older than 70 years) compared to young proband (younger than 20 years)583. GH is known to 
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induce liver IGF-1 expression, but it was longtime unknown if circulating GH influences skeletal 
muscle IGF-1 gene expression584,585. Hameed et al.586 showed that GH treatment increased IGF-1 
levels in elderly man and when combined with resistance exercise more is spliced towards MGF, 
resulting in 450 % increase in MGF mRNA levels. This was significantly more than the change 
induced by resistance training alone (150%). However, treatments with GH, even in combination 
with resistance training, didn’t result in a significant increase in muscle CSA, compared to 
resistance training alone587. Although the senescent muscle remains responsive to hypertrophy, 
there is a limit to the improvement that can be obtained given the loss of muscle fibers that has 
occurred. 
In summary, IGF-1 can beneficially influence aging muscles and delay sarcopenia. This has been 
attributed to increased regeneration, preservation of innervation, increased reinnervation, and 
reduced muscle protein breakdown. However, it’s unclear whether sustained IGF-1 levels can 
counteract the fundamental sarcopenia promoting processes and, the other way round, whether 
decreasing IGF-1 levels actually cause sarcopenia. Increased IGF-1 level may rather induce 
regeneration or reinnervation than prevent the pathogenic process leading to sarcopenia per se.
1.4.9.2.3 Inflammation and sarcopenia 
Irreparably damaged skeletal muscle undergoes autolysis, followed by an inflammatory response 
that is critical for efficient muscle regeneration. A number of studies have suggested a link 
between aberrant inflammatory/cytokine signaling and sarcopenia588-591. Especially TNF-α and 
IL-6 have been implicated in the inflammatory response in skeletal muscle. An age-associated 
increase in the expression of these inflammatory markers is thought to contribute to the etiology 
of sacopenia592,593. 
TNF-α is a central mediator orchestrating cellular inflammatory and apoptotic signaling pathways. 
It is primarily produced by activated macrophages and has been evidenced in patients with heat 
failure, sepsis, and other inflammatory diseases that result in secondary muscle weakness. Elevated 
levels of TNF-α in aged muscles have been postulated to increase apoptosis and to impair the 
inflammatory response to injury594. Phillips and Leeuwnburgh595 investigated the effects of age 
on TNF-α levels and on TNF-α signaling cascade in slow soleus and fast superficial vastus 
lateralis (SVL) of adult (6 month old) and aged (26 month old) rats. In the aged animals, loss of 
muscle fibers was accompanied by an increase in plasma levels and myocyte expression of TNF-
α. Signaling through TNF-α was distinct in aged soleus and SVL. In soleus muscle, a greater 
capacity to cultivate inflammatory signaling through NF-κB was observed, whereas in SVL TNF-
α stimulated apoptotic signaling was elevated. Consistent with this finding, reduction in muscle 
mass, CSA, and fiber number were greater in SVL than in soleus muscle. The decision of selecting 
life or death signaling pathways in response to TNF-α may be distinct according to fiber type 
and appears to be linked to the extent of fiber loss experienced in the aging muscle. Thus, TNF-α 
transmitted signals may constitute a proponent in the pathogenesis of sarcopenia.
Il-6 plays a central role in host defenses and acts upon a wide variety of tissues. It influences 
such diverse processes as immunoglobulin secretion in B-cells, maturation of megakaryocytes 
and neuronal cells, and differentiation of cytotoxic T-cells. Serum IL-6 levels are increased with 
age and correlate with the functional status among subjects over 70 years old596. Elevated levels 
of IL-6 can initiate muscle wasting597 and experiments using IL6-deficient mice showed that IL-
6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy598. Functional 
overloading did not lead to muscle hypertrophy in IL-6 deficient mice due to reduced proliferation 
of satellite cell and subsequent impaired accretion of myonuclei to muscle fibers.
Direct evidence for TNF-α and IL-6 to play a causal role in sarcopenia is missing despite the 
age-related increase in their expression and despite their involvement in muscle mass regulatory 
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processes. Other cytokines whose activities are closely related to TNF-α, or IL-6 such as IL-1 and 
interferon-gamma also cause cachexia and may potentially influence sarcopenia599. Aging appears 
to be accompanied by constitutive inflammatory processes that are reflected by elevated cytokine 
levels. However, whether inflammation causes sarcopenia or, alternatively, sarcopenia leads to 
inflammation is not yet clear. 
1.4.9.2.4 Myostatin
Myostatin (growth/differentiation factor-8, GDF-8), a member of the transforming growth factor-
β (TGF-β) superfamily, negatively regulates pre- and postnatal myogenesis. It inhibits satellite 
cell activation and muscle regeneration postnatally. Myostatin was first discovered by McPherron 
et al.600 who demonstrated that a phenotype of exaggerated muscle hypertrophy correlated with 
mutations in the myostatin gene. Such knockout mutations of myostatin in animals caused the so-
called double-muscled phenotype. Double-muscled animals are characterized by an increase in 
muscle mass of about 20%, due to general skeletal muscle hyperplasia, an increase in the number 
of muscle fiber rather than in their individual diameter601. Research on aged myostatin mutant mice 
indicates that the absence of myostatin reduces age-related sarcopenia602. Whereas aged wild-
type muscle became increasingly oxidative and fiber atrophy was prominent, fiber type switching 
was not observed and atrophy was minimal in aged myostatin-null mice. In addition, muscle 
regeneration following notexin injury was accelerated in myostatin-null muscle. Beside positive 
acting factors, negative regulators of myogenesis may also play a role in aging of the skeletal 
muscle. However, a direct involvement of myostatin in sarcopenia has not been observed and, 
importantly, myostatin levels do not change according to age. Myostatin mRNA concentrations, 
assayed using quantitative RT-PCR, were similar in young and old human muscle569.
1.4.9.2.5 Myogenic regulatory factors (MRF)
The family of myogenic regulatory factors (MRFs), including MyoD, myogenin, Myf-5, and 
MRF4, are involved in regulation of myogenic cell differentiation during embryogenesis. MRFs 
are characterized by basic helix-loop-helix sequences that bind DNA and transactivate most 
muscle-specific genes by recognizing a consensus sequence present in their regulatory region. 
MyoD has been especially related to proliferation of satellite cells, whereas myogenin has been 
related to muscle differentiation and expression of muscle-specific proteins. These MRFs are 
generally thought to be marker of skeletal muscle growth and hypertrophy, since they can modulate 
satellite cell division and their incorporation in mature muscle fibers. MyoD and myogenin 
transcripts are expressed at high levels in muscles of newborn mice and their level continuously 
declines through postnatal life to become virtually undetectable in the adult mouse603. In the 
muscles of older mice, these transcripts are again expressed at high levels. MRF4 transcripts, in 
contrast, are present at a constant level throughout an animal’s life. Conversely, the expression 
of Myf-5 conspicuously increases in adult and senile muscle. Complex regulatory networks are 
activated during muscle aging with each of the MRFs showing a distinct pattern of expression. 
Increased expression of MRFs has not only been demonstrated in muscle of aged mice, but also 
in regenerating muscle of young rodents604-606, and in denervated muscles607-609, outlining the role 
of MRFs in muscle regeneration and innervation. Marsh et al.610 assessed MRF mRNAs during 
regeneration of skeletal muscle after bupivacaine injection in young, adult, and old rats. Without 
treatment, Myogenin, MyoD, and MRF4 mRNA all were increased in old compared to young 
and adult muscles, a finding that may reflect a continued attempt to generate new muscle fibers 
and ameliorate muscle atrophy in old muscle. During regeneration at 5-14 days after bupivacaine 
injection, expression of the MRF genes was increased in young, adult and old rats. Thereafter, 
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MRF mRNA levels returned to control values in young and adult rats. In old rats, however, only 
MRF4 expression returned to control level, whereas myogenin and MyoD expression remained 
upregulated. The authors proposed that either the ability to downregulate myogenin and MyoD 
mRNAs in regenerating muscle is diminished in old muscles, or the continuing myogenic effort 
includes elevated expression of these mRNAs. Since myogenin and MyoD levels are sensitive 
to the innervation status of the muscle, it is possible that their prolonged expression during 
regeneration in old muscles could be related to incomplete reinnervation. Impaired reinnervation of 
denervated or newly synthesized muscle fibers is thought to substantially contribute to sarcopenia 
(see above). MRFs have also been suggested to play a role in the control of skeletal muscle fiber 
type composition. Voytik et al.611 found that different muscles accumulated different proportions 
and combinations of MRF transcripts. Myogenin mRNA was for example detected at higher levels 
in muscles exhibiting a slow-twitch phenotype, whereas MyoD transcripts were predominantly 
found in fast-twitch muscles. Therefore, the authors proposed that MRFs could be involved in 
both the initial establishment as well as maintenance of fiber type diversity in the developing 
organism. Consequentially, age-related changes in MRF expression pattern could contribute to the 
shift in fiber type frequencies seen in sarcopenia.
Together, the expression of MRFs is subject to age-related changes that are amplified in senescence. 
However, these changes might rather be a consequence than a cause of sarcopenia. The elevated 
demand for regeneration in aged muscles in concert with incomplete innervation induces MRFs to 
upregulate the expression of muscle specific genes needed for regeneration and innervation. Such 
genes include AChR and other components of the NMJ as well as genes involved in satellite cell 
activation, differentiation and fusion. Thus, increase in MRFs is counteracting and not inducing 
sarcopenia. Sustained high expression of MRFs in age indicates that the muscle regeneration 
system is still working although, finally, not successful. Unsuccessful regeneration and incomplete 
innervation is not likely to be caused by impaired MRF regulation or action, since upregulation of 
MRFs and of muscle specific genes controlled by them can be detected.
1.4.9.2.6 Systemic alterations do not cause sarcopenia
Age-related endocrine changes may not play a major role in the etiology of sarcopenia, since they 
fail to explain important characteristics of the sarcopenic phenotype. It is for example unclear how 
systematic alterations, such as reduced blood concentrations of anabolic hormones and growth 
factors, increased levels of cytokines, and decreased protein synthesis could explain the selective 
pattern of atrophy that results in the heterogeneous distribution of fiber thickness with aging423. The 
severe atrophy of some fibers accompanied by compensatory hypertrophy of other fibers within 
the same muscle can’t be caused by a process that affects the whole muscle. Clearly, the etiology 
of sarcopenia must involve processes intrinsic to individual myocytes, or the motoneurons that 
innervate them, in such a way that only some cells are affected whereas others are not. Systematic 
alterations could intensify the problem without being the cause. 
1.4.10 treatment or prevention of sarcopenia
Age-related endocrine changes, nutritional deficiencies and physical inactivity in the elderly are 
thought to contribute to the pathogenic process leading to sarcopenia. Therefore, the substitution 
of anabolic hormones and growth factors, such as testosterone, growth hormones, and IGF-1, as 
well as agents that reduce the levels of inflammatory cytokines have been under investigations for 
the development of therapies against sarcopenia. As alternative or complementary approaches, 
programs aimed at changing nutritional behaviors and increasing physical activity, have been 
composed. 
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Exercise training in the elderly is clearly beneficial in restoring strength and function532. Coggan 
et al.530 assessed skeletal muscle adaptations to 9-12 months endurance training in 60- to 70-yr-old 
mean and women. They found a 23% increase in maximal O
2
 consumption, an increase in the area 
of both type I (12%) and type II (10%) fibers, increased capillary density, and increased activities 
of mitochondrial enzymes. These adaptations of the skeletal muscles of older men and women are 
very similar to those observed in young people. Another study suggests that endurance training 
attenuates the age-associated loss of relative strength (strength per muscle area or volume) but 
fails to prevent the age-associated loss of muscle mass or absolute strength174. Physical exercises 
may well be capable of increasing muscle strength612, but longtime prevention of age-related 
decline in strength may not be possible. Similarly, endurance training was associated with 60-
100% higher muscle citrate synthase activity and improved metabolic responses in young and older 
men but could not prevent an age-related decrement in these variables or an age-related decrease 
in muscle mass524. Relatively short time of resistance exercises also suppresses or attenuates the 
age-related increase in skeletal muscle TNF-α levels and the reduction in protein synthesis rate in 
concert with a substantial increase in muscle strength612. Together, exercise training shows clearly 
beneficial effects but it is questionable whether it fundamentally reverses sarcopenia. Several lines 
of evidences rather indicate that physical exercises only attenuate or delay the development of 
sarcopenia but fail to stop or even reverse it.
Nutritional or hormonal interventions in treating the consequences of sarcopenia or slowing 
its progress can also be partially successful. Anabolic hormone replacement, especially in 
combinations with aerobic, resistance, and stretching exercise programs can have beneficial effects 
on sarcopenia in the elderly162. Supraphysiological testosterone doses induce substantial gains in 
muscle mass and strength in older men, but these high doses are associated with a high frequency 
of adverse effects561. Such adverse effects of testosterone therapy include increased hematocrit, 
increased size of the prostate, increased prostate specific antigen level, and unfavorable effects on 
lipid profiles613. Testosterone is currently not recommended for the treatment of sarcopenia and a 
careful evaluation of potential risk and benefits has to be performed.
The effect of growth hormone replacement in the elderly population remains controversial. A 
number of studies have shown that supplementation with GH to stimulate IGF-1 levels to levels 
observed in young adults can increase lean body mass, decrease adipose tissue, and increase thigh 
strength614,615. However, a number of studies that combined GH administration with resistance 
training in elderly men failed to show beneficial effect of GH above exercise alone, in terms 
of muscle strength or muscle protein synthesis616,617. Moreover, significant adverse effects due 
to GH administration, including fluid retention, carpal tunnel compression, gynecomastia, and 
arthralgias have been reported618,619. Together, exclusive pharmalogical interventions, such as 
growth hormones and testosterone, increase lean mass (and muscle mass), but do not alter strength 
much and bears substantial risks of adverse effects620.
Blackman et al.621 assessed the effects of GH and sex steroid applications on lean body mass, fat 
mass, muscle strength and maximum oxygen uptake in 57 women and 74 men at ages between 65 
and 88 years. GH applications with or without sex steroids resulted in increased lean body mass 
and reduced fat mass in both aged women and men. Only sex steroids together with GH increased 
muscle strength marginally and maximum oxygen uptake in men, whereas in women no treatment 
had an effect on strength or cardiovascular endurance. Adverse effects, however, were frequent 
and the authors concluded that GH interventions in the elderly should be confined to controlled 
studies. Recently, in a placebo-controlled randomized trial of GH, testosterone or both, significant 
effect on muscle size and body composition was only found in the combination group562.
Caloric restriction (CR) without malnutrition could be a saver strategy to prevent or delay 
sarcopenia622. Restricting energy intake to 60% of ad libitum evokes an extension of maximal 
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lifespan by approximately 25-40% in rodents and better preserves organ function623. The maximal 
life extension effect in humans may not be as pronounced, but the health benefits of CR in 
humans are considerable624,625. The effects of CR on skeletal muscle and sarcopenia have been 
demonstrated in several studies. Mild CR (8%) prevented age-associated reduction of plantaris 
fiber CSA and increase in extramyocyte space in old rats626. Moderate CR (30-40%) delayed 
age-related loss of muscle mass in rhesus monkeys627 and attenuated age-associated reduction 
of muscle CSA and fiber number in rats595. However, beneficial effects of CR on muscle mass 
and fiber number was not always found. Food restriction to 65-70% of normal levels did for 
example not prevent age-related loss of fibers or mass of rat soleus and EDL muscles199. Many 
of the different molecular pathways that are affected by CR, involve alterations of mitochondrial 
function. The age-related decline in activities of ETC complexes observed in mice with ad libitum 
food access was completely prevented by CR437. CR also reduces the prevalence of mtDNA 
deletion mutations and the abundance of fiber displaying ETS abnormalities in old rodents. The 
preservation of mitochondrial structural and functional integrity by CR is believed to result from 
the reduction of oxidative stress and damage. Reduction in mitochondrial ROS generation and 
increase in mitochondrial protein turnover appear to be the important aspects of the effects of CR 
on mitochondria. Consequently, CR prevented the 50% decline in muscle mass-specific maximal 
aerobic function seen between young-adult and aged rats429. Reduction in oxidative stress may 
also promote the ability of CR to attenuate age-associated signs of apoptosis in rat gastrocnemius 
muscle, possibly by preventing age-associated increase in serum levels and myocyte expression 
of TNF-α476,595. Finally, CR prevented most of the age-associated alterations in skeletal muscle 
gene expression, analyzed by oligonucleotide microarrays539-541. CR resulted in a metabolic 
reprogramming characterized by a transcriptional shift toward energy metabolism, increased 
biosynthesis, and protein turnover and reduced the expression of genes associated with stress 
response and DNA repair. Together, CR may be a safe and efficient strategy to delay the onset 
of sarcopenia. However, beneficial effects on muscle strength and function have not yet been 
demonstrated and are essential for a strategy to counteract sarcopenia. Moreover, most of the 
successful studies on the beneficial effects of CR have been preformed with rodents and to a lesser 
extend monkeys. Human studies are crucially needed to confirm the beneficial influences of CR 
on sarcopenia and generally expectation of life.
All therapies applied so far could only partially counteract the loss of muscle strength, without 
principally reverse the deleterious effects of sarcopenia. Without knowledge of the basic 
mechanisms underlying sarcopenia, it will not be possible to efficiently treat sarcopenia.
1.4.11 Sarcopenia in C.elegans
The nonparasitic nematode Caenorhabditis elegans is a microscopic organism that has been 
found during the last decade to be a powerful genetic system in which to study molecular and 
biochemical events in organismal aging628. Under laboratory conditions, worms develop from an 
embryo to sexual maturity in 3 days, and then reproduce over a 3- to 4-day period. The usual total 
adult lifespan is 12 to 18 days. Recently, it has been found that aging worms developed sarcopenia 
starting at an age of about 7 days629. In C. elegans sarcopenia was characterized by reduction 
in muscle cell size due to loss of cytoplasm and myofibrills, and by disorganization among the 
remaining myofibrils. The nervous system of the worms, on the other hand, remained largely 
intact during aging. Even severely compromised animals showed only little if any neuronal cell 
death and no major loss or restructuring of neuritis or nuclei, indicating that at the cellular level 
the nervous system was well preserved in aging C. elegans. However, changes in biophysical 
properties, such as nerve conduction and synaptic transmission, could not be ruled out. Affected 
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worms showed a progressive decline in mobility and poorly coordinated movements evoked only 
by direct stimulation.
Interestingly, like in mice and men, sarcopenia did not develop in a stereotyped fashion at a 
given age. Instead it developed at different ages and at different rates in a cohort of genetically 
identical worms grown in culture together. This is surprising for an organism in which genetic 
or developmental variation between animals do virtually not exist. Stochastic factors appear to 
significantly contribute to senescent decline. Keeping this finding in mind, considerable variation 
of the onset and developmental rates of sarcopenia between individuals in inbred rodent strains 
or in humans, where genetic or developmental variations are huge compared to the worms, 
becomes equitable. Moreover, sarcopenia served as the best single predictor of mortality in an 
aging population of worms. It was a better predictor of mortality than chronological age, which 
suggested that sarcopenia represented the true biological age of a given worm. Consistent with 
this association, worms carrying the age-1 mutation, which extended the lifespan by 60 to 100%, 
showed corresponding delays in the appearance of sarcopenia. Sarcopenia could be a measure 
of biological age whose development is directly associated with the basic cellular and molecular 
mechanisms involved in aging628.
The finding of sarcopenia in worms questions several influences that have been claimed to 
contribute to sarcopenia in humans. The hormonal milieu of the worm is for example different 
from those of mammals and many hormones linked to sarcopenia, such as IL-6 and sex hormones, 
are lacking. Also, in contrast to mammals, in which low levels of IGF-1 have been associated with 
sarcopenia, in worms, reductions in IGF-1 signaling prevent sarcopenia and result in increase in 
longevity. Thus, age-related changes in hormone levels may not induce sarcopenia in worms and, 
by inference, mammals. Furthermore, during aging, the worm nervous system remains largely 
intact, excluding the death of motoneurons as pathogenic mechanism inducing sarcopenia. 
However, it might be rather alterations in synaptic structure and function than extensive neuronal 
loss contributing to age-related cognitive and motor deficits in higher organisms. Thus, higher 
resolution of synaptic function and NMJ structure in nematodes will be required to identify 
molecular and subcellular changes that accompany neuronal aging in C.elegans. Alternatively, 
there is some evidence that the causes of sarcopenia might rather lie within the aging muscle cell 
itself. Oxidative damage and mitochondrial dysfunction are for example candidate mechanisms. 
Interventions aimed at preventing oxidative damage and protein misfolding extended the worms 
lifespan, although the effects on sarcopenia have not been examined630-632. 
1.4.13 Conclusion
A critical reduction in muscle mass, strength, and number of muscle fibers, increased heterogeneity 
of fiber size, fiber type grouping, and signs of muscle regeneration are the most prominent 
pathological hallmarks of sarcopenia, the form of skeletal muscle atrophy that occurs at advanced 
age. Available evidence suggests that muscle fiber reduction may be due to denervation and 
incomplete reinnervation of neuromuscular connections that occurs lifelong but accelerates with 
aging. A strong regenerative phenotype of senescent skeletal muscles indicates the activation of 
repair mechanisms that involve activation, proliferation and differentiation of satellite cells to 
induce hypertrophy and to form new myotubes. Whereas compensatory hypertrophy can partially 
counteract muscle atrophy, the loss of muscle fibers can’t be prevented.  Final maturation and 
incorporation of regenerated muscle fibers appears to be impaired, most likely due to the absence of 
correct innervation. Sarcopenia coincides with the loss of a substantial fraction of the motoneurons 
and severe deterioration of the NMJs. These events are candidates that may prevent effective 
regeneration and could substantially contribute to the pathogenic ensemble leading to sarcopenia. 
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An age-related decrease in IGF-1, which is known to preserve neuromuscular architecture and 
facilitate innervation in senescence, may contribute to the impaired regeneration phenotype. 
Another interesting mechanism for a fundamental sarcopenia promoting role is the damage to 
skeletal muscle mitochondria by reactive oxygen species that accumulates over a lifetime and 
results in the removal of the muscle cell by apoptosis. Followed by impaired regeneration due 
to incorrect innervation, these events may form the core mechanisms underlying sarcopenia. 
However, numerous other age-related changes that may contribute to the etiology of sarcopenia 
have been described. Most of them can explain certain features of sarcopenia, but not the whole 
phenotype and may rather contribute to than actually cause sarcopenia. Other age-related changes, 
including decreased physical activity as well as nutritional, metabolic and hormonal alterations, 
may rather be a consequence than a cause of sarcopenia. The understanding of the influence of the 
different sarcopenia promoting processes may help to develop better therapies to counteract the 
age-associated loss of muscle mass and function. 
1.5 Aim of this study
Recent studies showed that the NMJ requires the protective action of the proteoglycan agrin, 
in order to escape from a dispersal mechanism controlled by synaptic activity21,32. We recently 
found that agrin is cleaved by the neuronal serine protease neurotrypsin at two homologous, 
highly conserved sites, resulting in the dissociation of the C-terminal domain containing the 
NMJ-organizing and protecting function119. Excessive cleavage of agrin at the NMJ following 
neurotrypsin overexpression in motoneurons resulted within days in severe NMJ alterations, very 
similar to the phenotype of agrin-deficient mice13,26,31. The aim of this study was to investigate the 
influence of neurotrypsin overexpression and, hence, excessive agrin cleavage, on the NMJs and 
skeletal muscles of adult mice. The neurotrypsin-overexpressing mice are viable but show clear 
motor deficits, including muscle weakness and impaired motor coordination. To elucidate the 
role of proteolytic agrin cleavage at the NMJ on skeletal muscle structure and function, skeletal 
muscles and their NMJs have to be investigated in conditions with enhanced agrin cleavage. The 
aim is to learn more about the function of agrin and its cleavage for the maintenance of the NMJ 
in adult mice. Moreover, we are interested in the interplay between nerve and muscle, especially 
in a situation where it is disrupted. The reaction of the neuromuscular system to disturbances 
could give insights into the mechanism of neuromuscular degeneration, regeneration and repair. 
The increase of our knowledge of such processes is of high importance in regard to numerous 
neuromuscular diseases, whose underlying mechanisms are still poorly understood.
Furthermore, we would like to address the question whether the pathogenic processes ending 
with sarcopenia may result from impaired NMJs. Therefore, histopathological alterations in 
neurotrypsin transgenic mice have to be compared with those of sarcopenia. As in conditions with 
enhanced agrin cleavage, deterioration of the NMJ has been observed with aging92-95,148,399-401, and 
could result in partial or total loss of the postsynaptic specialization, in muscle fiber denervation, 
and, finally, in atrophy and loss of muscle fibers. NMJ destabilization could be the onset of a final 
common pathway resulting in sarcopenia.
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2.1 Animals
Neurotrypsin-deficient mice
The generation of neurotrypsin-deficient mice (Ntd) has been previously described119,121. The last 
two exons of the neurotrypsin gene, coding for the protease domain, have been deleted in these 
mice. Neurotrypsin-deficient mice do not express a functional form of neurotrypsin, which results 
in the absence of the neurotrypsin-specific cleavage fragments of agrin, agrin-90 and agrin-22. 
Transgenic mice for conditional overexpression of neurotrypsin
The generation of neurotrypsin transgenic mice has been previously described (Bolliger et al., 
in preparation). Neurotrypsin and agrin were overexpressed under the control of the promoter 
of the Thy1.2 allele of the Thy1 gene633. The Thy1.2 expression cassette was reported to drive 
transgene expression pan-neuronally, with a relatively late onset around postnatal days 6-10634. 
Therefore, expression of neurotrypsin and agrin under the control of the Thy1 promoter should 
ensure that earlier developmental stages are not perturbed by the presence of excessive amounts 
of transgenic neurotrypsin and agrin. However, all transgenic animals died within 2-3 weeks after 
birth. The result suggested an earlier activity of the Thy1 promoter than expected. To circumvent 
early lethality, we generated transgenic mice bearing a dormant (conditional) transgene by 
insertion of the transcriptional stop signal flanked by loxP sites between the Thy1 promoter 
and the neurotrypsin-encoding segment. To generate the pThy1-loxP-Stop-loxP-neurotrypsin 
construct the loxP-flanked transcription stop sequence from the pBS302 plasmid (Invitrogen) was 
inserted in either direction between the Thy1 promoter and the neurotrypsin-coding segment. The 
loxP-Stop-loxP cassette completely abolished the lethal phenotype that was observed with the 
constitutively expressed transgene not only when it was inserted as initially described635,636, but 
also in the inverted orientation. The transgenic lines selected for this study contained the inverted 
orientation of the loxP-Stop-loxP cassette. They were backcrossed for ten generations to C57BL/
6J to produce the congenic strains, B6;C3-Tg(PRSS12) 491, 493, 494 Zbz and B6;D2-Tg(Prss12) 
497, 533 Zbz.
Selective overexpression of neurotrypsin in spinal cord motoneurons
Mice bearing the conditional neurotrypsin transgene were crossed with mice expressing Cre 
recombinase under the control of the motoneuron-specific Hb9 promoter [B6.Cg-Tg(Hb9-Cre) 
mice14; provided by S. Arber, University of Basel, Basel, Switzerland] to induce recombination 
and selective activation of the Thy1-neurotrypsin transgene in motoneurons. This procedure 
allows maintenance breeding of the transgenic mouse lines bearing the transgene in a dormant 
state and to generate offspring overexpressing neurotrypsin on experimental demand. Moreover, 
the selective activation of the transgene in motoneurons was possible. We found that all transgenic 
animals generated by Cre recombinase-mediated excision of the loxP-Stop-loxP cassette were 
viable and did not exhibit any gross abnormalities. For the present study 493xHb9-Cre, 497xHb9-
Cre, and 533xHb9-Cre were used. For convenience and to underlie the motoneuron-specific 
expression pattern these mice are referred to as Nto-moto and Nto-moto2. The expression of the 
transgene was verified at the protein level by Western blotting of neurotrypsin (Fig. 12b, 19b). 
The proteolytic activity of the transgenic neurotrypsin was assessed by Western blotting of agrin-
90, which results from cleavage at both the α and the β site of agrin. 
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Transgenic mice with constitutive overexpression of neurotrypsin 
To generate mouse lines with constitutive overexpression of active neurotrypsin conditional 
transgenic mice of line B6;C3-Tg(PRSS12) 491, 494 Zbz and B6.D2-Tg(Prss12) 533 Zbz were 
crossed with transgenic mice expressing Cre-recombinase under the control of the cytomegalovirus 
(CMV) promoter. The CMV promoter is active as early as in the embryonic two-cell to eight-cell 
stage embryo637. Therefore, loxP-based recombination results in a general deletion of the floxed 
segment and, thus, the germline transmission of the excised state. The constitutively transgenic 
mice were backcrossed for ten generations to C57BL/6 mice to produce the congenic strains 
B6.C3-Tg(PRSS12) 491.1 Zbz, B6.D2-Tg(Prss12) 533.1 Zbz and B6.C3-Tg(PRSS12) 494.1 
Zbz. For convenience these mouse lines are referred to as Nto1, Nto2, and Nto3, respectively. 
Expression and proteolytic activity of the transgenic neurotrypsin were assessed by Western 
blotting (Fig. 12a, 19a). An increase of agrin-90 in spinal cord homogenates of neurotrypsin-
overexpressing mice was found.
Transgenic mice overexpressing inactive neurotrypsin
For a control transgenic mice overexpressing a catalytically inactive form of neurotrypsin 
under the same, i.e. the Thy1 promoter, were generated. Inactive neurotrypsin was generated 
by mutating the essential active site serine 711 (corresponding to serine 195 of chymotrypsin) 
to alanine. Because in all serine proteases, the active site serine is involved in a covalent 
intermediate of the proteolytic reaction, its mutation results in a complete loss of catalytic 
function. To generate the pThy1-neurotrypsin construct containing the serine-to-alanine 
mutation of the active site serine, a PCR fragment was amplified using mouse neurotrypsin 
cDNA as a template and 5’-CGTGTGGACAGCTGCCAGGGAGACGCTGGAGGA-3’ and 
5’-CTCAAGCTTAGTTACAGACTGGTGACACTTTTTATC-3’ as primers. This fragment was 
reintroduced into full-length neurotrypsin. The mutated neurotrypsin cDNA was inserted into the 
XhoI site of the Thy1.2 cassette. The founders were backcrossed for ten generations to C57BL/6J 
to produce congenic strains. In the present study we used line B6.D2-Tg(Prss12(S711A)) 785 Zbz 
(Nto-inact). Overexpression of neurotrypsin and levels of agrin-90 in this line are shown in Fig. 
12a. Quantification indicated that agrin-90 in these mice was at wild type levels (Fig. 12d).
Transgenic mice overexpressing cleavage-resistant agrin
The cDNA of the transmembrane form of rat agrin was subcloned into pBluescript. The arginine 
of the α cleavage site and the lysine of the β cleavage site were both mutated to alanine by site-
directed PCR mutagenesis and thereby rendered resistant to neurotrypsin cleavage. The 5’ end 
of the secreted form of agrin up to the first follistatin domain was obtained by RT-PCR using 
primers mNTAClaf (5’-CGCATCGATGTTCCGGGCTGCGCCATGGTCC-3’) and mNTAr (5’-
GTCCCGGGACCCACATGGCCCTTG-3’) and total RNA from mouse spinal cord as template. 
The 5’ region of transmembrane rat agrin upstream of the SmaI restriction site immediately 
following the DNA region encoding the first follistatin domain was then replaced by the 5’ region 
of secreted murine agrin. The assembled DNA sequences of mutant (cleavage-resistant) and 
wild type agrin were inserted into the Thy1.2 expression cassette. The transgenic founders were 
backcrossed for ten generations with C57BL/6 mice to produce congenic strains. In this study, 
we used the line B6.D2-Tg(Agrn)1381Zbz (Ag) for overexpression of wild type agrin and the 
line B6.D2-Tg(Agrn(R995A;(K1754A))1385Zbz (rAg) for overexpression of cleavage-resistant 
agrin. The transgenic overexpression of agrin in neurons was confirmed by immunocytochemical 
staining (Bolliger et al., in preparation). 
Double-transgenic mice overexpressing neurotrypsin and agrin 
To overexpress neurotrypsin in combination with agrin, the constitutive neurotrypsin-
overexpressing line B6.C3-Tg(PRSS12)491.1Zbz (Nto1) was crossed with mice of lines B6.D2-
Tg(Agrn)1381Zbz (Ag) or mice of lines B6.D2-Tg(Agrn(R995A;(K1754A))1385Zbz (rAg). 
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Double transgenic offspring was referred to as Nto1/rAg and Nto1/Ag, respectively.
Aged mice
C57BL/6 mice were used for the aging analysis. Animals specified as aged were 24 months old, 
according to a median life expectation of about 31 months460. It was carefully paid attention that 
these animals did not suffer from unrelated age-associated diseases that might influence muscle 
morphology.
Mice overexpressing synaptophysin.
The synaptophysin-GFP (spGFP) transgenic mice have been previously described638. They were 
generated using the Thy1.2 expression cassette and had no detectable phenotype. The expression 
of the transgene did not affect the physiology (quantal content, post-tetanic potentiation and 
depression) and anatomy (ultrastructure of pre- and postsynaptic terminals, paralysis-induced 
nerve sprouting) of NMJs.
2.2 Antibodies 
The goat antiserum G87 was raised against the protease domain of human neurotrypsin (produced 
in E. coli) and was purified by affinity chromatography. The rabbit antiserum R132 was raised 
against agrin90 of rat agrin (produced in HEK293T cells) and affinity-purified. The goat antiserum 
G92 was raised against agrin-22 (produced in HEK293T cells). Rabbit anti-synaptophysin 
antibodies were purchased from DakoCytomation, mouse anti-β-actin (clone AC-74) and anti-α-
tubulin (clone DM 1A) from Sigma, rabbit anti-neural cell adhesion molecule (NCAM) and rabbit 
anti-Na
v
1.5 from Chemicon, rabbit anti-phospho (Ser10)-acetyl (Lys14)-histone H3 (PAcH3) 
from Upstate, and rabbit anti-myogenin from Millipore. Secondary antibodies for immunoblotting 
(anti-rabbit, anti-goat, and anti-mouse peroxidase conjugates) were from Sigma. Secondary 
antibodies for immunofluorescence (donkey anti-rabbit Cy3 and Cy5, donkey anti-goat Cy5, 
and donkey anit-rabbit amino-methyl-coumarin-acetate (AMCA) conjugates) were from Jackson 
ImmunoResearch.
2.3 electrophoresis and immunoblotting 
Spinal cord extracts and muscle extracts were prepared by incubating the tissues in lysis buffer (150 
mM NaCl, 1% Triton X-100, protease inhibitors, in 20 mM Tris-HCl, pH 7.5). After homogenization 
and centrifugation of the extracts, supernatants were collected and protein concentrations were 
measured by a Bradford assay (Bio-Rad Laboratories). Proteins were resolved by SDS-PAGE on 
4-12% Bis-Tris gels (Invitrogen) and blotted to PVDF membranes (Millipore). The membranes 
were dried (10 seconds incubation in methanol, air-drying for 15 minutes) and incubated for 90 min 
with primary antibodies in blocking solution (5% Roche Western blocking reagent, 0.1% Tween-
20, in TBS). After washing with TBS containing 0.1% Tween-20, the blots were incubated with 
peroxidase-conjugated secondary antibodies for 60 min, and washed again. ChemiGlow (Alpha 
Innotech) was applied and immunoreactive bands were detected on a Fuji Imager LAS3000. For 
reprobing, membranes were incubated twice for 30 min in stripping solution (0.1% SDS, 1% 
Tween-20, in 200 mM glycine-HCl, pH 2.5). The signals were quantified using the open source 
NIH ImageJ image analysis software. All blots were performed in triplicates.
2.4 Grip strength and footprint analysis
Forelimb grip strength was measured using a standard device including a metal grip bar and 
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a tension spring balance. The animal was hold by the tail, allowed to grab the bar, and pulled 
constantly in one direction. The maximal strength until the mouse loosed the bar was recorded. 
Each animal was tested in 15 trials from which the 5 highest and lowest values were cancelled to 
minimize variations. This procedure was repeated at 3 consecutive days, resulting in 15 values per 
mouse, from which the average was calculated.
Footprint analysis was performed in a box with a small channel on an interchangeable sheet of 
paper. Fore- and hindpaws of a mouse were carefully labeled with black drawing ink (Pelikan). 
Most of the mice walked voluntarily and at constant speed through the channel to the other end of 
the box, thereby leaving their footprints. Mice that moved not voluntarily, stopped during the walk, 
changed their speed, jumped or ran at high speed were not included in the analysis. The footprints 
were digitized and processed using ImageJ. Fore- and hindpaw prints were discriminated by their 
distinct shapes. The stride length was measured as the averaged distance between all consecutive 
forepaw and consecutive hindpaw prints. Paw placement was quantified by measuring the distance 
between corresponding fore- and hindpaw prints. 
2.5 Preparation of muscle cross-sections 
Mice were euthanized by CO
2
 inhalation and two skeletal muscles, musculus soleus and musculus 
extensor digitorum longus (EDL), were removed. The muscles were embedded in tissue-tek 
(Sakura) and frozen in isopentane cooled to -75 °C.
The muscles were placed in a cryostat (Leica CM3050) pre-cooled to -16 °C and serial 12 µm 
cross-sections were cut from the midbelly region of the muscles.
2.6 Skeletal muscle histochemistry
Muscle sections were either stained with hematoxylin and eosin (H&E) or for myofibrillar 
actomyosin ATPase (mATPase) activity. Before staining with H&E, sections were fixed in 
methanol for 5 minutes at -20°C. After washing, they were incubated for 10 minutes in hematoxylin 
solution according to Mayer (Fluka). After one minute of incubation in 70% ethanol containing 
several drops of HCl the sections were developed for three minutes under warm running water. 
Then, three minutes of counterstaining in 10 g/l Eosin Y (Sigma) was followed by dehydration 
in ethanol, clearing in xylene, and the embedding in eukitt quick-hardening mounting medium 
(Fluka). Staining for mATPase activity was performed after preincubation at pH 4.3 according 
to a modification of the procedure of Brooke and Kaiser 229,639. Sections were incubated at room 
temperature for 7 min in a solution consisting of 54.3 mM sodium acetate and 32.6 mM sodium 
barbital, adjusted with HCI to pH 4.30. After washing with a solution containing 18 mM CaCl
2
 
and 100 mM Tris-HCI, pH 7.8, the sections were incubated at room temperature for 45 min in a 
medium containing 4.5 mM ATP, 19.5 mM CaCl
2
, 116 mM 2-amino-2-methyl-l-propanol at pH 
9.4. After three successive 3-min incubations in 11 mM CaCl
2
, the sections were incubated two 
times for 1.5 min in 2% (w/v) CoCl
2
 and then incubated six times for 30 sec in 10 mM sodium 
barbital and once in distilled water. After 45 sec of incubation in 2% (v/v) (NH
4
)
2
S, sections were 
washed in tapwater, dehydrated in ethanol, cleared in xylene, and embedded in eukitt quick-
hardening mounting medium (Fluka).
Images were taken with a Leica DFC350FX digital camera that was mounted on a Leica DM-
RXE inverted light microscope. Image analysis was performed using ImageJ.
H&E stained sections were used to determine the number of fibers, the cross-sectional area (CSA) 
of muscle and individual fibers, the fiber shape, and the amount of centrally nucleated fibers. 
For each muscle several cross-sections from the midbelly region of the muscle were used to 
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count the number of fibers and to measure the CSA. The biggest two sections per muscle were 
used for analysis, leading to four numbers per animal, from which the average was calculated. 
At least four animals in each group were compared. The CSA and the shape of the individual 
muscle fibers were determined by manually outlining all fibers in one muscle per animal using 
ImageJ. To assess the fiber shape, the circularity was used (circularity = 4π * area / perimeter2). 
The circularity of a perfect circle is one and fibers deviating from a circle (i.e., those being more 
angular) exhibit a smaller area relative to their perimeter and, hence, their circularity is smaller 
than one. Centralized nuclei were counted on one section per animal and the percentage of fibers 
with centrally located nuclei was calculated. For all parameters, the average from at least four 
animals in each group was taken.
Cross-sections stained for mATPase activity were used for fiber typing. The proportion of darkly 
stained fibers was determined on two sections per muscle, leading to four numbers per animal, from 
which the average was taken. At least four animals in each group were used for the comparison. 
Fiber type grouping was analyzed using the method of enclosed fibers267,640. The number of type 
I and type II fibers at the boarder or inside of a muscle were counted and the number of enclosed 
type I and type II fibers (internal fibers that are surrounded by only the fibers of its own types) 
was determined. The formula defined by Lexell and Downham267 was used to calculate T1 and T2 
values. For each muscle two sections were analyzed, resulting in four T1 and T2 values per animal, 
from which the averages were calculated. At least four animals in each group were compared.
2.7 Immunostaining of soleus muscles
To analyze the NMJs, soleus muscles were dissected, rinsed in PBS, and fixed in methanol at -
20°C for 10 min. The muscles were washed in PBS and teased into small bundles of fibers using 
thin forceps. After incubation in blocking solution (5% horse serum, 1% BSA, 1% Triton X-100, 
0.1% sodium azide, in PBS) for 2 hr, different combinations of antibodies were added. The first 
antibodies were applied overnight at 4°C. After washing in PBS containing 0.5% Triton X-100, 
fluorescently-labeled secondary antibodies were added together with fluorophore-conjugated α-
bungarotoxin for 4h at room temperature. To label presynaptic terminals, rabbit anti-synaptophysin 
antibodies were used, followed by Cy3-conjugated donkey anti-rabbit antibodies and Alexa Fluor 
488-conjugated α-bungarotoxin (0.1 µg/ml, Molecular Probes). To label nerve endings, muscle 
of spGFP transgenic mice were incubated with rabbit anit-neurofilament antibodies followed 
by Cy5-conjugated donkey anti-rabbit antibodies and tetramethylrhodamine (TMR)-conjugated 
α-bungarotoxin (1 µg/ml, Sigma). For staining of agrin-90, muscles of spGFP transgenic mice 
were incubated with R132 followed by Cy5-conjugated donkey anti-rabbit antibodies and TMR-
conjugated α-bungarotoxin (1 µg/ml). To stain agrin-90 and agrin-22 muscles were incubated 
with R132 and G92 followed by AMCA-conjugated donkey anti-rabbit antibodies, Cy5-
conjugated donkey anti-goat antibodies, and TMR-conjugated α-bungarotoxin (1 µg/ml). After 
washing, samples were embedded in fluorescent mounting medium (DakoCytomation). Z-serial 
images were collected using a Leica SP1 or SP2 confocal laser scanning microscope using a 63x 
objective. Images from different laser channels were sequentially collected to avoid cross-talking. 
Only endplates oriented in the plane of the image area were used.
To quantify NMJ fragmentation, maximal projections of confocal stacks of the presynaptic 
synaptophysin and the postsynaptic α-bungarotoxin stainings were made. The image analysis 
program ImageJ was used to count the number of fragments (unconnected fluorescently labeled 
spots, which were bigger than 2 µm2) per junction and to measure the size of the synaptic area 
(total fluorescently labeled area).
To detect denervated muscle fibers thin muscle cross-sections (12 µm) were fixed in methanol 
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at -20°C for 5 min, washed in PBS and incubated with antibodies against NCAM and Na
v
1.5 
in blocking solution overnight at 4°C. After washing in PBS containing 0.5% Triton X-100, 
the cross-sections were incubated with Cy3-conjugated donkey anti-rabbit antibodies for 4 hr 
at room temperature. After washing, samples were embedded in fluorescent mounting medium 
(DakoCytomation) and analyzed with a Leica DM-RXE fluorescent microscope. Staining for 
phosphorylated and acetylated histone H3 (PAcH3) was done on isolated muscle fibers. The 
soleus muscles were fixed in 4% PFA in PBS for 30 min and extensively teased into single muscle 
fibers. They were incubated with PAcH3 antibodies in blocking solution overnight at 4°C. After 
three washing steps in PBS/0.5% Triton X-100, Cy3-conjugated donkey anti-rabbit antibodies 
and the nucleic acid stain Hoechst (5 µg/ml, Invitrogen) were applied for 4 hr. After washing, the 
single muscle fibers were carefully mounted in fluorescent mounting medium (DakoCytomation), 
so that the overlapping of fibers was avoided, and analyzed under Leica DM-RXE fluorescent 
microscope.
2.8 Number of motoneurons 
The spinal cords of two animals (i.e. a wild-type and a transgenic or an adult and an aged) were 
prepared in parallel and compared. They were dissected, aligned, embedded in tissue tek (Sakura) 
and frozen in liquid isopentane cooled to -70°C. Ten serial 12 µm sections were cut at four different 
position in the lumbar and sacral regions of the spinal cords. The sections were dried for 1 hour at 
room temperature and fixed in 4% PFA in PBS. After washing in PBS the sections were incubated 
for 10 minutes in cresyl violet staining solution (0.5% cresyl violet acetate solved in warm water 
containing 0.3% acetic acid). After rinsing in water, the sections were dehydrated in ethanol, 
cleared in xylene, and embedded in eukitt quick-hardening mounting medium (Fluka). The alpha 
motoneurons were identified according to Blondet et al.641 by their location in the ventral horn 
of the cord, their size (cell body diameter ≥ 30 µm358,363 and area ≥ 350 µm2), and the presence 
of a clearly identifiable nucleus. They were counted through the ten serial sections at the four 
positions. Thereby, the motoneurons were followed through the sections and it was taken care to 
count every motoneuron only once. The number of motoneurons was compared between the two 
spinal cords, which were processed in parallel, and relative differences were calculated. This was 
repeated for at least five sets of animals and the average of the differences were compared. Images 
were taken with a Leica DFC350FX digital camera that was mounted on a Leica DM-RXE light 
microscope. Image analysis was performed using NIH ImageJ image analysis software.
2.9 Statistical analysis
All data is presented as means ± standard deviations (s.d.). Transgenic animals were always 
compared to their wild type littermates. Aged C57BL/6 mice were compared to adult animals 
from the same strain. n always referred to the number of animals.
Statistical values were calculated with SPSS. Data was checked for normal distribution using 
Shapiro-Wilk and one-sample Kolmogorov-Smirnov tests and for homoscedasticity (homogeneity 
of variance) using Levene’s tests. 
To compare means, two-tailed Mann-Whitney tests were used. Multiple comparisons (comparison 
of wt, Nto1, Nto1/rAg, Nto1/Ag animals) were performed with one-way ANOVAs (analysis of 
variance), followed by Tukey (homoscedasticity) or Tamhane’s T2 (heteroscedasticity) post-hoc 
tests. For pairwise comparisons (number of motoneurons), Wilcoxon Signed Ranks tests were 
applied.
Significance levels were defined at 0.05, 0.01 and 0.001.
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3 ReSultS
3.1 transgenic overexpression of neurotrypsin in mice results in an increased 
agrin cleavage
To study the effect of agrin cleavage at the neuromuscular junction on structure and function of 
skeletal muscles we analyzed a series of transgenic mouse lines (Bolliger et al., Fig. 11). Two 
transgenic mouse lines overexpressing the agrin-cleaving serine protease neurotrypsin pan-
neuronally (Nto1, Nto2) were generated, using a conventional overexpression cassette composed 
of the Thy 1 promotor634 and the ORF of neurotrypsin. Distinct neurotrypsin overexpression 
level in the different lines, were thought to cause dose-dependent effects. Furthermore, mice 
overexpressing neurotrypsin exclusively in motoneurons (Nto-moto) were generated by adding 
a transcriptional stop sequence, flanked by two loxP sites, between the Thy 1 promotor and the 
ORF of neurotrypsin. For selective activation of the transgene, these mice were crossed with a 
mouse line expressing cre recombinase under control of the Hb9 promotor14. Hb9 is a transcription 
factor that is selectively and transiently expressed in precursors of motoneurons642. These mice 
were used to confirm that the motoneuronal neurotrypsin expression is sufficient to induce the 
neuromuscular phenotype and to exclude any influence of the central nervous system. A drawback 
of these animals was the variation in the level of neurotrypsin expression. The recombination to 
activate the transgene is thought to proceed differentially in every single motoneuron, leaving 
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Figure 11 Schematic representations of the 
transgenic constructs used to generate the 
analyzed mouse lines. Neurotrypsin and agrin 
expression were under control of the Thy-
1 promotor. Motoneuron specific expression 
was achieved by using a silent transgene that 
can be activated by cre recombinase catalyzed 
recombination. Cre was under control of the Hb9 
promotor, which is only and transiently activated 
in motoneurons. Thus, recombination and hence, 
activation of the transgene took only place in 
double-transgenic motoneurons (arrow). For a 
rescue experiment,  neurotrypsin transgenic mice 
(Nto1) were crossed with mice overexpressing 
either cleavage-resistant agrin (rAg) or wild type 
agrin (Ag).
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different number of copies of the activated transgene behind. This process results in a substantial 
variation of the neurotrypsin expression level among motoneurons and among animals. A second 
drawback was the difficulty to perform a rescue experiment (see below). Therefore, most of the 
analysis was performed on line Nto1. Nto2 and Nto-moto were used to confirm the findings.
 As a control, a mouse line overexpressing a catalytically inactive form of neurotrypsin, due to 
a mutation of the essential active site serine to alanine, was generated (Nto-inact). Mutation of 
the active site serine results in a complete loss of catalytic function in all serine proteases. This 
transgene was also expressed under control of the Thy 1 promotor. For a rescue experiment, 
neurotrypsin-overexpressing mice (line Nto1) were crossed with a mouse line overexpressing a 
Figure 12 The overexpression of neuro-
trypsin results in increased agrin cleavage 
in different transgenic mouse lines. (a) 
A representative Western blot from P10 
mice. Spinal cord homogenates from 
neurotrypsin-overexpressing (Nto1, 
Nto2) mice, neurotrypsin-deficient mice 
(Ntd), wild type mice (wt), and mice 
overexpressing a catalytically inactive 
variant of neurotrypsin (Nto-inact) were 
analyzed. The neurotrypsin protease 
domain was detected at 27 kDa and was 
clearly enriched in the samples from Nto1, 
Nto2, and Nto-inact, and absent in Ntd 
mice. The enrichment was stronger in 
Nto1 than in Nto2. Note that the protease 
domain of human neurotrypsin (overexpressed in Nto1) was slightly shifted towards lower molecular weight 
compared with mouse neurotrypsin (overexpressed in Nto2 and Nto-inact). The overexpression of neurotrypsin 
was associated with an increased agrin cleavage, which is represented by the accumulation of the agrin 90 kDa 
fragment (agrin-90), in the Nto1 and Nto2 mouse lines. Nto-inact did not show an increased immunoreactivity for 
agrin-90. Agrin-90 was completely absent in Ntd mice. ß-actin was used as loading control. (b) Increased signals 
for neurotrypsin and agrin-90 were also observed in mice overexpressing neurotrypsin exclusively motoneuronally 
(Nto-moto). (c) Representative Western blot from aged wt, Ntd, and Nto1 mice. Signals for neurotrypsin and agrin-
90 were still detectable in aged wt, but their intensity was decreased compared to P10. The upper part of the agrin 
signal was absent in aged animals, regardless whether neurotrypsin was present or not. Note that neurotrypsin was 
still overexpressed in senescent Nto1 mice. (d) Quantitative analysis of the agrin-90 signals. A significant increase 
in the immunoreactivity for agrin-90 was detected in spinal cord homogenates from Nto1, Nto2, and Nto-moto P10 
mice compared to wild type littermates (wild type values set to 100%). The signal intensity was higher in Nto1 than 
in Nto2 and Nto-moto mice. No difference was observed between Nto-inact and wild type mice. All Western blots 
were performed in triplicates. The number of animals for each group is indicated inside each bar. Error bars represent 
s.d. *P < 0.05, **P < 0.01, ***P < 0.001.
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neurotrypsin-resistant agrin variant (rAg) in which the basic amino acids at P1 positions of the 
α and β cleavage sites were mutated to alanine. These mutations have been shown to completely 
abolish any cleavage by neurotrypsin119. Mice overexpressing neurotrypsin and a wild type agrin 
variant (Nto1/Ag) were used as negative control of the rescue experiment. Both agrin forms 
were overexpressed under control of the Thy 1 promotor. The rescue experiment with the Nto-
moto mice was not performed, because the triple crossing (Nt/cre/rAg) would have demanded a 
high number of animals and would have been very time consuming. Neurotrypsin deficient mice 
(Ntd), in which the protease domain has been deleted, were also available. To compare several 
neuromuscular aspects of neurotrypsin transgenic with those of aged mice, aged wild-type mice 
were also investigated. Initial results indicated similarities, possibly leading to insights into the 
age-associated neuromuscular degeneration referred to as sarcopenia. Mice specified as adult were 
always 4 months old, whereas animals referred to as aged or senescent were 24 months old. For 
most of the analysis, female animals were used. Males were only occasionally analyzed to confirm 
the most important findings. 
Neurotrypsin overexpression and the neurotrypsin-dependent agrin cleavage were verified by 
Western blotting of spinal cord homogenates of P10 mice (Fig. 12a, b). The G87 antibody was 
used to detect the neurotrypsin protease domain. This domain represents the activated form of 
neurotrypsin, after activation cleavage at the zymogen activation site. SDS-Page under reducing 
conditions was applied to separate the protease domain from the non-catalytic part and consecutive 
immunoblotting resulted in a signal at 27 kDa. An increased immunoreactivity for the neurotrypsin 
protease domain was detected in all transgenic mice compared to their wild type littermates. 
The different lines showed distinct expression levels (Nto1 > Nto2 and Nto-moto). The signal 
for the neurotrypsin protease domain was completely absent in the neurotrypsin deficient mice. 
Overexpression of active neurotrypsin was associated with increased agrin cleavage. A fragment 
of about 90 kD (agrin-90), which results from specific proteolytic cleavage of agrin at its α and 
β cleavage sites119,121, was detected with the R132 antibody. All mouse lines overexpressing an 
active form of neurotrypsin showed an increased immunoreactivity for agrin-90. Quantification 
revealed not only significant increases in agrin-90 levels for all transgenic mouse lines, but also 
distinct agrin-90 amounts in the different lines (Fig. 12d). The enrichment of agrin-90 was in 
good correlation with the neurotrypsin overexpression level in different transgenic mouse lines 
(Nto1 > Nto2 and Nto-moto). This dose-dependency of agrin cleavage indicated that neurotrypsin 
might indeed processes agrin in vivo. Overexpression of proteolytically inactive neurotrypsin did 
not affect agrin cleavage, demonstrating that the proteolytic activity was responsible for enhanced 
agrin processing in neurotrypsin-overexpressing mice. Consistent with previous results, agrin-90 
was completely absent in neurotrypsin deficient mice. These findings indicated that neurotrypsin 
could cleave agrin in vivo, and that its overexpression resulted in an excessive agrin cleavage in 
different transgenic mouse lines. 
Western blotting on aged spinal cord extracts indicated that neurotrypsin was still expressed in 
senescence, although the weak signal for the neurotrypsin protease domain was only marginally 
over background levels seen in Ntd mice (Fig. 12c). The signal for agrin-90 was clearly increased 
in aged wild type mice compared to Ntd mice. Thus, neurotrypsin expression and agrin cleavage 
were sustained in senescence. However, the levels of both neurotrypsin and agrin-90 were 
decreased compared to 10 days old animals. Interestingly, the upper part of the signals for full 
length agrin, representing the most heavily glycanated variants121, was absent in aged animals. 
This could represent increased cleavage or decreased synthesis of these agrin forms. Neurotrypsin 
appeared to be dispensable for this process, since the heaviest agrin variants were also absent in 
aged Ntd animals.
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3.2 Neurotrypsin-overexpressing and aged mice show motor dysfunction
The transgenic mice overexpressing active neurotrypsin in neurons were viable. However, after 
developing normally during the first week of life, they began to lag behind their normal littermates 
with regard to growth of body mass. In adult animals of line Nto1 body weight dropped 9% 
following neurotrypsin overexpression (table I). Transgenic animals moved around slowly, 
with small steps. Their gait was insecure and hesitant, with frequent stops, during which they 
assumed a resting position with spread legs. However, they’re behavior, physical activity and 
food uptake appeared to be normal and they reached the same age as wild type littermates. In 
order to assess motor coordination of transgenic mice, their footprints were recorded (Fig. 13a). 
Quantification of stride length and paw placement revealed significant differences between 
transgenic mice and their wild type littermates. Stride length was reduced in transgenic mice and 
they placed their hindpaw at some distance instead of immediately behind their forepaw (Fig. 
13e). Mice overexpressing neurotrypsin selectively in motoneurons (Nto-moto) exhibited similar 
deficits, suggesting a motoneuronal or muscular rather than a central mechanism (Fig. 13b). 
Since muscular deficits could result in decreased muscular strength, the forelimb grip strength 
was measured. Indeed, it was reduced by more than 10% in transgenic animals when compared 
with wild type littermates (Fig. 14). Thus, not only coordination, but also strength was affected. 
Mice overexpressing catalytically inactive neurotrypsin (Nto-inact) and double transgenic mice 
overexpressing neurotrypsin together with cleavage-resistant agrin (Nto1/rAg) were normal 
in regard to body weight, motor coordination and grip strength, whereas mice concomitantly 
overexpressing neurotrypsin and wild type agrin (Nto1/Ag) were not (Fig. 13a, c, e, 14). Thus, 
proteolytic processing of agrin at the α and β cleavage sites by neurotrypsin was responsible for 
reduced body weight and motor deficits.
Aged wild type mice exhibited remarkably similar motor deficits. Their gait was insecure and 
hesitant. They took small steps and placed their hindpaw at some distance rather than immediately 
behind the forepaw (Fig. 13d, e). Their forelimb grip strength was significantly reduced, when 
compared with adult animals (Fig. 14). Body mass, however, was not reduced but significantly 
increased in aged animals, which was to a great extent attributable to an increase in body fat 
(table I).
line genotype n
Nto1 wt 26 24.2 ± 2.3 8.50 ± 0.59 9.62 ± 0.76 0.76 ± 0.04
Nt 28 22.0 ± 1.7 ** 7.55 ± 0.45 *** 8.94 ± 0.67 ** 0.75 ± 0.05
x rAg Nt/rAg 9 24.2 ± 1.6 ° 8.50 ± 0.89 °°° 9.64 ± 0.66 ° 0.75 ± 0.03
x Ag Nt/Ag 11 22.0 ± 0.9 *** 7.40 ± 0.34 *** 8.88 ± 0.56 * 0.74 ± 0.04
Nto-inact wt 5 24.6 ± 1.3 8.50 ± 0.69 9.89 ± 0.58 0.75 ± 0.03
iNt 5 23.7 ± 2.9 8.37 ± 0.87 9.46 ± 1.06 0.75 ± 0.02
adult 11 24.1 ± 3.4 8.72 ± 0.99 9.66 ± 1.06 0.76 ± 0.03
aged 9 41.2 ± 7.2 *** 8.75 ± 0.67 8.73 ± 0.61 * 0.43 ± 0.07 ***
body mass (g)
muscle mass per
muscle mass (mg) body mass (mg/g)muscle mass (mg)
EDLsoleus
Both body mass and muscle mass were reduced in female animals overexpressing active neurotrypsin. Note that the 
loss of soleus muscle mass was more pronounced than the loss of EDL muscle mass. Concomitant overexpression of 
neurotrypsin-resistant agrin and neurotrypsin restored the wild type situation, wild type agrin did not. Aged animals 
exhibited increased body mass, no change in soleus muscle mass and a small reduction in EDL mass. n indicates the 
number of animals for each group. Data represent mean ± s.d. *P < 0.05, **P < 0.01, ***P < 0.001 compared to wild 
type littermates or adult controls, °P < 0.05, °°P < 0.01, °°°P < 0.001 compared to Nto1.
table I 
Body and muscle masses in female mice
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3.3 excessive agrin cleavage results in morphological changes of the skeletal 
muscle similar to aging
To better understand the pathogenic process resulting in motor deficits in neurotrypsin-
overexpressing mice, the skeletal muscle morphology was studied. A slow (m. soleus) and a fast 
twitch (m. extensor digitorum longus, EDL) muscle of adult mice were analyzed for alterations 
following neurotrypsin overexpression and excessive agrin cleavage. In concert with functional 
impairment and reduction in body weight, muscle mass was significantly reduced in neurotrypsin-
overexpressing animals compared to 
wild type littermates. In line Nto1, wet 
weight of soleus and EDL muscle were 
reduced 11% and 7%, respectively 
(table I). Additional overexpression 
of resistant agrin rescued from the 
neurotrypsin-induced muscle mass 
loss, whereas wild type agrin did not. 
Loss of body mass, muscle strength 
and muscle mass all were of similar 
magnitude and caused by enhanced 
agrin cleavage at the neurotrypsin 
specific α and β cleavage sites. Thus, 
at first glance, the loss of muscle 
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Figure 13 Neurotrypsin overexpression and 
enhanced agrin cleavage induces aging-like 
motor impairments. (a-d) Footprints recorded 
from Nto1 (a), Nto-moto (b), Nto-inact (c) 
and aged mice (d). Animals overexpressing 
active neurotrypsin as well as aged animals 
took small steps and exhibited an insecure 
gait. In contrast to wild type animals, they 
did not place their fore- and hindpaws at the 
same spot. Concomitant overexpression of 
cleavage-resistant neurotrypsin rescued from 
the motor coordination impairment, whereas 
wild type agrin did not. (e) Quantification 
of stride length and paw placement. Stride 
length was defined as the distance between 
consecutive fore- and hindpaw prints. Paw 
placement was quantified by measuring the 
distance between corresponding hind- and 
forepaw prints. Neurotrypsin overexpression 
and aging resulted in reduced stride length and 
impaired paw placement. The overexpression 
of neurotrypsin-resistant agrin rescued from 
the motor phenotype, wild type agrin did 
not. Inactive neurotrypsin had no effect. The 
number of animals for each group is indicated 
inside each bar. Error bars represent s.d. Scale 
bars, 5 cm. **P < 0.01, ***P < 0.001 compared 
to wild type littermates or adult controls, °°°P 
< 0.001 compared to Nto1.
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mass and strength may simply be a 
consequence of reduced body mass. 
However, impairment of motor 
coordination implies a more complex 
disturbance. 
Indeed, quantitative analysis of the 
number of fibers in hematoxylin and 
eosin stained muscle cross sections 
revealed a dramatic loss of muscle 
fibers in conditions with enhanced 
agrin cleavage (Fig. 15). This effect 
was observed in female (table II) and 
male mice (table III). The number 
of myofibers did not differ between 
sexes, neither for wild type nor for 
transgenic animals. All transgenic 
animals overexpressing an active form 
of neurotrypsin suffered from the 
fiber loss, although the severity varied 
considerably. Up to 30 % of all fibers 
of the soleus muscle are lost in line Nto1, only about 10 % in line Nto2. Qualitatively the same 
effect was observed in the EDL muscle. In agreement with the reduction in muscle mass, slow-
twitch soleus was more affected than fast twitch EDL muscle. The severity of the fiber loss was 
consistent with the level of neurotrypsin overexpression and the amount of agrin cleavage, both 
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Figure 14 Forelimb grip strength was measured in 15 trials at each 
of 3 consecutive days. The strength was reduced in neurotrypsin-
overexpressing and in aged mice compared to adult wild types (wt 
values set to 100%). Overexpression of resistant agrin together 
with neurotrypsin restored the wild type situation, wild type agrin 
did not. Inactive neurotrypsin did not affect forelimb grip strength. 
The number of animals for each group is indicated inside each 
bar. Error bars represent s.d. **P < 0.01, ***P < 0.001 compared 
to wild type littermates or adult controls, °°°P < 0.001 compared 
to Nto1.
table II 
Number of fibers in soleus and EDL muscles of female mice
Enhanced agrin cleavage and aging are associated with a loss of muscle fibers. The number of fibers of soleus 
and EDL muscles of female mice were counted on muscle cross-sections. All animals were compared to wild 
type littermates. The overexpression of active neurotrypsin was associated with a loss of muscle fibers in 
both soleus and EDL muscles. Overexpression of cleavage-resistant but not wild type agrin rescued from 
the fiber loss. Note that the loss of fibers was more pronounced in line Nto1 than in line Nto2. Motoneuron-
specific neurotrypsin overexpression was sufficient to induce the effect. Inactive neurotrypsin or the absence 
of neurotrypsin did not affect the muscle fiber number. Aging also resulted in a loss of muscle fibers in both 
soleus and EDL muscle. n indicates the number of animals for each group. Data represent mean ± s.d. *P < 
0.05, **P < 0.01, ***P < 0.001 compared to wild type littermates or adult controls, °°°P < 0.001 compared 
to Nto1.
line genotype n rel. wt n rel. wt
Nto1 wt 24 932 ± 56 15 1008 ± 51
Nt 21 651 ± 50 *** 0.70 11 865 ± 55 *** 0.86
x rAg Nt/rAg 9 929 ± 48 °°° 1.00 8 969 ± 31 °°° 0.96
x Ag Nt/Ag 10 637 ± 49 *** 0.68 7 855 ± 73 *** 0.85
Nto2 wt 4 939 ± 21 4 1031 ± 32
Nt 6 861 ± 29 * 0.92 4 907 ± 76 * 0.88
Nto-moto wt 9 941 ± 40 5 1002 ± 51
Nt/cre 6 535 ± 43 ** 0.57 5 715 ± 64 ** 0.71
Nto-inact wt 7 942 ± 23 5 977 ± 62
iNt 7 952 ± 38 1.01 5 979 ± 42 1.00
Ntd wt 6 952 ± 55 6 988 ± 82
ko 7 943 ± 37 0.99 6 1007 ± 40 1.02
adult 10 960 ± 30 7 1000 ± 51
aged 15 813 ± 63 *** 0.85 6 824 ± 37 ** 0.82
m. edl
number of fibers number of fibers
m. soleus
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being stronger in line Nto1 than in line Nto2. A higher neurotrypsin expression level resulted 
in an increased agrin cleavage and in more extensive muscle fiber loss. This dose dependency 
indicated that neurotrypsin overexpression and enhanced agrin cleavage could induce the muscle 
fiber loss. The strongest phenotype was observed in Nto-moto mice, which lost more than 40% 
of their myofibers. A direct comparison of the neurotrypsin expression level and the amount of 
agrin cleavage to the other lines was not possible, due to the motoneuron-restricted expression 
pattern. However, the severe phenotype of these animals suggested that the motoneuronal 
neurotrypsin overexpression was sufficient and especially important to induce muscle fiber 
loss. The overexpression of inactive neurotrypsin did not affect the number of fibers, neither 
in the soleus nor in the EDL muscle, proving that the proteolytic activity of neurotrypsin was 
Figure 15 Muscle thickness and fiber number is reduced in conditions with enhanced agrin cleavage. Representative 
hematoxylin and eosin (H&E) stained cross-sections from soleus muscles illustrate reduced muscles thickness and 
fiber number in female mice from line Nto1 and Nto-moto. Concomitant overexpression of a cleavage-resistant agrin 
variant and neurotrypsin restored the wild type muscle morphology, whereas wild type agrin did not. Animals from 
line Nto2 and aged animals only exhibited minor changes in muscle thickness, but the number of fibers appears to 
be reduced. Cross-sections from Nto-inact and Ntd mice were not distinguishable from wild type sections. Scale bar, 
0.5 mm.
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needed. Furthermore, the concomitant overexpression of a neurotrypsin-resistant agrin variant 
and neurotrypsin (Nto1/rAg) rescued the fiber loss in both soleus and EDL muscle. This was not 
the case if a wild type agrin variant (Nto1/Ag) was used (table II, Fig. 15). Therefore, cleavage of 
agrin at the neurotrypsin-specific α and β cleavage sites was necessary to establish the phenotype. 
The absence of neurotrypsin, in contrast, did not cause any change in the number of muscle fibers 
in Ntd mice.
line genotype n rel. wt n rel. wt
Nto1 wt 14 952 ± 39 6 1002 ± 48
Nt 12 644 ± 46 *** 0.68 5 839 ± 37 ** 0.84
x rAg Nt/rAg 4 931 ± 22 °°° 0.98
x Ag Nt/Ag 4 706 ± 46 *** 0.74
Nto2 wt 4 973 ± 12
Nt 5 871 ± 25 * 0.90
Nto-moto wt 7 977 ± 38 4 1001 ± 23
Nt/cre 4 546 ± 58 ** 0.56 2 757 ± 36 0.76
Nto-inact wt 3 942 ± 14
iNt 5 945 ± 50 1.00
Ntd wt 3 923 ± 18
ko 4 974 ± 20 1.05
adult 10 948 ± 27 6 1008 ± 44
aged 8 870 ± 32 *** 0.92 4 858 ± 119 * 0.85
number of fibers number of fibers
m. edl m. soleus
table III
Number of fibers in soleus and EDL muscles of male mice
Neurotrypsin and aging induced loss of muscle fibers was also observed in male muscles. n indicates the 
number of animals for each group. Data represent mean ± s.d. *P < 0.05, **P < 0.01, ***P < 0.001 compared 
to wild type littermates or adult controls, °°°P < 0.001 compared to Nto1.
line genotype n rel. wt n rel. wt
Nto1 wt 24 1.58 ± 0.16 15 1391 ± 100
Nt 21 1.41 ± 0.19 ** 0.89 12 1773 ± 178 *** 1.27
x rAg Nt/rAg 9 1.64 ± 0.17 °° 1.04 7 1437 ± 138 °°° 1.03
x Ag Nt/Ag 10 1.38 ± 0.10 * 0.88 7 1838 ± 155 *** 1.32
Nto2 wt 4 1.61 ± 0.14 4 1349 ± 81
Nt 6 1.53 ± 0.07 0.95 4 1550 ± 80 * 1.15
Nto-moto wt 9 1.63 ± 0.14 5 1408 ± 85
Nt/cre 6 1.35 ± 0.17 * 0.83 5 2241 ± 250 ** 1.59
Nto-inact wt 7 1.60 ± 0.07 5 1372 ± 29
iNt 7 1.57 ± 0.07 0.98 5 1392 ± 95 1.02
Ntd wt 6 1.57 ± 0.04 5 1364 ± 113
ko 7 1.56 ± 0.09 0.99 6 1354 ± 116 0.99
adult 10 1.63 ± 0.12 6 1410 ± 95
aged 15 1.54 ± 0.09 0.95 7 1597 ± 76 ** 1.13
fiber CSA (µm2)muscle CSA (mm2)
table IV
Cross-sectional areas (CSAs) of the whole soleus muscle and individual muscle fibers
Reduction in muscle thickness was accompanied by an increase in mean fiber thickness in female animals 
from neurotrypsin-overexpressing mouse lines Nto1, Nto2, and Nto-moto. Note that the effects were more 
pronounced in line Nto2 than in line Nto1. Motoneuronal neurotrypsin overexpression was sufficient to 
induce both reduction in muscle CSA and increase in mean fiber CSA. Cleavage-resistant agrin restored 
the wild type situation, wild type agrin did not. Aged soleus muscles also tended to be thinner and to 
consist of thicker muscle fibers. n indicates the number of animals for each group. All fibers of each muscle 
were used for quantification. Data represent mean ± s.d. *P < 0.05, **P < 0.01, ***P < 0.001 compared to 
wild type littermates or adult controls, °°P < 0.01, °°°P < 0.001 compared to Nto1.
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To examine the influence of muscle fiber loss on muscle thickness, the cross-sectional area (CSA) 
of the soleus muscle was measured (table IV, Fig. 15). It was reduced in all mice overexpressing 
active neurotrypsin compared to their wild-type littermates. Reduced muscle thickness was most 
likely a consequence of the fiber loss and the cause for reduced muscle strength. Surprisingly, 
reduction in muscle CSA was clearly less pronounced than the loss of fibers, attributable to a 
significant increase in the CSA of the individual muscle fibers (table IV). However, measurements 
of individual fiber thicknesses revealed not a general increase, but a greater heterogeneity of 
the fiber CSAs. Both the fraction of atrophied fibers and the fraction of hypertrophied fibers 
were significantly increased in neurotrypsin-overexpressing animals (Fig. 16, 17). This finding 
suggests that not all fibers are equally affected. The loss and atrophy of certain fibers may be 
partially compensated by the hypertrophy of unaffected fibers. The increase of the mean fiber 
thickness could be a compensatory mechanism to the fiber loss, keeping the animal mobile. The 
whole muscle atrophy, the increase in mean fiber CSA and the greater fiber size variability was 
observed in all line overexpressing active neurotrypsin. Also here, the extent of the effects was 
consistent with the level of neurotrypsin and agrin cleavage, all being stronger in line Nto1 than 
in line Nto2 (table IV, Fig. 16b, Fig. 17). The strong phenotype in Nto-moto mice indicated 
that neurotrypsin overexpression in motoneurons sufficiently explained the observed phenotype 
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Figure 16 Similar changes of the skeletal muscle morphology due to neurotrypsin overexpression and aging. (a) 
H&E stained cross-sections from soleus muscle of female mice overexpressing neurotrypsin or neurotrypsin together 
with cleavage-resistant or wild type agrin. Increased heterogeneity of fiber thickness, centralized nuclei (arrows) and 
angular fibers (arrowheads) were observed in conditions with enhanced agrin cleavage (Nto1, Nto1/Ag). Muscles of 
Nto1/rAg mice were not distinguishable from those of wild type littermates. (b) Cross-sections from Nto2 muscles 
showed similar but weaker alterations of the muscle morphology. (c) Motoneuronal neurotrypsin overexpression 
was sufficient to induce heterogeneity of muscle thickness, as well as the accumulation of angular and centrally 
nucleated muscle fibers. (d, e) The overexpression of an inactive neurotrypsin form and the absence of neurotrypsin 
did not affect the skeletal muscle morphology. (f) Cross-sections from aged mice were strikingly similar to those from 
neurotrypsin transgenic mice. Greater heterogeneity of fiber thickness, centralized nuclei, and angular fibers can be 
observed upon both excessive agrin cleavage and aging. Scale bars, 0.1 mm.
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(Fig. 16c). Line Nto-inact did not show any fiber size alterations, outlining the importance of 
the proteolytic activity (Fig. 16d). The overexpression of a neurotrypsin-resistant agrin variant 
together with neurotrypsin rescued the fiber size alterations, whereas the overexpression of a wild 
type agrin variant did not. The cleavability of agrin was again crucial to induce the phenotype.
Beside the number and the size of the myofibers, their shape was analyzed on soleus muscle 
cross-sections. The circularity, which is a measure of the compactness of a shape, was used. 
It describes the ratio of the perimeter to the area. The circularity of a perfect circle is one and 
more angular fibers exhibit smaller circularities. The mean circularity of the soleus muscle fibers 
was significantly decreased in conditions with enhanced agrin cleavage (table V). Consistently, 
angular fibers, which are characterized by a low circularity, appeared (Fig. 16, 18). Because angular 
fibers are considered to be indicators of denervation158,197, their appearance suggested ongoing 
denervation of muscle fibers. Denervation is known to induce severe muscle atrophy, indicating 
that the loss of neuronal input may be responsible for both the accumulation of atrophied fibers 
Figure 18 Appearance of an-
gular fibers in conditions with 
enhanced agrin cleavage and 
in senescence. Frequency his-
togram of the fiber circularity 
in soleus muscles showed that 
the amount of angular fibers 
(low circularity) was increased 
due to overexpression of active 
neurotrypsin and aging.
All fibers of each muscle 
were analyzed. The number 
of animals for each group is 
indicated in parentheses. Error 
bars represent s.d. 
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Figure 17 Increased hetero-
geneity of fiber thickness is a 
common feature of neurotrypsin 
transgenic and aged muscles. 
Frequency histogram of fiber 
thickness in soleus muscles 
from Nto1, Nto2, Nto-moto, 
Nto-inact, and aged mice. Note 
the accumulation of atrophied 
and hypertrophied muscle fibers 
in mice overexpressing active 
neurotrypsin and in aged mice. 
The effect was clearly weaker 
in line Nto2 than Nto1. Cleav-
age-resistant agrin restored the 
wild type situation, wild type 
agrin did not. Inactive neu-
rotrypsin did not induce fiber 
size variability. 
All fibers of each muscle were 
measured for the quantification. 
The number of animals for each 
group is indicated in parenthe-
ses. Error bars represent s.d
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and the loss of fibers. Another characteristic of neurotrypsin transgenic muscle was increased 
central nucleation of myofibers (table V, Fig. 16). In wild types, the nuclei of the muscle fibers 
were located at the boarder of the fiber and centralized nuclei were rarely observed. Following 
neurotrypsin overexpression and enhanced agrin cleavage, centrally nucleated fibers appeared. 
Almost 3 % of the soleus muscle fibers contained centralized nuclei in transgenic animals from line 
Nto1. Centrally nucleated fibers are commonly recognized as regenerated myofibers272, indicating 
a regeneration reaction of the muscle to the extensive fiber loss. Angular, as well as centrally 
nucleated fibers appeared in all mouse lines overexpressing active neurotrypsin and the extent of 
these alterations was consistent with the level of neurotrypsin expression and agrin cleavage (Nto1 
> Nto2). The motoneuronal overexpression caused the same effect and the rescue experiment was 
also successful in this respect. The concomitant overexpression of cleavage-resistant agrin with 
neurotrypsin (Nto1/rAg) restored the wild type situation, whereas wild type agrin (Nto1/Ag) did 
not.
In summary, excessive cleavage of agrin, induced by neurotrypsin overexpression in motoneurons, 
was responsible for the degenerative muscular alterations in young adult mice. Concomitant 
overexpression of neurotrypsin and a cleavage-resistant agrin variant completely restored the 
wild-type situation in all aspects tested. Denervation of the individual muscle fibers is suspected 
to induce atrophy and degeneration of a subset of muscle fibers. Muscle intrinsic regeneration 
mechanisms are activated but fail to prevent the massive loss of skeletal muscle fibers. However, 
some of the remaining fibers become hypertrophied to compensate, at least partially, the reduction 
in muscle thickness following fiber loss.
Similar alterations of the muscle morphology have previously been described in senescence as a 
consequence of the age-associated muscle degeneration referred to as sarcopenia. One of the most 
striking characteristics of sarcopenia is the loss of muscle fibers. Unlike other catabolic conditions 
such as cachexia or disuse that lead to muscle atrophy, sarcopenia is the result of a loss of muscle 
Centrally nucleated and 
angular fibers are com-
mon characteristics of 
agrin cleavage-induced 
and age-associated sarco-
penia. The percentage of 
soleus muscle fibers with 
central myonuclei was 
significantly increased 
due to neurotrypsin 
overexpression in female 
animals from line Nto1, 
Nto2, and Nto-moto. The 
increase was smaller in 
Nto2 than in Nto1 and 
could be rescued by over-
expression of cleavage-
resistant agrin. Aged muscles also showed an increased proportion of centrally nucleated fibers. The circularity was 
used as measure for the fiber shape. Decreased fiber circularity was found in muscles from Nto1, Nto2, Nto-moto, and 
in aged mice,  indicating the appearance of more angular fibers with low circularities. Cleavage-resistant agrin but 
not wild type agrin restored the wild type situation. Inactive neurotrypsin or the absence of neurotrypsin had neither 
an influence on myonuclei position nor on fiber shape. n indicates the number of animals for each group. All fibers of 
each muscle were used for quantification. Data represent mean ± s.d. *P < 0.05, **P < 0.01, ***P < 0.001 compared 
to wild type littermates or adult controls, °P < 0.05, °°P < 0.01, °°°P < 0.001 compared to Nto1.
table V
Central nucleation and circularity of soleus muscle fibers
centrally nucleated fibers (%)
line genotype n n
Nto1 wt 15 0.44 ± 0.11 15 0.819 ± 0.011
Nt 12 2.94 ± 0.76 *** 12 0.789 ± 0.013 ***
x rAg Nt/rAg 7 0.40 ± 0.10 °°° 7 0.815 ± 0.005 °°°
x Ag Nt/Ag 7 2.41 ± 0.54 *** 7 0.785 ± 0.011 ***
Nto2 wt 4 0.34 ± 0.18 4 0.817 ± 0.010
Nt 4 0.79 ± 0.11 * 4 0.795 ± 0.007 *
Nto-moto wt 5 0.41 ± 0.10 5 0.828 ± 0.004
Nt/cre 5 2.23 ± 0.59 ** 5 0.783 ± 0.015 **
Nto-inact wt 5 0.48 ± 0.15 5 0.816 ± 0.013
iNt 5 0.48 ± 0.12 5 0.817 ± 0.017
Ntd wt 5 0.41 ± 0.20 5 0.824 ± 0.006
ko 6 0.45 ± 0.31 6 0.821 ± 0.007
adult 6 0.45 ± 0.14 6 0.821 ± 0.011
aged 7 1.88 ± 0.86 ** 7 0.802 ± 0.007 **
fiber shape (circularity)
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fibers, as well as a marked heterogeneity in the CSA of the remaining myofibers232,238. Skeletal 
muscles of aged mice were analyzed for comparison of the neurotrypsin- and aging-induced 
effects (Fig. 15, 16f). Indeed, strikingly similar muscle morphological changes were found. As 
in conditions with enhanced agrin cleavage in young adult mice, loss of myofibers and increased 
fiber size variability were observed with aging (tables II, III, Fig. 17). Compensatory fiber 
hypertrophy resulted in increased mean fiber thickness (table IV). Angular fibers and centralized 
nuclei indicated ongoing denervation and muscle fiber regeneration, respectively (table V). A 
significant reduction in whole muscle CSA was not found but the same tendency was observed 
(table IV). The gain in body mass in aged animals that increases the loading of the muscle may 
induce the compensatory mechanism to a higher extend than in transgenic animals. Interestingly, 
the EDL muscle showed significant age-associated reduction in mass, whereas the soleus muscle 
mass did not change with age, despite a similar drop in muscle fiber number (table I).
In summary, surprisingly similar morphological changes were found in the muscles of young 
adult mice exhibiting enhanced agrin cleavage and in aged wild type mice. This finding suggested 
a common etiology for both, agrin cleavage- and aging-induced muscle degeneration. Excessive 
agrin cleavage seems to precociously induce sarcopenia in young adult mice.
3.4 Additional transgenic mouse lines exhibit the same phenotypes
Beside the Nto1, Nto2, and Nto-moto additional mouse lines were investigated, including a third 
line overexpressing neurotrypsin neuronally (Nto3), and two lines overexpressing neurotrypsin 
motoneuronally (Nto-moto2 and Nto-moto3). Western blotting confirmed the overexpression of 
neurotrypsin and the accumulation of agrin-90 in line Nto3, Nto-moto2 and Nto-moto3 (Fig. 19a, 
b). The number of fibers of the soleus was assessed to get an impression about the severity of 
the muscle wasting effect (Fig. 19c). All of the transgenic lines exhibited a decreased number of 
fibers, confirming the previous findings. Loss of muscle fibers is a reliable and repeatable result 
of motoneuronal neurotrypsin overexpression. Line specific effects, such as insertion place or 
copy number of the transgene, may influence the expression level of neurotrypsin and hence, the 
severity of muscle fiber loss. 
genotype n number of fibers
Nto3 wt 9 937 ± 48
Nt 15 643 ± 38 ***
Nto-moto2 wt 5 941 ± 44
Nt/cre 4 671 ± 97 *
Nto-moto3 wt 6 911 ± 19
Nt/cre 3 791 ± 16 *
Ntd Nto3 wt Nto-moto2 wtNtd Nto-moto3
25
agrin
full length
agrin-90
neurotrypsin
ß-actin
a b
250
150
100
75
kDa
c
Figure 19 Neurotrypsin overexpression is associated with enhanced agrin cleavage and skeletal muscle fiber loss 
in additional mouse lines. Western blots from spinal cord homogenates from P10 mice overexpressing neurotrypsin 
neuronally (a) or motoneuronally (b). All transgenic mice showed an increased immunoreactivity for neurotrypsin 
and for agrin-90. ß-actin was used as loading control. (c) The number of fibers is significantly reduced in transgenic 
animals from line Nto3, Nto-moto2, and Nto-moto3 compared to wild type littermates. n indicates the number of 
animals. Data represent mean ± s.d. *P < 0.05, ***P < 0.001.
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3.5 Influence of enhanced agrin cleavage on postnatal skeletal muscle 
development 
The postnatal development of skeletal muscles of neurotrypsin transgenic animals was analyzed 
to assess the time scale of agrin cleavage-induced skeletal muscle degeneration. A temporal 
correlation between onset of neurotrypsin overexpression and skeletal muscle fiber loss was 
expected. The Thy 1 expression cassette was reported to drive transgene expression with a relatively 
late onset around postnatal days 6-10634. However, previous findings from our lab indicated that 
neurotrypsin overexpression from the Thy 1 promotor may start slightly earlier (Bolliger et al., 
in preparation). Soleus muscles from mice at different ages between 10 days and 10 months were 
collected and the number of fibers was counted on cross-sections. A mouse line overexpressing 
neurotrypsin motoneuronally (Nto-moto2) was used. At P10 wild type and transgenic animals had 
a similar number of myofibers (Fig. 20a). Shortly after, the number of fibers started to decrease 
in transgenic animals. In wild types, however, the fiber number increased with age in the first two 
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Figure 20 The sarcopenic phenotype is installed in a couple of weeks. (a) Developmental study of the soleus muscle 
fiber number in animals from line Nto-moto2 starting 10 days postnatally (P10). In wild type mice (wt), growth 
of the muscle was associated with a slight increase in the number of fibers during the first two to three weeks 
after birth, whereas in transgenic animals muscle fibers were lost in this time period. (b) The ratio of the fiber 
numbers of transgenic relative to wt muscles greatly decreased in the first 50 days after birth and remained unchanged 
thereafter. (c) The soleus muscle CSA increased in the first month postnatally, attributable to the growth of the muscle. 
Differences between neurotrypsin-overexpressing and wt animals mostly parallel the findings from the fiber numbers. 
At P10 and P12, soleus muscle thickness was the same in transgenic and wt animals. A difference in muscle CSA was 
observed at P15 and increased until about day 50. Thereafter, muscle thickness remained constant in both transgenic 
and wt animals. (d) Mean muscle fiber thickness (estimated from the division of muscle CSA by fiber number) did not 
differ between wt and transgenic animals during postnatal development. After day 50, the individual myofibers were, 
in average, thicker in transgenic than in wt animals, most likely due to compensatory hypertrophy. This difference 
remained constant during adulthood. n ≥ 2 animals per genotype and time point. Error bars represent s.d.
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to three weeks postnatally. At P15 a clear difference was visible, which was further increased 
until about postnatal day 60 (Fig. 20b). Later, the ratio of fiber numbers stayed constant. The 
start of the muscle wasting, around 10 days postnatally, appeared to be delayed in regard to the 
onset of neurotrypsin overexpression, which was suspected to start around five days postnatally. 
Nevertheless, it is plausible that the onset of overexpression, the cleavage of agrin, as well as 
atrophy and degeneration of the muscle fibers need some time before the impact on the muscle 
morphology can be detected. After P60, an age when the mice are thought to be mature, the 
number of fibers stayed remarkably constant. During initial postnatal growth of the muscle, in 
contrast, the action of neurotrypsin appears to be especially fatal, installing the basic muscle 
Figure 21 Relative increase in type I fibers and type grouping upon neurotrypsin overexpression and aging. Soleus 
muscle cross sections from female animals, stained for myofibrillar actomyosin ATPase (mATPase) activity after 
preincubation at pH 4.3. Only the slow, type I fibers are stained. Muscles from Nto1, Nto-moto, and aged animals 
showed a relative increase in darkly stained type I fibers compared to adult wild type animals. In addition, fiber type 
grouping was observed. Two cross-sections from Nto1 animals are shown to demonstrate the substantial variation 
in the proportion of the fiber types among neurotrypsin-overexpressing animals. The overexpression of cleavage-
resistant agrin together with neurotrypsin restored the wild type situation, whereas wild type agrin did not. Inactive 
neurotrypsin and the absence of neurotrypsin did not affect the fiber type distribution. Scale bar, 0.5 mm.
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phenotype in a couple of days.
Muscle CSA was increased during the first 6 weeks postnatally, regardless whether neurotrypsin 
was overexpressed or not (Fig. 20c). Differences in muscle thickness between transgenic animals 
and wild type littermates were observed at day 15 postnatally, at the time when also the number 
of muscle fibers started to differ. During adulthood, muscle CSA and fiber number did not change 
greatly neither in wild type nor in transgenic animals. Therefore, the difference in muscle thickness 
was most likely a consequence of the muscle fiber loss. Growth of the surviving individual muscle 
fibers appeared not to be affected by neurotrypsin overexpression, since mean fiber CSA was 
similar in transgenic and wild type mice during postnatal development (Fig. 20d). At day 45, 
however, mean fiber thickness started to differ in transgenic compared to wild type animals, 
suggesting compensatory hypertrophy as a reaction to the muscle fiber loss.
3.6 Loss of type II fibers exceeds loss of type I fibers both in young adult mice 
with enhanced agrin cleavage and in aged wild type mice
Muscle type specific actomyosin ATPase (mATPase) staining was used to analyze the soleus 
muscle for the occurrence of slow (type I) and fast (type II) muscle fibers. Type I fibers are 
Results
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Figure 22 Type I fiber preference and type grouping are common features of neurotrypsin transgenic and aged 
muscles. Soleus muscle cross-sections from female animals stained for mATPase activity after preincubation at pH 
4.3. Only the slow, type I fibers are stained. (a) Comparison of cross-sections from wt, Nto1, Nto1/rAg and Nto1/Ag 
animals. Increased proportion of type I fibers and accumulation of enclosed fibers (asterisks) were observed in Nto1 
and Nto1/Ag animals. The accumulation of enclosed fibers indicated fiber type grouping. Concomitant overexpression 
of neurotrypsin-resistant agrin and neurotrypsin restored the wild type situation. (b) Cross-sections from Nto2 mice 
exhibited only minor effects. (c) Motoneuronal neurotrypsin overexpression was sufficient to induce both relative 
increase in type I muscle fibers and accumulation of enclosed fibers. (d, e) Cross-sections from mice overexpressing 
inactive neurotrypsin (Nto-inact) and from neurotrypsin deficient mice (Ntd) were not distinguishable from wild type 
cross-sections. (f) Type I fiber preference and type grouping was also observed in senescence. Scale bars, 0.1mm.
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known to express an acid-stable myosin isoform, whereas type II fibers express an acid-labile 
myosin isoform. Preincubation at pH 4.3 was used to abolish myosin activity in type II fibers 
and subsequent staining for mATPase activity made it possible to discriminate between darkly 
stained type I fibers and unstained type II fibers. The number and proportion of type I fibers 
was determined. The proportion of type I fibers was higher in female (about 40 %) than in male 
(about 30 %) wild type mice. However, the comparison between wild type and transgenic animals 
revealed striking differences for both males and females. 
In females, a significant increase in the proportion of type I fibers was observed following 
neurotrypsin overexpression (Fig. 21, 22, 23a). However, absolute numbers were decreased 
for both type I and type II fibers (table VI). The severity of the effect was in good correlation 
with the agrin cleavage (Nto1 > Nto2) and the overexpressing of neurotrypsin selectively in 
motoneurons (Nto-moto) also induced the preference towards type I fibers. Inactive neurotrypsin 
or the absence of neurotrypsin did not cause any effect. The additional overexpression of resistant 
agrin restored the wild type situation, whereas additional overexpression of wild type agrin did 
not. Thus, neurotrypsin-dependent cleavage of agrin at its α and β sites induced the preference 
towards type I fibers. Interestingly, the concomitant overexpression of a cleavable agrin variant 
and neurotrypsin resulted in a more pronounced type I fiber preference than the overexpression 
of neurotrypsin alone (Fig. 23a). The number of type I fibers was significantly increased in the 
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Figure 23 Quantification of the proportion of type I fibers in the soleus muscle of female (a) and male (b) mice. (a) 
Note the relative increase in type I fibers due to overexpression of active neurotrypsin in line Nto1 and Nto-moto, 
and due to aging. Line Nto2 showed only a minor effect. Concomitant overexpression of cleavage-resistant agrin and 
neurotrypsin restored the wild type situation (Nto1/rAg). Interestingly, the overexpression of wild type agrin together 
with neurotrypsin (Nto1/Ag) further increased the proportion of type I fibers compared to the overexpression of 
neurotrypsin alone (Nto1). (b) In males, type I fiber preference was observed in muscles from Nto2, Nto-moto and 
for aged mice. In line Nto1, the proportion of type I fibers was decreased. This effect could be rescued by additionally 
overexpressing cleavage-resistant agrin.
The number of animals for each group is indicated inside each bar. Error bars represent s.d. *P < 0.05, **P < 0.01, 
***P < 0.001 compared to wild type littermates or adult controls, °P < 0.05, °°P < 0.01, °°°P < 0.001 compared to 
Nto1.
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line genotype n no of type I fibers
Nto1 wt 17 40 ± 4 378 ± 49
Nt 12 49 ± 7 * 313 ± 54 **
x rAg Nt/rAg 8 40 ± 2 °° 371 ± 25 °
x Ag Nt/Ag 10 59 ± 8 ***/° 372 ± 48 °
Nto2 wt 4 41 ± 2 382 ± 20
Nt 6 43 ± 4 368 ± 34
Nto-moto wt 6 42 ± 3 402 ± 23
Nt/cre 3 60 ± 18 349 ± 7 *
Nto-inact wt 5 39 ± 2 362 ± 10
iNt 5 40 ± 3 377 ± 40
Ntd wt 4 41 ± 3 380 ± 36
ko 8 41 ± 3 381 ± 23
adult 11 39 ± 3 377 ± 28
aged 13 54 ± 4 *** 437 ± 34 **
type I fibers (%) The absolute number of type I fibers was decreased in line 
Nto1 and Nto-moto, despite 
type I fiber preference. Resistant 
agrin rescued this effect. 
The pronounced type I fiber 
preference in Nto1/Ag animals 
even prevented absolute loss of 
type I fibers. In aged muscles, 
the absolute number of type I 
fibers was actually increased. n 
indicates the number of animals 
for each group. Data represent 
mean ± s.d. *P < 0.05, **P < 
0.01, ***P < 0.001 compared 
to wild type littermates or adult 
controls, °P < 0.05, °°P < 0.01.
table VI 
Relative and absolute number of type I fibers in female soleus muscle
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Figure 24 Enhanced agrin cleavage and aging induce fiber type grouping. Fiber type grouping in female soleus muscles 
was quantified using the method from Lexell et al.267. T values equal 0 indicate a random fiber type arrangement, 
T values lower than 0 fiber type segregation, and T values above 0 fiber type grouping. T1 and T2 values represent 
arrangement of type I and type II fibers, respectively. (a) In adult wild type muscles T1 and T2 were slightly negative. 
Following neurotrypsin overexpression T1 and T2 were increased to more than 1, indicating grouping of both type 
I and type II fibers. Concomitant overexpression of cleavage-resistant agrin and neurotrypsin restored the wild type 
situation, whereas wild type agrin did not. (b) Positive T values in aged mice indicated age-associated fiber type 
grouping. Note that the age-dependent increase in T2 was clearly stronger than the increase in T1.
The number of animals for each group is indicated in parentheses. The top of the box represents the upper quartile, 
the bottom the lower quartile, and the black line the median. The whiskers indicate the highest and lowest values that 
are no outliers. Filled circles represent outliers that do not lay within 1.5 fold the interquartile range. *P < 0.05, **P < 
0.01, ***P < 0.001 compared to wild type littermates or adult controls, °P < 0.05, °°P < 0.01, °°°P < 0.001 compared 
to Nto1.
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double transgenic animals compared to single transgenic littermates, although the overall number 
of fibers was the same. Thus, transgenic wild type agrin influences the fiber type distribution in 
neurotrypsin-overexpressing animals without actually affecting the fiber number. The type I fiber 
preference in Nto1/Ag animals was so extensive that the absolute number of type I fibers stayed 
at wild type levels, despite the 30% drop in fiber number (table VI). 
The increase in the proportion of type I fibers in concert with a reduction of both type I and type 
II fibers in neurotrypsin transgenic animals could be the result of two processes: The predominant 
loss of type II fibers, or the takeover of type II fibers by adjacent type I motoneurons, promoting 
a fiber type change. The later happens after denervation and reinnervation of muscle fibers and 
is usually accompanied by fiber type grouping. The method of enclosed fibers, developed by 
Lexell and Downham267 was used to quantify fiber type grouping. This method depends on T1 
and T2 values, which are measures for the randomness of the arrangement of type I and type 
II fibers, respectively. T values equal to 0 indicate a random distribution, T values lower than 0 
indicate fiber type segregation, and T values above 0 indicate fiber type grouping. Both T1 and 
T2 value was significantly increased in conditions with enhanced agrin cleavage, suggesting fiber 
type grouping (Fig. 24a). Accordingly, clusters of histochemically identical fibers were observed 
in neurotrypsin-overexpressing muscles (Fig. 21, 22). Concomitant overexpression of cleavage-
Results
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Figure 25 Neurotrypsin overexpression does not cause a consistent increase in type I fibers in male muscles. Soleus 
muscle cross-sections from male animals stained for mATPase activity after preincubation at pH 4.3. Only the slow, 
type I fibers are stained. (a) Neurotrypsin overexpression caused a decrease in the proportion of type I fibers in 
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resistant agrin and neurotrypsin rescued from the grouping phenotype, whereas concomitant 
overexpression of wild type agrin and neurotrypsin did not. Enhanced agrin cleavage induced 
fiber type grouping in young adult mice, indicating continuous denervation and reinnervation with 
consecutive type change. Whether this type change is responsible for type I fiber preference can’t 
be deduced, since a grouping of both type I and type II fibers was observed. Thus, reinnervation 
by both type I and type II motoneurons had to take place. Nevertheless, the ratio of reinnervation 
could be responsible for the increase in type I fiber proportion. 
In males, type I fiber preference and type grouping were also detected in soleus muscles of Nto2 
and Nto-moto animals (Fig. 23b, 25b, c). In line Nto1, however, the situation was completely 
different. A significant decrease in the proportion of type I fibers was observed in transgenic mice 
compared to wild type littermates (Fig 23b, 25a). In severe cases, only few type I fibers were left. 
The rescue experiment, using transgenic expression of resistant agrin, was successful, indicating 
that the type II preference was caused by the cleavage of agrin and not by an unspecific side effect, 
such as the disruption of a gene due to the transgenic insertion. However, it is difficult to explain 
the differences between males and females from the line Nto1, especially because both males and 
females behaved similarly in all other lines. An additional mouse line was analyzed to clarify the 
situation. The proportion of type I fibers in male and female mice from line Nto-moto2 was clearly 
increased upon neurotrypsin overexpression, confirming the findings from line Nto2 and Nto-
moto (Fig. 23b, 25g). The contrary effect in males from line Nto1 appeared to be an exception that 
was not observed in another neurotrypsin-overexpressing condition.
Again, aging was accompanied by remarkable similar effects. The proportion of type I fiber was 
significantly increased in the soleus muscle of aged compared to adult animals and fiber type 
grouping was observed, very much resembling the situation in neurotrypsin transgenic mice 
(Fig. 21, 22f, 23, 25f). However, type I fiber preference was more pronounced in aged than in 
Nto1 animals, although the phenotype was milder in regard to other histological parameters (Fig. 
23). Therefore, the absolute number of type I fibers was actually increased in aged compared to 
adult mice, despite the total loss of muscle fibers (table VI). Nevertheless, like in the transgenic 
situation, denervation and reinnervation processes are likely to have taken place, since a clear type 
grouping was observed (Fig. 24b). For aged animals, T2 values were significantly greater than T1 
values, suggesting preferential type II fiber grouping. However, several assumptions have to be 
taken for statistical assessment of type grouping and the differences in T1 and T2 values may not 
necessarily reflect a biological process but could also have methodological reasons.
3.7 Deterioration of the NMJ is responsible for age- and agrin cleavage- 
induced sarcopenia
3.7.1 excessive agrin cleavage and aging are associated with fragmentation of the NMJ
The connection between motoneuronal neurotrypsin overexpression and muscle fiber degeneration 
was though to be at the NMJ. Neurotrypsin overexpression in the motoneuron induces enhanced 
agrin cleavage at the NMJ. This process could influence the structure of the NMJ, because agrin 
line Nto1. Cleavage resistant agrin rescued from this phenotype, wild type agrin did not. (b) Cross-sections from 
line Nto2 showed a small increase in type I fiber proportion. (c) Type I fiber preference and an accumulation of 
enclosed fiber was observed in soleus muscles from Nto-moto animals. (d, e) Overexpression of inactive neurotrypsin 
and the absence of neurotrypsin did not affect the muscle morphology. (f) Aging was accompanied by a relative 
increase in type I fibers and a tendency for fiber type grouping. (g) Muscle cross-sections from a second mouse line 
overexpressing neurotrypsin motoneuronally exhibited type I fiber preference and accumulation of enclosed fiber. 
Scale bars, 0.1 mm.
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cleavage has been shown to regulate the stability of the NMJ (Bolliger et al., in preparation).
We used the soleus muscle of female mice to study the effect of neurotrypsin overexpression on 
the NMJ. The synaptic terminals were visualized by indirect immunofluorescence with antibodies 
against synaptophysin and the postsynaptic specialization by staining the AChRs with fluorophore-
conjugated α-bungarotoxin. Normally, adult NMJ show a typical pretzel-like appearance, 
with a perfect alignment of the pre- and postsynaptic elements. The NMJs of neurotrypsin-
overexpressing mice exhibited enhanced fragmentation of both pre- and postsynaptic sites (Fig. 
26a, b). The pretzel-like structure was replaced by numerous small spots but the alignment of 
pre- and postsynaptic sites was still maintained in the majority of NMJs. The degeneration of 
the NMJ was quantitatively analyzed by counting the number of fragments per junction and by 
measuring the area, which was occupied by pre- and postsynaptic elements (Fig. 27, 28). In wild 
type animals, most of the presynaptic terminals (about two third) were composed of one to four 
Nto-inact
synaptophysinAChR merge
aged
synaptophysinAChR merge
e f
Figure 26 Highly fragmented NMJs on the soleus muscles of neurotrypsin-overexpressing and aged mice. The NMJs 
were visualized by fluorescent staining of synaptophysin (red) to label the presynaptic nerve ending and acetylcholine 
receptors (green) to label the postsynaptic muscle membrane. Antibodies against synaptophysin followed by Cy3-
conjugated secondary antibodies, and Alexa-488 conjugated α-bungarotoxin were applied. Pictures were taken 
with a Leica LCS SP2 confocal microscope using a 63x objective. (a) NMJs on wild type muscles exhibited the 
typical pretzel-like appearance. (b) Highly fragmented NMJs appeared upon neurotrypsin overexpression. Pre-and 
postsynaptic elements were still perfectly aligned in the majority of cases. (c) Additional overexpression of a cleavage-
resistant agrin variant restored the pretzel shapes. NMJs on Nto1/rAg double transgenic animals often appeared very 
compact, with relatively small receptor-free areas (bottom rows). (d) The overexpression of wild type agrin did not 
rescue from the fragmentation phenotype. (e) The overexpression of a catalytically inactive neurotrypsin did not have 
any influence on NMJ structure. (f) Fragmented NMJs were also observed on the soleus muscle of aged mice. Scale 
bars, 20 µm.
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fragments, whereas highly fragmented 
terminals with more than 12 
fragments were rare. In neurotrypsin-
overexpressing animals, the amount 
of normal, pretzel-like presynapses 
was dramatically decreased (to about 
10 % in line Nto1) and the number of 
highly fragmented presynapses was 
significantly increased (Fig. 27a). 
About one third of the transgenic 
nerve endings were composed of more 
than 12 fragments. Consequentially, 
the averaged number of fragments per 
endplate was increased (Fig. 27b). 
Furthermore, the presynaptic area was significantly reduced in neurotrypsin transgenic animals 
(Fig. 28a). Thus, fragmentation does not only reflect a dispersal of existing presynaptic sites 
but also a loss of synaptic territory. Similar results were obtained for the postsynaptic site (Fig. 
27c, d, 28b). The mouse line overexpressing inactive neurotrypsin did not show an increased 
proportion of highly fragmented NMJs or a loss of synaptic area, confirming the crucial role 
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Figure 27 Quantification of NMJ fragmen-
tation on the soleus muscles of Nto1, Nto-
inact and aged mice. ImageJ was used to 
determine the number of fragments per 
endplate on maximal projections of confocal 
stacks from presynaptic synaptophysin 
(a, b) and postsynaptic α-bungarotoxin 
(c, d) stainings. (a, c) The proportions of 
highly fragmented pre- and postsynapses 
(more than 12 fragments) were increased in 
mice overexpressing active neurotrypsin. 
Additional overexpression of resistant agrin 
rescued from the fragmentation (Nto1/rAg), 
whereas wild type agrin did not (Nto1/Ag). 
Inactive neurotrypsin did not induce NMJ 
fragmentation. The fragmentation pattern in 
aged animals was strikingly similar. (b, d) 
The averaged number of fragments per NMJ 
was significantly increased in transgenic 
animals from line Nto1 and in aged animals. 
Cleavage-resistant agrin restored the wild 
type situation, cleavable agrin did not. Note 
that the number of postsynaptic fragments was 
always lower than the number of presynaptic 
fragments, due to slightly different staining 
patterns. Postsynaptic signals usually were 
more widespread than presynaptic signals. 
The number of animals for each group is 
indicated in parentheses (a, c) and inside each 
bar (b, d), respectively. All available endplates 
(at least 30 per animal) were quantified. Error 
bars represent s.d. **P < 0.01, ***P < 0.001 
compared to wild type littermates or adult 
controls, °°°P < 0.001 compared to Nto1.
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of the proteolytic activity of neurotrypsin (Fig. 26e, 27, 28). Concomitant overexpression of a 
cleavage-resistant agrin variant and neurotrypsin rescued from the fragmentation phenotype, 
restoring the typical pretzel-like appearances of the NMJs (Fig. 26c, 27). The synaptic area in 
the Nto1/rAg double transgenic animals was actually increased compared to wild-type littermates 
(Fig. 28). Interestingly, endplates with more compact shapes, represented by a smaller proportion 
of receptor-free area, were frequently observed in these animals and mainly contributed to the 
increase in synaptic area (Fig. 26c). Overexpression of a wild-type agrin variant together with 
neurotrypsin did not show any rescue effect (Fig. 26d, 27, 28). 
The pathogenic mechanisms resulting in age-associated and neurotrypsin-induced muscle wasting 
were thought to be similar, due to the striking resemblance in regard to movement, strength and 
muscle morphology. To substantiate this hypothesis, the NMJs of aged mice were analyzed. Indeed, 
structural alterations that were strikingly similar to those seen under conditions with enhanced 
agrin cleavage were observed. The proportion of highly fragmented junctions was significantly 
increased in aged compared to adult animals (Fig. 26f). Only about 15% instead of about 70% 
of the presynaptic terminals were composed of 1 to 4 fragments, but 20 % of more than 12 
(Fig. 27a). In average, presynapses of aged mice consisted of significantly more fragments than 
the adult junction (Fig. 27b). Similar results were obtained for the postsynaptic site (Fig. 27c, 
d). The fragmentation was less severe in aged than in Nto1 mice, resulting in a slight left shift 
of the distribution curves. This was in agreement with the muscle phenotype, which was more 
pronounced in Nto1 than in aged mice. The severity of NMJ fragmentation and muscle wasting 
nicely correlated. Unlike in transgenic animals, the synaptic area was not significantly changed in 
aged compared to adult mice (Fig. 28).
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Figure 28 Loss of synaptic area following 
neurotrypsin overexpression. The fluorescent 
area was measured after application of 
antibodies against synaptophysin (a) and 
α-bungarotoxin (b) to label pre- and post-
synaptic sites, respectively. Both pre- and 
postsynaptic areas were significantly 
reduced in neurotrypsin-overexpressing 
animals compared with wild type littermates. 
Concomitant overexpression of resistant 
agrin together with neurotrypsin not only 
restored the wild type situation, it actually 
resulted in an increase in synaptic area. 
Wild type agrin had no rescue effect. The 
overexpression of inactive neurotrypsin 
and aging did neither influence pre- nor 
postsynaptic area. Note that postsynaptic 
area was higher than presynaptic area, since 
postsynaptic signals were more widespread. 
The number of animals for each group is 
indicated inside each bar. All available 
endplates (at least 30 per animal) were 
quantified. Error bars represent s.d. *P < 
0.05, **P < 0.01, ***P < 0.001 compared to 
wild type littermates or adult controls, °°°P 
< 0.001 compared to Nto1.
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3.7.2 Fragmentation may lead to the 
disappearance of the NMJs
As mentioned above, colocalization of 
pre- and postsynaptic elements was still 
observed in the majority of the NMJs on 
the soleus muscles of transgenic mice 
(Fig. 26b). However, in about 5 % of the 
structures, this colocalization was not 
maintained. At some NMJs, only a small 
part of the presynapse was not directly 
opposed by postsynaptic receptors (Fig. 
29a). At these sites, the postsynaptic 
signal had a diffuse, cloudy appearance. 
At more severely affected NMJs, the 
complete AChRs staining was diffuse 
and weak, whereas the presynaptic 
signal still was strong and precisely 
defined (Fig. 29b). Sometimes, the 
postsynaptic signal was hardly detectable 
(Fig. 30a). This finding suggested an 
ongoing dispersal of the postsynaptic 
receptor aggregates. In agreement with 
this hypothesis, endplates in which the 
postsynapse was completely absent 
were occasionally found (Fig. 30b). 
In these structures, highly fragmented 
presynaptic nerve endings were not opposed by α-bungarotoxin signals, indicating the absence 
of the postsynaptic AChR aggregates. Partial or total loss of AChR clusters was only found in the 
most fragmented NMJs (>12 fragments). These structures could represent final stages and indicate 
imminent disappearance of the NMJ. Excessive agrin cleavage appears to induce fragmentation, 
loss of synaptic area and eventually dispersal of NMJs. Thus, agrin might have a crucial role in 
the maintenance of NMJs during adulthood.
Figure 29 Partial misalignment of pre- and 
postsynptic sites may reflect an intial step on 
the way to NMJ dispersal. The NMJs on soleus 
muscles were visualized by synaptophysin 
antibodies (red) and Alexa-488 conjugated α-
bungarotoxin (green). (a) Misalignment of a 
small portion of the pre- and postsynaptic sites 
was observed in a subset of NMJs on neurotrypsin 
transgenic muscles. Note the diffuse appearance 
of the postsynaptic signals in these regions 
(arrow). (b) Misalignment of a bigger portion 
of the pre- and postsynapse and weakening 
of the postsynaptic signals. Note the cloudy, 
diffuse appearance and the low intensity of the 
postsynaptic α-bungarotoxin signals in contrast 
to the well-defined presynaptic signals.
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Abandoned presynaptic terminals, which were not opposed by postsynaptic sites, were also 
occasionally found in aged animals (Fig. 31). Thus, age-dependent fragmentation may also result 
in the dispersal of the NMJ. Together, our results demonstrate a highly similar NMJ phenotype 
in mice exhibiting excessive agrin cleavage and in aged wild type mice. NMJ stability might be 
crucial for both neurotrypsin and aging induced sarcopenia.
synaptophysinAChR mergeb
Figure 30 Agrin-cleavage induced fragmentation of the NMJ eventually lead to the disappearance of postsynaptic 
AChR aggregates. The NMJs on soleus muscles were visualized by synaptophysin antibodies (red) and Alexa-488 
conjugated α-bungarotoxin (green). (a) Continuous dispersal of AChR aggregates resulted in almost complete absence 
of postsynaptic signals in a subset of NMJs on neurotrypsin transgenic muscles. Only weakly stained remnants of 
AChR clusters were left. As internal control, neighboring normally stained NMJs are included. (b) Remaining nerve 
terminals deprived of postsynaptic AChR aggregates were occasionally observed on neurotrypsin transgenic muscles, 
indicating the complete dispersal of the postsynaptic receptors. Note that partial or total loss of AChR aggregates only 
occurred in the most fragmented NMJs (>12 fragments). Scale bars, 20 µm.
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Throughout the muscle of 
transgenic and aged mice, 
NMJs at different stages were 
found: unaffected, pretzel-
like appearances, differently 
fragmented structures, and 
abandoned nerve terminals, 
which were not opposed by 
postsynaptic specializations. 
The availability of 
differentially affected NMJs 
may be represented by the 
muscle morphology. Atrophied 
and hypertrophied fibers that 
coexist within the same muscle 
could differ in the structure of 
their endplates; intact NMJs 
are capable to support muscle 
fibers to become hypertrophied, 
whereas severely fragmented 
NMJs may not be able to 
sustain synaptic transmission, resulting in atrophy of the associated muscle fibers.
3.7.3 enhanced agrin cleavage at fragmented NMJs
Because the cleavage of agrin was thought to induce the dispersal of postsynaptic sites, we expected 
the disappearance of full-length agrin from highly fragmented, abandoned nerve terminals. To probe 
for the presence of agrin at fragmented NMJs triple stainings for synaptophysin, AChRs and agrin 
were prepared. Unfortunately, co-immunostainings for agrin and synaptophysin were not possible 
due to incompatibility of the antibodies. Instead, we used synaptophysin-GFP mice (spGFP) and 
crossed them with Nto1 mice. The fluorescently labeled transgenic synaptophysin revealed a similar 
staining pattern as the synaptophysin antibodies. However, the presynaptic sites appeared slightly 
punctuated, most likely due to accumulation of transgenic synaptophysin at certain places inside 
the presynaptic region. This accumulation appeared not to have any morphological or functional 
significance638. NMJs on the soleus muscle of spGFP and spGFP/Nto1 animals were stained for 
agrin-90 using the R132 antibody and for AChRs using fluorophore-conjugated α-bungarotoxin. 
In spGFP animals, agrin precisely colocalized with pre- and postsynaptic sites, representing its 
association with the basal lamina of the synaptic cleft (Fig. 32a). Surprisingly, fragmented NMJs 
in spGFP/Nto1 double transgenic animals still were positive for agrin, even when postsynaptic 
sites were absent (Fig. 32b, c). Thus, agrin remained aligned with abandoned presynaptic nerve 
endings. However, since an antibody against agrin-90 was used it could not be distinguished 
whether the signal corresponded to full length or to cleaved agrin. Agrin-90 may remain associated 
to the synaptic basal lamina after cleavage, because binding sites for α-dystroglycan, heparin, and 
integrins are present on this fragment99. To more directly analyze neurotrypsin-dependent agrin 
cleavage at the NMJ, the C-terminal cleavage fragment, agrin-22, was visualized using the G92 
antibody together with agrin-90, AChR aggregates and synaptophysin. In spGFP animals, agrin-
22 precisely colocalized with agrin-90 and the pre- and postsynaptic markers, suggesting the 
presence of full-length agrin at the basal lamina of these NMJs (Fig. 33a). In spGFP/Nto1 mice, 
synaptophysinAChR merge
Figure 31 Rarely, presynaptic nerve endings (red) that are devoid of 
postsynaptic AChR aggregates (green) were also observed on the soleus 
muscles of aged animals.  Scale bar, 20 µm.
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the signal for agrin-22 was clearly weaker in most of the endplates (Fig. 33b). In some cases, 
often characterized by severe fragmentation of pre- and postsynaptic sites, immunostaining for 
agrin-22 resulted in a diffuse signal at the place of the NMJ or even in the complete absence of 
any signal. Agrin-90 however was still present at those sites, indicating an increased cleavage 
of agrin and subsequent diffusion of agrin-22. Interestingly, weak or absent agrin-22 signals 
often co-occurred with weak α-bungarotoxin signals, which reflected ongoing dispersal of AChR 
aggregates. Thus, enhanced agrin cleavage, resulting in the disappearance of agrin-22 and hence, 
the loss of agrin’s NMJ protecting function, could be responsible for the disappearance of the 
postsynaptic AChR clusters. In agreement with this hypothesis, agrin-22 has not been found in 
structures were the postsynaptic sites were completely absent (Fig. 33c). However, stainings for 
agrin-22 often showed high background, especially in cases with low signal intensities. Therefore, 
wt Nto1
synaptophysinAChR mergeagrin-90 synaptophysinAChR mergeagrin-90
a b
synaptophysinAChR mergeagrin-90c
Figure 32 Agrin-90 remains attached to highly fragmented NMJs. Postsynaptic AChR aggregates were stained with 
tetramethylrhodamin (TMR)-conjugated α-bungarotoxin (red) and agrin-90 with R132 (blue) on soleus muscles 
of synaptophysin-GFP (green) transgenic mice. Note that the presynaptic synaptophysin-GFP label had a slightly 
punctuated pattern in these transgenic mice. (a) Agrin-90 precisely colocalized with both pre- and postsynaptic 
markers in wild type mice. (b) Fragmentation of the NMJs in Nto1 mice did not affect the alignment of agrin-90 with 
pre- and postsynaptic sites. (c) Even when postsynaptic AChRs were absent in heavily fragmented structures, the 
colocalization of agrin-90 and synaptophysin was preserved. In some of these cases, the signal strength of agrin-90 
appeared to be reduced (bottom row). Scale bars, 20 µm
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a better agrin-22 detection method would be needed to quantify these findings and to confirm the 
speculations.
3.7.4 Innervation of fragmented NMJs stays intact
To ensure that events at the NMJ and not axonal or motoneuronal degenerations were the cause 
of NMJ fragmentation, the innervation of transgenic endplates was studied. Fluorescently 
labeled antibodies against neurofilament, an intermediate filament specifically found in neurons, 
were used to stain nerve fibers. These experiments were also performed in spGFP transgenic 
mice to take advantage of the intrinsic presynaptic marker. Postsynaptic AChRs were stained 
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Figure 33 Visualization of agrin cleavage at highly fragmented NMJs. Triple stainings of agrin-90 with R132 (blue), 
agrin-22 with G92 (magenta), and AChR aggregates with TMR- conjugated α-bungarotoxin (red) on soleus muscles 
of synaptophysin-GFP (green) transgenic mice. (a) Agrin-90 as well as agrin-22 precisely colocalized with pre- and 
postsynaptic markers in wild type muscles, suggesting the presence of full-length agrin. (b) Following neurotrypsin 
overexpression in Nto1 mice, signals for agrin-22 appeared weak and diffuse in some NMJs, but still colocalized 
with agrin-90 in others. Enhanced cleavage of agrin followed by diffusion of agrin-22 at some NMJs might be the 
reason. Note that the absence of agrin-22 did not necessarily result in the immediate disappearance of the postsynaptic 
sites (bottom row). (c) Dispersal of postsynaptic AChR aggregates from heavily fragmented structures always co-
occurred with the absence of agrin-22 (asterisks). Agrin-90, in contrast, still was associated with such structures. 
This observation suggested that the cleavage of agrin and the diffusion of agrin-22 could induce the dispersal of 
postsynaptic sites. Scale bars, 20 µm.
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Figure 34 Innervation of highly fragmented 
NMJs stays intact. (a-d) NMJs on soleus 
muscles of synaptophysin-GFP (green) 
transgenic mice were stained for AChR 
aggregates with TMR-conjugated α-
bungarotoxin (red) and for nerves with 
antibodies against neurofilament (blue). (a) 
In wild type muscles, single motor axons 
innervated the NMJs. (b) Heavily fragmented 
NMJs in Nto1 muscles were normally 
innervated. (c) The innervation stayed also 
intact when the postsynaptic AChR aggregates 
were dispersed.  (d) Sprouting of motor axons 
in Nto1 animals from nerve terminals (arrows) 
or from the node of Ranvier (arrowhead). The 
outgrowing axons formed small immature 
synapses (asterisks), which were either 
positive for only synaptophysin, or for both 
synaptophysin and α-bungarotoxin. (e) 
Accumulation of small immature synapses in 
soleus muscles from Nto1 animals. Stainings 
with synaptophysin antibodies (red) and Alexa-
488 conjugated α-bungarotoxin (green).
Scale bars, 20 µm (a-d), 10 µm (e).
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using fluorophore-conjugated α-bungarotoxin. The innervation pattern of fragmented NMJs in 
neurotrypsin transgenic animals appeared to be normal (Fig. 34a, b). Single nerve fibers innervated 
greatly fragmented NMJs as they did in normal pretzel-like endplates. Even structures, in which 
the postsynaptic sites were absent, were correctly innervated (Fig. 34c). This finding indicates that 
fragmentation and dispersal of the NMJs occurs despite correct innervation and thus, excludes 
axonal or motoneuronal degeneration as cause of NMJ deterioration. However, rarely, sprouts 
extending from an endplate (terminal sprouts) or an axon (nodal sprouts) to form new, small 
synaptic sites were observed, suggesting the reinervation of denervated fibers by neighboring 
motor axons (Fig. 34d). Furthermore, very small fluorescently labeled spots could represent the 
attempt of terminal axons, which have lost their contacts to the muscle, to form new synaptic sites 
(Fig. 34e). In summary, denervation and reinnervation events in conditions with increased agrin 
cleavage could be reflected by two processes: Motor axons that have lost their synaptic sites may 
regrow and search for new targets to innervate and denervated muscle fibers may induce sprouting 
of adjacent nerves to enforce reinnervation.
3.8 Analysis of denervated muscle fibers in the soleus muscle
Appearance of angular muscle fibers, fragmentation of the NMJs, and axonal sprouting all 
indicated that denervation of muscle fibers might cause their atrophy and degeneration. We tried 
to directly detect denervated muscle fibers in the soleus muscle to confirm this hypothesis. Several 
characteristics of denervated muscle fibers can be used to detect them on muscle cross-sections, in 
single muscle fiber preparations or by Western blotting on muscle protein extracts. 
It has been reported that the neural cell adhesion molecule (NCAM) is redistributed upon denervation 
of muscle fibers208,257. Normally, NCAM resided at the NMJ, but after denervation, it appeared all 
over the fiber membrane. We co-stained muscle cross-sections with an antibody against NCAM 
and α-bungarotoxin (Fig. 35a). Fibers, which were single labeled for NCAM, were counted as 
denervated. The NMJs served as internal control, because they contain NCAMs and AChRs and, 
hence, should be stained with both NCAM antibodies and α-bungarotoxin. The endplates on all 
muscle sections were clearly double stained, confirming the specificity of the NCAM antibody. 
Neurotrypsin overexpression and aging were associated with a slightly higher proportion of 
denervated muscle fibers but the differences were not significant (Fig. 35d). However, we faced 
several problems with this method that put its reliability into question. First, the variation between 
cross-sections from the same muscle was considerable. Second, the labeled fibers were often 
clustered at the boarder of the muscle, and third, mechanically damaged fibers regularly were 
NCAM positive. Unfortunately, an explicit negative control (all fibers innervated), as well as a 
positive control (all fibers denervated) was missing. Thus, an influence of the preparation on the 
immunostainings could not be completely excluded. The treatment of the cross-sections during 
staining or especially cutting was suspected to lead to false positive results.
A second method was based on the findings, that the tetrodotoxin-resistant sodium channel 
(Na
v
1.5) is expressed after denervation, but absent in innervated adult muscle330. An antibody 
against this sodium channel was applied on cross-sections from transgenic animals (Fig. 35b). 
However, no immunostained fibers were detected in transgenic or wild type muscles; only some 
fragmented, degenerated remains of fibers were labeled. Whether the antibody was not working 
on immunostainings or whether all fibers were innervated could not be answered, due to the 
absence of adequate controls.
Another possibility to detect denervated muscle fibers came from observation of the histone 
acetylation pattern of myonuclei. The acetylation and phosphorylation of histone H3 was increased 
after denervation643. Single muscle fibers were prepared from the soleus muscle to analyze the 
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Figure 35 Analysis of denervated muscle fibers in 
transgenic and aged soleus muscle did not lead to 
reliable results. (a) Overlays of soleus muscle cross-
sections from adult wild type, Nto1, and aged animals 
stained for NCAM (red) and AChR (green). Arrows 
indicate NCAM positive fibers and arrowheads indicate 
double stained NMJs. (b) Soleus muscle cross-sections 
immunostained for tetrodotoxin-resistant sodium 
channels (Na
v
1.5). Only fragmented remnants of fibers 
were labeled. (c) Single soleus muscle fiber stained for 
phosphorylated and acetylated histone H3 (PAcH3). 
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immunostaining of the nuclei. After fixation, very thin forceps were used to tease the muscle 
into single fibers. An antibody against acetylated and phosphorylated histone H3 was applied 
(αPAcH3). The nucleic acid stain Hoechst was used as nuclear marker and staining intensity 
control. Fibers with PAcH3 positive nuclei were frequently observed (Fig. 35c). However, in some 
cases it was quite difficult to judge whether the nuclei were stained or not, since the intensities 
did not differ greatly. Quantitative analysis revealed a non-significant increase in PAcH3 positive 
fibers in neurotrypsin transgenic and in aged animals (Fig. 35d). However, the control level of 
positive fibers in adult wild type muscles was very high (about 27 %). Previous studies have 
only found 1-2% of denervated fibers in adult animals208,257,330, indicating that a lot of the PAcH3 
positive fibers may not represent denervated fibers. Moreover, the variation between different 
animals, regardless whether transgenic or not, was considerable. Together, this method may not 
be feasible to detect some denervated fibers in whole muscle preparations. It might be possible 
to find differences between normally innervated and fully denervated muscles but not relatively 
small changes in a slightly denervated muscle.
The expression of the transcription factor myogenin, an activator of muscle specific genes, has been 
shown to be upregulated in denervated607,608 and regenerating skeletal muscles604-606. Because the 
α-myogenin antibody was not working for immunostainings, Western blotting on gastrocnemius 
muscle extracts was performed (Fig. 35e). A signal for myogenin at 25 kDa was detected. Signal 
intensities in neurotrypsin transgenic and wild type muscle extracts were not systematically different, 
although considerable variations between individual animals were observed. The upregulation 
of myogenin in few denervated 
muscle fibers may not be enough 
to significantly alter the myogenin 
level in the whole muscle. Moreover, 
it has been shown that myogenin up- 
and downregulation is a fast process 
and can be accomplished in days610. 
In aged animals, however, the signal 
for myogenin was more than 4-fold 
increased (Fig. 35f). Whether this 
is due to denervated fibers, ongoing 
regeneration of the muscle or other 
age-related changes in protein 
synthesis is currently unclear.
Different methods for the detection of 
denervated muscle fibers were used, 
but none of them led to significant 
and reliable results. Technical 
problems with the methods, like for 
The nuclear Hoechst stain was used to mark the myonuclei. Muscle fibers with PAcH3-positive nuclei (asterisks) 
were observed in wild type, Nto1 and aged muscles. (d) Quantification of the percentage of NCAM and PAcH3 
positive fibers in wild type, neurotrypsin-transgenic and aged muscles. Significant differences were not detected. All 
fibers of each muscle were measured for all quantifications. n indicates the number of animals. Data represent mean 
± s.d. (e) Western blot of gastrocnemius muscle extracts probed for myogenin. Immunoreactivity for myogenin was 
increased in aged muscles. α-tubulin was used as loading control. (f) Quantification of myogenin signal intensities. In 
aged muscles the amount of myogenin was more than 4-fold increased compared to adult wild types (wild type value 
set to 100%). Neurotrypsin overexpression did not influence myogenin expression. The number of animals for each 
group is indicated inside each bar. Error bars represent s.d. *P < 0.05 compared to wild type.
Scale bars, 0.1 mm (a), 50 µm (b), 0.2 mm (c).
Figure 36 Cresyl violet stained spinal cord cross-section. The 
motoneurons can be found in the ventral horns (red boxes). Scale 
bar, 0.2 mm.
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example the absence of good controls, were one of the reasons. Furthermore, the actual amount of 
denervated muscle fibers could be very low in transgenic muscles, since the time a fiber remains 
denervated, before it gets reinnervated or degenerated, might be relatively short. A low number of 
denervated fibers would be difficult to detect with the applied methods.
3.9 the number of motoneurons is not altered in neurotrypsin-overexpressing 
or aged mice
The fragmentation of the NMJ results in disconnection between motoneuron and muscle fiber. 
Muscle fibers are extensively lost, but the fate of the motoneurons remains elusive. We analyzed 
the number of motoneurons in spinal cord cross-sections to address this question. The spinal 
Figure 37 The number of motoneurons in the 
spinal cord is not affected by neurotrypsin 
overexpression or aging.  (a-c) Cresyl 
violet stainings of two consecutive spinal 
cord cross sections from a wild type (a), 
a neurotrypsin transgenic (b) and an aged 
mouse (c). Motoneurons were identified by 
their size, their position, and the existence 
of a clear nucleus. They were carefully 
traced through the sections. Numbers 
identify the same motoneurons in serial 
sections. (e) Comparison of the number 
of motoneurons in six pairs of mice, each 
including a wild type and neurotrypsin-
overexpressing animal from line Nto1, 
which were processed in parallel. The 
motoneurons were counted in ten consecutive sections at four different positions in the lumbar and sacral part of the 
spinal cord. No significance difference was detected. (f) Comparison of the number of motoneurons in 5 pairs of mice, 
each including an adult and an aged animal. No significant difference was detected. Scale bars, 0.1 mm.
d
e
adult aged % of adult
pair 1 283 286 101
pair 2 214 198 93
pair 3 212 212 100
pair 4 212 209 99
pair 5 246 237 96
98
no of motoneurons
wt Nto1 % of wt
pair 1 270 242 90
pair 2 286 283 99
pair 3 236 242 103
pair 4 270 267 99
pair 5 244 248 102
pair 6 208 219 105
99
no of motoneurons
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cord of a neurotrypsin-overexpressing and a wild type mouse were aligned and processed in 
parallel. Ten serial 12 µm cross-sections were cut at four different positions in the lumbar and 
sacral regions of the spinal cords and stained with cresyl violet (Fig. 36). The motoneurons were 
identified by their size, their position in the ventral horns and the presence of a clearly identifiable 
nucleus. They were counted throughout the 10 serial sections at 4 different positions in the lumbar 
and sacral part of the spinal cord (Fig. 37a-c). Thereby, the individual motoneurons were traced 
through the sections, to make sure that every motoneuron was only counted once. The total 
number of motoneurons in these four stacks of 10 sections was compared between the two spinal 
cords, which were processed in parallel, and relative differences were calculated. Such a pairwise 
comparison didn’t reveal any difference in the number of motoneurons between neurotrypsin 
transgenic and wild type mice (Fig. 37d). Comparison of aged and adult animals did not reveal 
any differences either (Fig. 37e). Thus, neither in neurotrypsin-overexpressing nor in aged wild 
type animals was NMJ fragmentation and muscle fiber loss preceded or accompanied by a loss of 
motoneurons. 
3.10 the role of neurotrypsin and agrin cleavage in age-associated muscle 
wasting
3.10.1 Neurotrypsin is not essential for the development of sacropenia
Our results suggest an important role of the NMJ stability in the etiology of sarcopenia. A very 
severe sarcopenia-like muscle wasting can be established by destabilizing the NMJ, without 
affecting axons or motoneurons. Therefore, NMJ destabilizing (neurotrypsin) or stabilizing (agrin) 
agents could be crucial players in the progressive age-associated decline of skeletal muscle mass 
and function. The balance between neurotrypsin and agrin could determine the stability of the 
Figure 38 The absence of neu-
rotrypsin or the overexpression 
of cleavage-resistant agrin (rAg) 
or wild type agrin (Ag) do not 
influence the muscle morphology 
in aged mice. H&E stained soleus 
muscle cross-sections of aged fe-
male mice that are deficient for 
neurotrypsin or overexpress agrin 
either together with neurotrypsin 
or alone all showed signs of sarco-
penia.
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NMJ, thereby influencing the ability of a motoneuron to establish a stable contact to its target 
muscle fiber.
To address the involvement of neurotrypsin-dependent agrin cleavage in the etiology of sarcopenia, 
Figure 39 The absence of neurotrypsin and the overexpression of neurotrypsin-resistant agrin (rAg) or wild type 
agrin (Ag) do not prevent age-associated sarcopenia. (a-e) H&E stained cross-sections of aged female wt (a), Ntd 
(b), Nto1/rAg (c), rAg (d), and Ag (e) mice showed similar age-dependent alterations characteristic for sarcopenia. 
Hypertrophied and atrophied as well as centrally nucleated (arrows) and angular fibers (arrowheads) were observed. 
Note that muscles from both cleavage-resistant and wild type agrin-overexpressing animals appeared to exhibit less 
of the sarcopenic features. Scale bar, 0.1 mm.
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aged (24 months-old) neurotrypsin deficient mice (Ntd) were analyzed. They were not distinguishable 
from aged wild type animals, neither from the appearance nor from the muscle morphology (Fig. 
38, 39a, b). Aged Ntd mice similarly suffered from muscle fiber loss, and exhibited the same 
heterogeneity of muscle fiber thickness (table VII, Fig. 40). Centrally located nuclei and angular 
muscle fibers were observed with a similar frequency than in aged wild type mice (table VII). 
Finally, aged Ntd muscles exhibited type I fiber preference and fiber type grouping to the same extent 
as aged wild type muscles (Fig. 41, 42a, b, table VII). These findings indicate that neurotrypsin 
does not play an important 
role in the etiology of 
sarcopenia. Moreover, 
the accumulation of 
agrin-90 in aged spinal 
cords appears not to be 
a necessary condition 
for sarcopenia, since it 
does not occur in Ntd 
animals. Nevertheless, 
neurotrypsin-independent 
agrin cleavage or 
degradation at the NMJ 
could be involved in 
the pathogenic process 
leading to sarcopenia. 
The absence of any agrin 
cleavage fragments in 
spinal cord extracts of Ntd 
mice does not exclude 
the existence of another 
agrin cleaving process at 
the NMJ, because agrin 
processing in the synaptic 
cleft can’t be detected 
in spinal cord extracts. 
Direct analysis of agrin 
cleavage at the NMJ was 
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Figure 40 Frequency histogram of the fiber size in soleus muscle of aged female 
Ntd, Nto1/rAg, rAg, and Ag mice. No significant difference was detected but 
fiber thickness was slightly less heterogeneous in rAg- and Ag-overexpressing 
muscles. All fibers of each muscle were measured for all quantifications. The 
number of animals for each group is indicated in parentheses. Error bars represent 
s.d. 
line genotype n n n n n
Ntd wt 7 803 ± 40 5 1570 ± 99 5 1.79 ± 0.49 5 0.795 ± 0.006 5 55 ± 3
ko 9 826 ± 55 6 1572 ± 91 5 1.78 ± 0.21 6 0.795 ± 0.011 7 53 ± 5
Nto1 wt 8 805 ± 57 7 1557 ± 91 7 1.70 ± 0.49 7 0.797 ± 0.010 7 53 ± 4
x rAg Nt/rAg 6 782 ± 121 6 1563 ± 135 6 1.76 ± 0.62 6 0.800 ± 0.010 5 49 ± 6
x rAg rAg 4 857 ± 44 4 1466 ± 184 4 0.75 ± 0.30 * 4 0.805 ± 0.008 4 56 ± 2
x Ag Ag 5 854 ± 17 5 1480 ± 66 5 0.81 ± 0.21 * 5 0.807 ± 0.005 4 55 ± 5
type I fibers (%)number of fibers fiber CSA (µm2) fiber shape (circularity)centrally nucleated fibers (%)
The absence of neurotrypsin or the overexpression of resistant agrin do not significantly improve muscle morphology 
in aged muscles. Comparison of the muscle morphology of aged female wt, Ntd, Nto1/rAg, rAg, and Ag mice. Note 
the slight differences of rAg- and Ag-overexpressing animals compared to wild types in regard to fiber number, fiber 
CSA, centrally nucleated fibers, fiber shape and percentage of type I fibers. The difference in the relative amount of 
fibers possessing centralized nuclei was statistically significant. n indicates the number of animals for each group. 
Data represent mean ± s.d. *P < 0.05 compared to wild type littermates.
table VII 
Morphology of aged muscles 
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not possible since spinal cord extracts do not include the NMJs and in whole muscle extracts, 
the amount of NMJ constituents is by far too low. Alternatively, agrin could also be completely 
degraded, not leaving detectable fragments behind. So far, it was not possible to confirm or exclude 
age-associated enhancement of agrin cleavage at the NMJ.
3.10.2 Agrin cleavage at the neurotrypsin-dependent cleavage sites may be dispensable for 
sarcopenia
Since enhanced agrin cleavage precociously induced sarcopenia in adult mice, we speculated that 
agrin cleavage could be involved in the etiology of sarcopenia. Thereby, a second agrin cleaving 
protease, distinct from but related to neurotrypsin might be important. It has been shown that the 
concomitant overexpression of a neurotrypsin-resistant agrin variant and neurotrypsin delayed 
the NMJ maturation. In absence of neurotrypsin, in contrast, the NMJ maturation was normal 
(Bolliger et al., in preparation). To explain this finding, a protease with the same site specificity as 
neurotrypsin has been proposed. This protease would not be expressed in the central nervous system 
but would have access to the NMJ, where it can cleave agrin. Consequently, the overexpression of 
the proteolysis-resistant agrin variant (rAg) could prevent agrin cleavage by this protease in age, 
delaying or preventing sarcopenia. Alternative to cleavage, reduced agrin synthesis in senescence 
could also result in a lower amount of agrin’s signaling component. Also this process could be 
counteracted by transgenic overexpression of agrin. Therefore, we analyzed aged Nto1/rAg-, rAg-
, and Ag-overexpressing animals at the age of 24 months for the occurrence of sarcopenia. We 
found that these mice exhibited the histopathological features of sarcopenia to almost the same 
extent as wild type mice, including a reduced number of fibers, increased heterogeneity of fiber 
thickness, angular fibers, centralized nuclei, and increased proportion of type I fibers together with 
fiber type grouping (Fig. 38, 39c-e, 40, 41, 42c-e). Significant differences were only detected in 
the relative amount of centrally nucleated muscle fibers, which was decreased in aged rAg- and 
Figure 41 Fiber type specific 
mATPase stainings after pre-
incubation at pH 4.3 of soleus 
muscle cross-sections did not 
reveal any difference between 
aged female wt, Ntd, Nto1/rAg, 
rAg, and Ag mice. All showed 
similar fiber type frequencies and 
a tendency for fiber type grouping. 
Scale bar, 0.5 mm.
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Ag-overexpressing animals compared to wild type littermates (table VII). However, changes in 
several other morphological parameters were observed, even though these changes were statistically 
not significant. The number of fibers was increased in senescent rAg- and Ag-overexpressing 
mice compared to wild type littermates. As a consequence, the compensatory hypertrophy was 
less explicit in these animals, resulting in a lower mean fiber CSA. Interestingly, the type I fiber 
Figure 42 Cross-sections of female soleus muscles from aged wt (a), Ntd (b), Nto1/rAg (c), rAg (d), and Ag (e) 
mice stained for mATPase activity after preincubation at pH 4.3. The proportion of darkly stained type I fibers was 
increased in all aged animals compared to adults. Enclosed fibers (asterisks) that are indicative of fiber type grouping 
were a common characteristic of aging in all mouse lines. Scale bar, 0.1 mm.
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preference was more pronounced in rAg- and Ag-overexpressing animals. Together, these results 
indicated that disabling agrin cleavage at the two neurotrypsin-sensitive positions did not prevent 
sarcopenia. However, a beneficial influence of transgenic agrin is possible, in situations where 
neurotrypsin is not overexpressed. This beneficial influence could be observed in both resistant 
agrin and wild type agrin-overexpressing mice. Thus, it might be rather related to the amount of 
agrin than to the prevention of cleavage at the neurotrypsin-specific positions. This result does not 
generally exclude but also not support increased agrin degradation or decreased agrin synthesis as 
a cause of sarcopenia. Additional supply with agrin, however, could have beneficial influence on 
sarcopenia. Whether this is due to interference with fundamental sarcopenia promoting processes, 
or with regeneration or compensation mechanisms remains elusive. 
Results
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4 DISCuSSIoN
We found that enhanced proteolytic cleavage of the NMJ stabilizer agrin, induced by transgenic 
overexpression of the neuronal serine protease neurotrypsin in motoneurons, results in reduced 
skeletal muscle mass and function with a sarcopenia-like histopathological phenotype. Characteristic 
alterations included a reduced number of muscle fibers, increased heterogeneity of fiber thickness,           
angular fibers, centralized nuclei, fiber type grouping, and an increased proportion of type I fibers 
(table VIII). In previous studies, agrin has been identified as proteolytic target of neurotrypsin.            
As in age-dependent sarcopenia, the characteristic muscular alterations were accompanied by 
severe fragmentation of the NMJs. In the most advanced cases, highly fragmented presynaptic 
nerve terminals were found without opposed postsynaptic specialization. These structures may 
represent a final stage indicating imminent NMJ dispersal, as agrin-free and therefore unprotected 
postsynaptic specializations are dispersed by a postsynaptic mechanism activated by acetylcholine-
dependent signals57,58. 
Induced proteolytic cleavage of NMJ agrin mimicks the neuromuscular phenotype of sarcopenia in 
all tested aspects. Thus, these mice exhibit an aging-like neuromuscular system, in a well-defined 
and otherwise healthy organism. The induction and expression of the sarcopenia phenotype at 
juvenile and young age by agrin cleavage-dependent NMJ degradation indicates a key role of the 
NMJ for the integrity of the neuromuscular system at advanced age and positions the impaired NMJ 
as an access point to the final common pathway controlling the pathogenic processes resulting in 
sarcopenia. Besides enhanced cleavage and inactivation of NMJ agrin, other mechanisms affecting 
NMJ integrity may adopt this pathway for their sarcopenia inducing activity, including prominent 
suspects for primary causes of sarcopenia, such as age-dependent death of motoneurons and a 
decreased capacity of aged motoneurons to innervate regenerated muscle fibers. Several studies 
in rats and humans indicated a loss of motoneurons with aging and suggested motoneuron death 
with associated muscle fiber denervation as a cause for sarcopenia144-146. However, quantitative 
considerations indicated that motoneuron loss may not fully account for the loss of muscle 
fibers147. Therefore, it has been hypothesized that, with aging, motoneurons become completely or 
partially disconnected from 
their target fibers, possibly 
by a degradative process at 
the NMJ148. In accordance 
with this view, our results 
exclude motoneuron 
death as a necessary 
condition for sarcopenia. 
Our quantifications 
showed normal numbers 
of motoneurons in both 
young adult neurotrypsin-
overexpressing and aged 
wild type mice. Therefore, 
denervation attributable to 
loss of motoneurons cannot 
be made accountable for 
NMJ decay and sarcopenia, 
Nto1 aged
motor coordination impairments + +
loss of strength + +
loss of muscle fibers ++ +
type I fiber preference + ++
fiber type grouping ++ +
heterogeneity of fiber thickness ++ +
centrally nucleated fibers ++ +
angular fibers ++ +
denervation of fibers ? ?
infiltration of fat and connective tissue - (+)
endplate fragmentation ++ +
loss of motoneurons - -
table VIII 
Neuromuscular deteriorations associated with sarcopenia 
Previously described age-associated neuromuscular degenerations and their 
occurrence or severity in neurotrypsin transgenic and aged mice. 
++ numerous, severe; + frequent, medium; (+) sometimes observed, mild; - not 
observed; ? not determined.
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neither in our experimental model nor in aged mice. 
 Together, the neurotrypsin transgenic mice can serve as model for sarcopenia, simplifying 
research on sarcopenia dramatically. Improvement of our understanding of sarcopenia, essentially 
the underlying molecular mechanisms, is crucial to develop novel strategies to treat or counteract 
the age-dependent muscle wasting.
4.1 Neurotrypsin can cleave agrin and agrin cleavage is sustained in 
senescence
As reported previously, agrin is a substrate of neurotrypsin in vitro119 and in vivo121. The transgenic 
overexpression of the active serine protease neurotrypsin in mice leads to an increase in the amount 
of the agrin-90. This fragment is specifically produced by neurotrypsin-dependent agrin processing, 
since it is completely absent in neurotrypsin deficient mice. In this study, several transgenic mouse 
lines overexpressing neurotrypsin were used. The overexpression of neurotrypsin was associated 
with an increased agrin cleavage in all mouse lines overexpressing active neurotrypsin. The 
amount of agrin fragment correlated with the neurotrypsin expression level, confirming that agrin 
is proteolytically processed by neurotrypsin in vivo. Importantly, the protein level of neurotrypsin 
determined not only the grade of agrin processing but also the severity of the histopathological 
skeletal muscle phenotype.
Neurotrypsin expression and agrin cleavage are sustained in senescence, although the levels 
are decreased. Thus, the cleavage of agrin may not only be important in early development but 
also during adulthood and age. Neurotrypsin expression and agrin cleavage have been shown to 
predominate in the first two weeks postnatally, and may be implicated in the development of the 
NMJ from plaques to pretzel. Agrin processing is thought to dissolve agrin-derived restraints on 
the NMJ, facilitating the spatially restricted dispersal of postsynaptic sites to reach the typical 
pretzel-like shape of the adult NMJ. During adulthood, the NMJ is rather stable, in agreement 
with decreased agrin cleavage. A basic level of agrin cleavage may ensure the plasticity of the 
NMJ during this period. Interestingly, the most heavily glycanated variants of agrin disappear 
in age. Whether this is mainly due to increased processing or decreased synthesis is not clear. 
Neurotrypsin is not or not alone responsible for the disappearance of these agrin variants, since they 
also disappear in Ntd mice, suggesting another neurotrypsin-independent agrin degrading process. 
Previously, it has been reported that the most heavily glycanated agrin variants predominate at 
synapses and are mainly cleaved by neurotrypsin in mouse brains121. Decreased amount of synaptic 
agrin, regardless whether due to increased processing or decreased synthesis, may substantially 
influence NMJ stability, and hence, the development of sarcopenia. 
4.2 Neurotrypsin overexpression leads to a sarcopenia–like decline in skeletal 
muscle mass and function
Different transgenic mouse lines overexpressing neurotrypsin neuronally or motoneuronally 
exhibited a loss of muscle function, mass and strength, which strikingly resembles sarcopenia.
Movement disorders, such as incorrect paw placement, short stride length, and trembling and 
staggered movement are typical for transgenic and for aged mice, suggesting similar etiologies. 
Since motoneuronal neurotrypsin overexpression is sufficient to induce this motor coordination 
impairment, muscular or neuromuscular processes and not a central mechanism are involved. 
The motor coordination impairment was accompanied by a loss of strength in both neurotrypsin-
overexpressing and aged mice. Consistent with this finding, muscle mass and thickness were 
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reduced. Loss of muscle mass and thickness has been shown to be the main reason for the loss 
of strength with aging. Multiple studies have shown a correlation between muscle mass and 
strength177,179,193,194. In agreement with this finding, reduction of skeletal muscle mass, strength and 
thickness all were of similar magnitude in transgenic mice (about 10 % in line Nto1). Whereas 
loss of strength could be explained by reduction in muscle thickness, the motor coordination 
impairment seen in transgenic and aged mice suggests more complex disturbances of the 
neuromuscular system.
The relatively moderate loss of muscle mass and CSA was accompanied by a dramatic loss of 
muscle fibers, which can account for more than 40 % of all fibers. The loss of fibers was by far 
more severe than the loss of muscle thickness and strength in neurotrypsin-overexpressing and 
in aged animals. This obvious discrepancy can be explained by a compensatory hypertrophy of a 
part of the remaining muscle fibers, which is responsible for an increased heterogeneity of muscle 
fiber thickness. Unlike in general muscle atrophy only a subset of muscle fibers is reduced in 
thickness, whereas others undergo a substantial expansion. The existence of hypertrophic and 
atrophic fibers within the same muscle has been reported to be an important characteristic for 
sarcopenic muscles238. The pathogenic mechanism underlying sarcopenia seems to distinguish 
between fibers within the same muscle, causing an increased variability of fiber thickness. 
Increased heterogeneity of fiber size in conditions with enhanced agrin cleavage provides evidence 
for similarities in the processes leading to age-related and agrin cleavage-induced sarcopenia. 
Healthy, unaffected fibers are hypertrophied to compensate the loss and atrophy of others, a 
process that can actually result in an increase in mean fiber thickness. This compensation process 
can be strikingly efficient: comparison of muscle mass per body mass revealed no change between 
wild type and neurotrypsin transgenic animals, despite a loss of more than 30% of the muscle 
fibers. With age, muscle mass and thickness not even dropped significantly, despite a dramatic 
loss of fibers. The age-related increase in body mass, increasing the load on the muscles, may 
further intensify the compensatory effect. Increased loading of a postural muscle, such as the 
soleus, can’t be completely avoided by a decline in activity and may lead to a greater training 
effect. Furthermore, age-related increase in non-contractile muscle content, due to the infiltration 
of fat and connective tissue may also counteract the fiber loss-induced reduction in muscle 
thickness. Relative non-contractile muscle components have been shown to significantly increase 
with age in rats and humans189,190,197,198,209,243,274-276. This may be attributable to decreased physical 
activity, since increase in non-contractile muscle components have also been observed following 
hindlimb suspension in rats508,513,514. In agreement with these reports, we occasionally observed the 
infiltration of fat and connective tissue in the muscle of aged mice suffering from sarcopenia, but 
not in the muscles of transgenic mice, which may maintain normal physical activity. 
The appearance of small angular fibers, which are considered to be evidence for denervation158,197, 
suggests that the disconnection of motoneuron and myofiber might be the onset of muscle fiber 
atrophy and loss in transgenic and in aged animals. Denervation removes the trophic influence 
on the fiber and leads to atrophy283,308,309. Especially experimentally induced partial denervation 
resembles sarcopenia329, suggesting that denervation of a subset of muscle fibers may be involved 
in the development of sarcopenia. Partial denervation can also explain the presence of atrophied 
potentially denervated fibers, among normal and hypertrophied fibers that obviously are still 
functionally innervated, within the same muscle. 
Furthermore, centrally nucleated muscle fibers provide evidence for regeneration in both 
neurotrypsin-overexpressing and aged animals. The muscle tries to overcome the loss of fibers 
by adding new centrally nucleated fibers. An age-related increase in centrally nucleated fibers has 
previously been found in several studies242,271. However, this regeneration is inefficient, since finally 
the loss of fibers can’t be stopped. Speculations about the reasons for incomplete regeneration in 
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senescence involve impaired proliferation284,285, activation292, or differentiation290 of satellite cells 
as well as incomplete innervation of regenerated fibers147. The presence of sarcopenia in young 
adult animals, which are not likely to suffer from age-related changes in satellite cell metabolism, 
strongly promotes incomplete innervation, possibly due to failure in NMJ formation, as reason for 
unsuccessful regeneration. Moreover, impairment in satellite cell metabolism would eventually 
also influence the ability of muscle fibers to get hypertrophied. Satellite cell recruitment and fusion 
appears to be requisite for load-mediated hypertrophy302-304,464. There is a causal link between 
satellite cell proliferation, increased myonuclear number, and fiber hypertrophy. The myonuclear 
domain, the amount of cytoplasm an individual nucleus is controlling, does not or only marginally 
change in response to overloading-induced hypertrophy. Therefore, the substantial skeletal muscle 
hypertrophy seen in neurotrypsin-overexpressing and in aged animals may exclude a general 
failure of satellite cell metabolism. 
4.3 Dose dependency and rescue experiments emphasize enhanced agrin 
cleavage as essential step to neurotrypsin-induced sarcopenia
The severity of the sarcopenia-like muscle wasting was in good correlation to the level of agrin 
cleavage in line Nto1 and Nto2. Enhancement of agrin cleavage, represented by increased 
amounts of agrin-90, leads to more extensive fiber loss, increased heterogeneity of fiber size, and 
more centrally nucleated and angular muscle fibers. This provides good evidence that enhanced 
neurotrypsin-dependent agrin cleavage causes the muscle wasting. Importantly, motoneuronal 
neurotrypsin expression is sufficient to induce the whole phenotype. It is presynaptically secreted 
and may cleave agrin at the basal lamina of the NMJ. In agreement with the importance of 
motoneuronal neurotrypsin expression, the Nto-moto mouse line showed a very severe phenotype, 
although the overall neurotrypsin expression and agrin cleavage in the spinal cord were at a similar 
level as in the weaker line Nto2. The expression level in motoneurons may actually be higher in 
Nto-moto than in Nto2 animals, where neurotrypsin is distributed over all neurons. Higher level 
of motoneuronal neurotrypsin expression may induce a more severe phenotype. 
Mice overexpressing an inactive form of neurotrypsin can’t be distinguished from wild type 
littermates in any respect, indicating that the proteolytic activity of neurotrypsin is responsible 
for the degenerative changes. Furthermore, the concomitant overexpression of neurotrypsin and 
a neurotrypsin resistant agrin form completely rescued from the muscle wasting phenotype. 
This indicates that the excessive cleavage of agrin by neurotrypsin is the important step towards 
neurotrypsin-induced sarcopenia. The cleavability of agrin at the neurotrypsin-specific α and β 
position is essential to precociously induce sarcopenia. All the described morphological alterations 
following neurotrypsin overexpression and excessive agrin cleavage can similarly be observed 
in aged mice. Interestingly the relative strength of the different histopathological alterations is 
similar in conditions with enhanced agrin cleavage and in senescence. Generally, all effects in 
aged animals are less severe than in Nto1, but more severe than in Nto2 mice. The presence of 
the whole ensemble of sarcopenic changes in young transgenic mice indicates that the pathogenic 
mechanism underlying agrin cleavage- and aging induced sarcopenia may be similar. 
4.4 Muscle specific differences in neurotrypsin-induced sarcopenia
To confirm that neurotrypsin-induced sarcopenia does not only affect the soleus muscle, a second 
muscle exhibiting completely different characteristics has been analyzed. The EDL is a fast-twitch 
muscle, which is mainly composed of type II fibers, in contrast to the slow-twitch soleus muscle. 
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Moreover, the EDL is a locomotor muscle, which is important for the movement of the animal, 
whereas the soleus is a postural muscle that is also activated when the animals does not move. In 
conditions with enhanced agrin cleavage, muscle mass and fiber number of both soleus and EDL 
muscle are reduced. However, the soleus muscle showed more pronounced decline in both mass 
and fiber number. Interestingly, considerable muscle specific differences can also be found in 
regard to the endplate fragmentation following excessive agrin cleavage. Especially sternomastoid 
and diaphragm muscle have been analyzed in this respect in our lab. Slow-twitch diaphragm 
showed very severe NMJ degeneration with a complete disappearance of normal endplates, 
whereas in sternomastoid muscle the NMJs were rather resistant against neurotrypsin-induced 
fragmentation. A low stability of slow, type I fibers or endplates could explain the deleterious 
effects on the slow-twitch muscles soleus and diaphragm. However, following neurotrypsin 
overexpression the soleus muscle becomes increasingly slow, indicating a higher stability of type I 
and not type II fibers. Alternatively and more plausible, the expression level of neurotrypsin in the 
motoneurons innervating distinct muscles could be different. We have shown that the expression 
level of neurotrypsin has a direct influence on the extent of agrin cleavage and the severity of 
the sarcopenia phenotype. Expression of neurotrypsin is controlled from the Thy1 promotor that 
could be differentially regulated in motoneurons innervating distinct muscles.
In aged animals, both soleus and EDL are similarly affected in regard to fiber number. Muscle 
mass, however, is more reduced in EDL muscle, which could be attributable to more extensive 
type II fiber atrophy. Selective reduction in type II fiber thickness has been found in numerous 
studies on aged rodents and humans232,239-245. Alternatively, compensatory hypertrophy might be 
more pronounced in a postural muscle, such as the soleus, than in a locomotor muscle, such as 
the EDL, due to a greater training effect. The use of a locomotor muscle might be reduced in age, 
as reduced physical activity is a common and often observed consequence of aging. However, 
decreased physical activity does not reduce loading on a postural muscle to the same extent. 
Therefore, compensatory hypertrophy may be more pronounced in soleus than in EDL muscle.
4.5 Fiber number estimations from cross-sections
There has been an extensive discussion about the problems of using histological sections for 
determination of fiber number522,523,644. The accuracy of the enumerations crucially depends upon 
whether or not a cross-section includes all the muscles fibers, and this in turn depends on the 
structure of the particular muscle. Especially for muscles with pennate fiber arrangements, wrong 
estimates of the fiber number form cross-sections can be made. However, in muscles with parallel 
fiber arrangements, such as the soleus and the EDL, this method of fiber enumeration appears 
to be feasible, as long as the muscle is cut at right angle to its long axis. Timson et al.645 used 
histological sections as well as the nitric acid digestion method522,646 to estimate the number of 
fibers in the soleus muscle of mice. Both methods gave similar results, confirming that fiber 
counting on cross-sections can be used to determine the soleus fiber number. Nevertheless, it is 
important to use sections from the mid-belly region of the muscle, because the number of fibers 
appearing in a histological section decreases from the belly to the distal end of the muscle. That is 
because the fibers of the soleus muscle do not run the entire length of the muscle. Consequently, 
the mean fiber length is only about 60-70% of the muscle length. In the present study, cross-
sections with an interspace of less than 150 µm covering the whole mid-belly region of the soleus 
muscle were prepared. The fibers appearing in the sections were counted, and only the two highest 
numbers were used for the fiber number estimates of the muscle. With this method, influences of 
the position of the cross-sections in the muscle can be minimized.
The soleus muscle of mice has been previously studied in regard to fiber number, area and 
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composition645. The soleus was found to be composed of about 950 fibers, regardless of the sex 
of the animals and the method of fiber enumeration. This value is very similar to the results in the 
present study. The fiber area was slightly smaller than our results, which could be attributed to 
different mouse strains and ages (BALB/c, 8-7 month old instead of C57Bl/6, 4 month old). The 
percentage of type I fibers was reported to be 57% and 46% for females and males, respectively. 
We found 40% and 30% of type I fibers for female and males, respectively. These variations 
are not surprising since it has been shown that the fiber type composition can vary considerably 
among different rodent strains200. Vaughan et al.258 determined the fiber type composition of the 
soleus muscle in two different mouse strains and found considerable differences. The percentage 
of alkali-labile type I fibers was 45.7% and 59.7% for males and females, respectively, in strain 
Hul129Re and 58.4% and 65.8% in strain HulT0. Genetic differences among different stocks of 
mice have been thought to influence the fiber type composition and could well be responsible for 
the lower percentage of type I fibers in our study. Furthermore, Timson et al.645 and Vaughan et 
al.258 used myofibrillar ATPase staining following preincubation at pH 10.3 and 10.4, respectively. 
This results in different staining intensities among the different type II fiber types and leaves 
the alkali-labile type I fibers unstained229. This method bears the risk of classifying some of the 
weakly stained type IIb fibers as non-stained type I fiber, leading to an overestimation of type I 
fiber numbers. In the present study we used mATPase staining following preincubation at pH 4.3, 
which only and strongly labels the acid-stable type I fibers. In this way, we could exclude the risk 
of wrong classification. Significant sex differences in regard to fiber type composition of the soleus 
muscle have been found in all studies. Vaughan et al.258 speculated about an influence of androgens 
on the percentage of type I fibers since this percentage was similar between castrate males and 
females. Interestingly, even castration at an age of 4 month, at an age by which the “male” pattern 
of fiber types should have been fully established, resulted in a significant increase in type I fibers. 
It therefore appeared that continuously high androgen levels are required to maintain the low 
proportion of alkali-labile type I fibers. Changes in fiber type composition can be established 
without interfering with innervation, which is generally thought to determine the fiber type230.
4.6 the whole sarcopenic phenotype is installed in a few weeks after the onset 
of neurotrypsin overexpression
A developmental study of the muscle fiber number showed, that the onset of the fiber loss was slightly 
before postnatal day 10 (P10). The onset of neurotrypsin overexpression has been determined to 
be around P6634 (Bolliger et al., in preparation). It takes only a few days until excessive agrin 
cleavage and destabilization of the NMJs results in loss of muscle fibers. Interestingly, most of the 
fibers are lost in the first month postnatally. Later, the number of fibers in transgenic animals stayed 
constant, although the overexpression of neurotrypsin was maintained (Fig. 7c). One possibility 
could be that neurotrypsin overexpression and excessive agrin cleavage interferes only with initial 
stages of muscle growth. Once the muscle fiber has been established, it is stable. However, a drop 
in the number of fibers during the third and fourth postnatal weeks indicates that already formed 
fibers are actively lost in transgenic animals. Alternatively, muscle fibers are constantly lost but 
regeneration could compensate for degeneration in adult mice, building a dynamic equilibrium. 
Morphological indications for regeneration, such as central nuclei and axonal sprouting, support 
this hypothesis. Regeneration might be delayed in respect to the start of the fiber loss, but could 
then be responsible to maintain a dynamic equilibrium. Nevertheless, during initial growth of 
the muscle, the action of neurotrypsin seems to be especially fatal. A few days after onset of 
neurotrypsin overexpression, muscle fibers are lost and some weeks later the whole sarcopenic 
phenotype is installed.
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Fiber hypertrophy can be observed in the transgenic animals after day 45 postnatally, when the 
growth of the muscle is about to be concluded. Since fiber hypertrophy is thought to compensate 
for atrophied or lost fibers it is not surprising that it is delayed in regard to the start of the fiber loss. 
After maturation, growth of individual muscle fibers in transgenic muscles continuous, probably 
as a reaction to increased loading after atrophy and loss of a subset of fibers.
In wild type animals, the muscle fiber number was found to increase during the first two to three 
weeks postnatally. Thereafter it remained constant during adulthood. Whether postnatal increase 
in fiber number actually occurs, and if it does, in which time scale and to which extent has been 
conversely discussed in the literature. Whereas some studies did not find any increase in the number 
of myofibers after birth647,648, others showed a substantial increase in the first postnatal weeks649-651. 
Rayne and Crawford644 analyzed the medial and lateral pterygoid muscle of rats at birth, and one 
and six weeks after birth. The number of fibers in the medial pterygoid muscle almost doubled 
in the first week after birth, and between first and sixth weeks there was a further small increase 
of about 20%. In the lateral pterygoid muscle, the postnatal rate of increase of fiber number was 
12 and 20% between newborn and one week old, and between one and six weeks old animals, 
respectively. Recently, it has been found that the there is no net gain in myofiber number of mouse 
EDL muscle between P7 and P56652. Myofiber CSA, in contrast increased more than 7-fold in the 
same time period. Together, most of the muscle fibers appear to be present at birth, although some 
increase in fiber number might occur during the first weeks postnatally. This may be attributable to 
the differentiation of myoblasts present in muscle fiber bundles at birth into myofibers. Not fully 
differentiated muscle fibers are not always included into the counting, leading to different results. 
However, it is well established that the main growth of the muscle after birth is due to expansion 
of the existing muscle fibers and that the number of fibers stays constant during adulthood. In 
agreement with these studies, we found a small increase in fiber number in the first two postnatal 
weeks that is accompanied by a large increase in fiber thickness. Increase in muscle CSA appears 
to be concluded around day 45, a finding that correlates with findings from earlier reports647. 
4.7 Deterioration of the NMJ is responsible for agrin cleavage- and aging-
induced muscle wasting
4.7.1 excessive agrin cleavage and aging results in fragmentation and dispersal of NMJs 
Analysis of the NMJs of neurotrypsin transgenic and aged animals supports the hypothesis that 
denervation of a subset of muscle fibers causes both agrin cleavage- and aging-induced sarcopenia. 
A higher proportion of fragmented NMJs may be an indication for the ongoing deterioration of 
the neuromuscular connections. Fragmentation included the replacement of the typical pretzel-
like shape by numerous small spots of pre- and postsynaptic specializations. In the majority of 
cases, the alignment of pre- and postsynaptic sites was maintained. However, partial misalignment 
between highly fragmented presynaptic nerve terminals and corresponding postsynaptic sites 
occurred. Moreover, presynapses that were opposed by a cloudy, very weak postsynaptic signal 
and, finally, presynapses that were not opposed by postsynaptic AChR clusters can occasionally 
be observed in conditions with excessive agrin cleavage and with aging. These structures could 
represent final stages on the way to the disappearance of the NMJ. Synaptic transmission is not 
likely to occur, resulting in a functional denervation. Importantly, these structures suggest, that the 
dispersal of the postsynaptic sites precede the degeneration of presynaptic nerve endings. 
The morphology of the NMJ has been shown to depend on the type of the corresponding muscle 
fiber653. Total number of nerve terminals and endplate branches increases progressively from type 
I, IIa, IIx to IIb fibers. Therefore, fiber type changes could have an influence on the amount of 
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fragments per endplate. We observed an increase in proportion of type I fibers upon both enhanced 
agrin cleavage and aging. More type I endplates with a low number of branches would lead to 
a decrease in the number of fragments. However, the opposite, an increase in the number of 
fragments, was observed. Thus, a causal role of fiber type changes on endplate fragmentation can 
be excluded in both neurotrypsin overexpression and aged animals. 
It is well-established that agrin is crucial for the maintenance of the NMJ13,26. The cleavage of 
agrin by neurotrypsin removes the C-terminal fragment, containing the AChR clustering activity 
of agrin, which is essential for the NMJ stabilizing function of agrin. Agrin cleavage is therefore 
likely to destabilize the NMJ, by removing the protective function of agrin. It has been shown 
that unprotected, agrin-free postsynaptic specializations were dispersed during postsynaptic 
differentiation in an acetylcholine dependent manner57,58. Consistent with this idea, silencing the 
expression of MuSK, the downstream target of agrin, leads to the disassembly of existing NMJs91. 
This process included fragmentation and severe disassembly of postsynaptic AChR clusters. In 
response to abrogation of postsynapse integrity, presynaptic nerve endings began to sprout. In 
some severe cases, the entire postsynaptic structure was lost and only the motor nerve terminal was 
remaining. Thus, presence of MuSK and agrin are required for ongoing maintenance of the NMJ. 
A similar mechanism may be responsible for the dispersal of the NMJs after excessive cleavage 
and hence, inactivation of agrin. Such a mechanism would also explain the sequence of events. 
The excessive agrin cleavage at the NMJ removes the protective function of agrin. Acetylcholine, 
which is released by the nerve terminals induce the dispersal of the unprotected postsynaptic sites. 
This event may start at a certain site at the NMJ, leading to partially misaligned structure, and 
subsequently proceed over the whole NMJ. The dispersal may occur by internalization as well 
as by distribution of AChR in the muscle membrane. The cloudy, weak signals seen for AChRs 
in conditions with enhanced agrin cleavage could represent internalized and low concentrated 
receptors. At a certain stage, the amount of receptors may be too low to be detected. The dispersal 
of the postsynaptic sites may then lead to the retraction of the presynapse. It has been shown 
that nerve terminals are dependent on ongoing production of trophic factors by the postsynaptic 
muscle fiber60. Dispersal of postsynaptic sites and hence, shutdown of trophic factor supply is 
likely to result in the retraction of the nerve terminal. If the retraction of the nerve would precede 
the dispersal of postsynaptic sites, non-occupied receptor cluster would be visible, because the 
postsynaptic apparatus can persist for a long time in the absence of a nerve84-86. The absence of 
agrin-mediated stabilization as well as the presence of ACh-mediated destabilization is needed for 
active dispersal of postsynaptic AChR clusters. Absence of the nerve leads to both absence of agrin 
and ACh, resulting in relatively stable postsynaptic AChR clusters. Such structures have not been 
observed in conditions with enhanced agrin cleavage, strongly suggesting that the dispersal of the 
postsynaptic site precedes and induces the dispersal of the presynaptic site. Whether excessive 
agrin cleavage is also responsible for the NMJ fragmentation and the muscle wasting observed 
with aging is presently unknown. However, the mechanism of agrin cleavage- and aging-induced 
neuromuscular degeneration seems to be strongly related. With aging, as with increased agrin 
cleavage, NMJ fragmentation of both pre- and postsynaptic sites in a concerned fashion rather 
suggests active dispersal of postsynaptic sites than unilateral deterioration of the nerve ending. 
Deterioration of nerve terminals would result in unoccupied AChR clusters, which persist due 
to the absence of nerve-derived dispersal. Such structures were not observed in aged animals. 
Interestingly, in response to nerve injury, aged NMJ exhibited significant fragmentation and loss 
of motor endplate area while the young NMJ remained relatively stable343. Similarly, following 
muscle unloading, aged NMJs undergo significant remodeling of both pre- and postsynaptic parts, 
whereas adult NMJs maintain normal morphological characteristics405. Aged endplates appear to 
be more sensitive to the stimulus of unloading, possibly due to a general increase in plasticity that 
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is accompanied by a decrease in stability. It’s possible that lower amounts of full-length agrin are 
responsible for the destabilization of aged NMJs. Both increased agrin cleavage and decreased 
agrin synthesis would influence the amount of full-length agrin capable of stabilizing NMJs.
4.7.2 endplate fragmentation is accompanied by a loss of synaptic area
The fragmentation is associated with a loss of synaptic area in transgenic animals. Although muscle 
thickness has been shown to greatly influence synaptic area82,83, this effect can’t be attributed to 
a decrease in muscle thickness, since mean muscle fiber thickness is actually increased in these 
animals. The fragmentation does not only include a dispersal of the existing pre- and postsynaptic 
sites into small spots, but also an active loss of these sites. Interestingly, the synaptic area was 
increased in Nto1/rAg animals compared to wild-type littermates. In concert with this finding, the 
NMJs of these animals exhibited a more compact shape with a reduced proportion of AChR-free 
area. Some of these endplates rather resembled large plaques with some perforations than mature 
pretzel-like structures. Previously, it has been shown that the maturation of endplates during 
postnatal development is delayed in mice concomitantly overexpressing neurotrypsin and resistant 
agrin (Bolliger et al., in preparation). This finding has been attributed to difficulties in resolving 
the agrin-induced restraints during maturation, since agrin can’t be cleaved by neurotrypsin. 
Nevertheless, most of the endplates reaches the pretzel stadium. However, it is plausible that the 
shape of these NMJs remain to be more compact in adulthood, because the generation of AChR 
free areas, which relies on the removal of agrin’s protective function by its cleavage, is impeded.
In aged animals, a significant decrease in synaptic area was not detected. This is not surprising, 
since the fragmentation was clearly less pronounced in aged than in transgenic animals. So far, a 
number of studies tried to analyze age-related alterations in the size of both pre- and postsynaptic 
parts of the NMJ93,343,401,402,405,406. However, consistent results were not obtained. High natural 
variations, influences of muscle and fiber type on NMJ size, and methodological difficulties 
complicate the analysis of age-related changes of synaptic area and may explain the variety of 
results obtained. Our data does not indicate an age-related decrease in endplate area in the age 
range analyzed. However, the transgenic situation implies that when the fragmentation eventually 
gets more severe at higher age, this could be accompanied by a loss of synaptic area.
4.7.3 Agrin cleavage appears to be increased at fragmented NMJs
Concomitant staining of NMJs for the two C-terminal cleavage fragments that result from 
neurotrypsin-dependent agrin processing provided insights into the dynamics of agrin-mediated 
NMJ stabilization. The agrin middle fragment, agrin-90, remains associated to fragmented NMJs, 
whereas the most C-terminal fragment, agrin-22, seems to disappear after cleavage. Signals for 
agrin-22 were clearly weaker in fragmented NMJs of neurotrypsin-overexpressing animals, 
whereas the signal intensity for agrin-90 appears not to change greatly. In some cases, agrin-22 
may be completely absent. These finding suggest that neurotrypsin-dependent agrin processing at 
the corresponding α- and β- cleavage sites results in the disappearance of agrin-22, whereas agrin-
90 remains associated with the NMJ. The small C-terminal fragment, which contains the AChR 
clustering activity, is likely to be diffusible, because it can be found in the cerebral spinal fluid 
and in the blood of mice and humans (unpublished observation). Agrin-90, in contrast, contains 
binding sites for α-dystroglycan, heparin, and integrins99 and might be trapped at the basal lamina 
of the synaptic cleft after cleavage. In contrast to full-length agrin, agrin-90 is not capable of 
inducing and protecting postsynaptic AChR clusters, indicating that the cleavage of agrin might be 
responsible for a loss in agrin-mediated NMJ stabilization. Further evidence for this hypothesis is 
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provided from the observation that agrin-22 and AChR aggregates concomitantly disappear from 
heavily fragmented NMJs. The absence of agrin-22, indicating enhanced agrin cleavage, prevents 
agrin signaling and hence, the stabilization of the postsynaptic AChR clusters. Accordingly, the 
absence of postsynaptic AChRs, leading to abandoned nerve terminals, was always accompanied 
by the absence of agrin-22. The absence of agrin-22, on the other hand, not always co-occurred 
with the absence of AChR aggregates, indicating that agrin processing and diffusion of agrin-22 
might precede the dispersal of postsynaptic sites. The question about the fate of agrin-90 after 
agrin cleavage can’t be answered conclusively. Agrin-90 always remained associated with the 
NMJ, even in abandoned nerve terminals lacking the postsynaptic sites. Since agrin-90 may not 
be diffusible in the basal lamina of the synaptic cleft, internalization is a plausible scenario. The 
signal at abandoned nerve terminal could represent agrin-90 that has not yet been internalized. 
Since such nerve terminals may not represent stable and long-living structures, it is plausible that 
agrin-90 is not internalized during the lifetime of these structures. Alternatively, it’s possible that 
a part of the signal could represent internalized agrin that lingers in vesicles beneath the NMJ.
4.7.4 evidence for denervation- and reinnervation events
The innervation of highly fragmented endplates remains largely intact. Therefore, degeneration 
of motoneurons can be excluded as cause for endplate fragmentation and dispersal. Moreover, 
the motoneurons still have the potential the innervate muscle fibers in neurotrypsin transgenic 
animals. Bolliger et al. (in preparation) found striking outgrowth of nerve fibers on the diaphragm 
muscle of neurotrypsin transgenic mice (Fig. 2c). The nerves were not capable of building 
stable NMJs and grew over the muscle surface. The formation of small, unstable synapses has 
been observed. Unfortunately, the outgrowth of nerves can’t be observed on the soleus muscle, 
because it has to be teased into small bundles of fibers to stain and image the NMJs. During this 
process the initial positions of muscle fibers to each other is lost. However, very small immature 
synapses could represent attempts of outgrowing motoneurons the form new synapses. Moreover, 
terminal sprouting of nerves from endplates were observed on the soleus muscle of neurotrypsin 
transgenic mice. Terminal sprouting is known to be induced by adjacent, inactive muscle fibers, 
since presynaptic blockade with botulinum toxin, nerve conduction block with tetrodotoxin and 
spinalization have been shown to induce terminal sprouting331. Fragmentation and dispersal of 
NMJs following enhanced agrin cleavage may lead to a loss of connection between nerve and 
muscle and, subsequently, to inactivity of the muscle fiber. Inactivity of the fiber induces sprouting 
of adjacent nerves to reinnervate the denervated fiber, a process that has been observed in conditions 
with enhanced agrin cleavage and that finally leads to fiber type grouping. Terminal sprouting has 
also been reported to substantially increase with age336,410, adding another line of evidence for a 
common pathway leading to neurotrypsin-induced and aging-induced muscle weakness.
4.7.5 Deterioration of the NMJs influences muscle morphology
In neurotrypsin transgenic and in aged mice, completely normal, as well as highly fragmented 
NMJs can be found. This pattern influences the muscle morphology and could be responsible 
for increased heterogeneity of fiber thickness. Muscle fibers with highly fragmented or dispersed 
NMJs loose the contact to their motoneurons and start to shrink, being angular and eventually 
degenerate. Subsequently, the loading on normally innervated fibers with healthy fully functional 
synapses increases. These fibers start to become hypertrophied and compensate, at least partially, 
for the loss and atrophy of fibers. This process is likely to be dynamic; healthy synapses may also 
start to get fragmented. 
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The muscle itself exhibits signs of regeneration, trying to overcome the loss of muscle fibers by 
adding new ones. However, regeneration is inefficient, probably due to difficulties in establishing 
stable and functional NMJs. The ability of motoneurons to form stable NMJs influences the 
efficiency of reinnervation of denervated or newly added muscle fibers and hence, the efficiency of 
regeneration. Without agrin’s synapse protecting function, it might be possible to build transient, 
unstable synapses, but not a fully functional endplate. Small immature spots with pre- and 
postsynaptic labeling could represent the attempts of motoneurons to induce new synaptic sites, 
without actually being successful. Similarly, terminal sprouts might not be able to reinnervate 
adjacent, denervated muscle fibers due to the inability to establish stable NMJs. Loss of muscle 
fibers in concert with incomplete compensatory hypertrophy leads to reduced muscle size and 
mass, which is responsible for the decline in muscle strength. The accumulation of partially or 
fully denervated, reinnervated, atrophied and hypertrophied or newly added muscle fibers, could 
be the reason for the coordinative problems of the mice. It could be difficult to control an unstable, 
de- and regenerating neuromuscular system. 
Interestingly, it has been shown that aged motoneurons appear to be less successful than adult 
motoneurons in innervating denervated muscles147. As in conditions with enhanced agrin cleavage, 
the inability to form stable NMJs might be the reason. Aged motoneurons may not be capable to 
establish a stable and enduring contact to the muscle. Fragmentation of the NMJ may also be a 
possible explanation for the differences in age-related loss of muscle mass and function. Muscle 
fibers that have lost their motoneuronal input can’t be activated but may still be present for a 
certain time. They contribute to muscle mass but not to muscle function. Such a process would 
lead to a discrepancy between loss of muscle mass and function, which has been observed with 
aging180,183,186,194,206,207. However, in a human study, age-related decline in specific force has been 
detected, despite the old subjects were able to fully activate their muscles210. It would be interesting 
to analyze specific force in neurotrypsin-overexpressing animals to understand to which extent 
NMJ deterioration can influence specific strength. So far, there is no evidence for loss of specific 
strength, since loss of soleus and EDL muscle mass and grip strength were of similar magnitude. 
However, precise analysis, including the measurement of strength and size of the same muscle, 
would be needed to address this issue.
4.8 Denervated muscle fibers were not detected in transgenic mice
The appearance of angular muscle fibers, nerve terminals that do not contact muscle fibers and 
terminal sprouts provide indirect evidence for the denervation of muscle fibers in transgenic and 
aged mice. Several methods to directly detect denervated muscle fibers in the soleus muscle were 
applied. However, a clear result could not be retrieved, although a tendency for an increased 
proportion of denervated fibers was observed. Three reasons may be responsible for the imperfect 
results. First, the methods were not sensitive enough or not correctly executed, second, denervated 
muscle fibers are quickly reinnervated or degraded, or third, denervated myofibers do rarely appear 
in transgenic or aged animals. 
We used different markers for denervated muscle fibers, but all of them were not completely feasible. 
Two of them had been previously detected in totally denervated muscles (AcPH3, myogenin)643 
and may be difficult to use in a partially or only slightly denervated muscle. The detection of the 
Na
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1.5 sodium channel was not possible, since the commercially available antibody did not to 
work for immunostainings. NCAM was most promising, but the detected differences were small 
in contrast to the variation in a muscle and the possibility of false positives due to the preparation. 
Together, it would be crucial to have adequate controls. A muscle, which is completely denervated 
and a muscle, which is completely innervated should be available.
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The amount of detectable denervated fibers depends on the time a denervated fiber stays denervated. 
If such fibers are quickly reinnervated or degenerated, their amount could be low, even when 
denervation frequently occurs. The detection would be difficult, especially, when the methods are 
not very sensitive. Nevertheless, an increased proportion of denervated fibers has been reported 
for aged rats and mice using NCAM antibodies208,257 or a combination of electrophysiological 
and immunohistochemical methods to detect tetrodoxin (TTX)-resistant sodium channels330, 
respectively. However, the proportion of denervated fibers varied substantially (8% and 4% vs. 
almost 50%), indicating methodological difficulties. 
Interestingly, a 4-fold increase of the signal for myogenin has been found in western blots from 
gastrocnemius muscle extracts from aged compared to adult animals. Myogenin is involved in 
several aspects of skeletal muscle fiber development and repair. It has been found to be upregulated 
in denervated607,608 and in regenerating muscles604-606. Transcription of myogenin is repressed 
by electrical activity and consequently, blockade of muscle electrical activity by denervation 
induces the re-expression of myogenin609. Therefore, age-related upregulation of myogenin could 
indicate the appearance of denervated muscle fibers. Myogenin expression increased almost 20 
fold following complete denervation of the tibialis anterior muscle of the mouse643. However, 
myogenin mRNA increased also 18-fold due to regeneration following bupivacaine injection, 
which causes a dissolution of the sarcolemma that leads to rapid muscle fiber necrosis and 
subsequent recapitulation of myogenesis610. Thus, myogenin upregulation does not necessarily 
indicate denervated fibers but could also indicate ongoing muscle regeneration. The 10 fold 
upregulated of mygenin mRNA in tibialis anterior muscle of aged rats has been attributed to a 
continued attempt to generate new muscle fibers and ameliorate muscle atrophy. Surprisingly, 
in contrast to the results in aged animals, increase in myogenin was not constantly observed 
in conditions with enhanced agrin cleavage, despite a strong regenerative phenotype. However, 
myogenin upregulation is very fast and reversible. Myogenin mRNA expression was for example 
strongly increased 5 days after bupivacaine injection into the tibialis anterior muscle of adult 
rats. Already 14 days after induction of necrosis and subsequent regeneration, myogenin mRNA 
is downregulated to almost baseline levels610. The measured myogenin level is just a snapshot 
and thus, might not necessarily represent the continuous grade of denervation and regeneration. 
Moreover, it is not known, how myogenin is regulated after prolonged time of degeneration and 
regeneration in adult animals, as it is the case in neurotrypsin-overexpressing mice. Myogenin 
might not be directly associated with the degree of regeneration and denervation, at least not under 
conditions were these processes continues over a prolonged time period.
Together, we couldn’t find direct evidence for the appearance of denervated muscle fibers in 
conditions with enhanced agrin cleavage or with aging, mostly due to methodological problems. 
Therefore, the performed experiments do not exclude, but also not confirm the denervation of 
muscle fibers as a step in the pathogenic process leading to sarcopenia. However, there is striking 
indirect evidence for denervation of muscle fibers in neurotrypsin transgenic and aged muscles, 
such as the appearance of angular muscle fibers, abandoned nerve terminals, and terminal 
sprouts.
4.9 the number of motoneurons is not affected by neurotrypsin 
overexpression or aging
A loss of motoneurons is not likely to cause the disassembly of both, pre- and postsynaptic sites, 
because the postsynaptic apparatus can be maintained in the absence of a nerve. Moreover, the 
innervation of fragmented endplates remains intact, indicating that events at the NMJs themselves 
and not motoneuronal loss induce NMJ fragmentation and dispersal. In agreement with these 
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findings, a loss of motoneurons has not been observed in transgenic animals. Endplate fragmentation 
and muscle wasting is not preceded or accompanied by a loss of motoneurons. The decay of the 
endplates is not caused by a retrieval or loss of the motoneurons and does also not primarily result 
in a loss of motoneurons. This supports our hypothesis, that the cleavage of agrin destabilizes 
the NMJ. The motoneuron itself seems not to be affected and could well have the potential to 
innervate new muscle fibers. The formation of immature synaptic sites, fiber type switching, and 
fiber type grouping suggest that innervation could be successful at the beginning. However, the 
ineffective regeneration of the muscle indicates that a stable connection may not be formed. 
In aged animals, a loss of motoneurons has also not been observed. This finding is contradictory to 
several studies, in which the loss of motoneurons has been associated with aging in humans145,332,352 
and rats234. However, our result is not surprising, taken the relative moderate loss of muscle fibers 
in aged mice compared to rats or humans and recent evidence that the loss of motoneurons does 
not fully account for the loss of muscle fibers395. Since few motoneurons are lost during normal 
aging, it has been hypothesized that motoneurons become completely or partially disconnected 
from the target fibers147. This hypothesis is supported by our data, which indicates a dispersal of 
the NMJ, leading to a loss of the connection between motoneuron and myofiber. So far, it was 
generally believed, that a loss of motoneurons is the start and the cause of age associated muscle 
loss654. The finding that the muscle loss is not accompanied by a similar loss of motoneurons, 
but a severe fragmentation of the NMJ, indicates, that the decay of the endplate could be the 
factor triggering sarcopenia. It has been suggested, that sarcopenia to a significant extent depend 
on a decreased capacity among motoneurons to innervate regenerating fibers147. The reason for 
the impaired innervating capacity of the motoneurons could well be the inability to build stable 
NMJs, which crucially depend on agrin.
4.10 Fiber type grouping indicates neuropathological processes following 
enhanced agrin cleavage and aging
Degradative processes at the NMJs may also be key to understand the fiber type redistribution 
towards an increased proportion of type-I fibers consistently found in sarcopenia. The NMJs of 
type I and II fibers exhibit different morphologies and therefore stabilities. Consistent with a role 
of NMJ degradation in sarcopenia, it has been found that the larger and less compact NMJs of type 
II fibers are more prone to fragmentation with aging402. Our fiber type assessment upon enhanced 
agrin cleavage in neurotrypsin-overexpressing mice also indicated an increased proportion of 
type I fibers. Since the absolute numbers were decreased for both type I and type II fibers, this 
result is qualitatively sufficiently explained by a preferential loss of type II fibers. However, as 
in aged humans with sarcopenia, our mice with enhanced agrin cleavage at the NMJ showed 
pronounced fiber type grouping. Type I fiber grouping occurs for example when denervated type 
II fibers are reinnervated by collaterals of the motor nerve of an adjacent type I fiber. Therefore, 
a relatively small difference in the percentage of lost type I and type II fibers may be accentuated 
by reinnervation and reprogramming of type II fibers by the motor nerves of the less affected type 
I fibers. Furthermore, type I motoneurons may have a higher potential to build a stable endplate. 
Together, a small difference in NMJ stability could lead to dramatic effects on the fiber type ratio. 
However, grouping of type I and type II fibers was observed, indicating that both type I and II 
motoneurons have the potential to reinnervate neighboring fibers. Fiber type grouping is thought 
to result from a continuous neurogenic disorder, since the motoneuron determines the type of the 
innervated fiber. So far, fiber type grouping has always been thought to indicate motoneuronal 
death. Death of a motoneuron leads to the denervation of the associated muscle fibers and opens 
the possibility for their reinnervation and reprogramming by sprouts from adjacent nerves. Our 
Discussion
1
findings demonstrate that the dispersal of NMJs can lead to extensive fiber type grouping without 
actually affecting the number or viability of motoneurons. Therefore, fiber type grouping is not 
necessarily associated with motoneuronal death. 
An interesting observation was the difference in the relative type I fiber increase in female animals 
overexpressing neurotrypsin alone and neurotrypsin together with wild-type agrin, respectively. 
The motoneurons additionally overexpressing agrin could have a higher potential to build at least 
transiently stable endplates, due to the additional supply with transgenic agrin. Thus, their potential 
to takeover denervated fibers and to induce fiber type changes might be higher, resulting in a 
higher frequency of fiber type changes in the double transgenic animals. Finally, this process does 
not lead to an increased number of muscle fibers, since the newly formed connection may not be 
stable. Agrin appears to have an essential role controlling the reinnervation of muscle fibers. The 
capability of a motoneuron to innervate a muscle fiber could be determined by its agrin content. 
A higher stability of type I endplates nicely explains the type I fiber preference in transgenic 
animals, but not the opposite effect in males from line Nto1. A negative insertion effect of the 
transgene is not likely, because the rescue experiment with the resistant agrin is working, indicating 
that the decrease in type I fibers is caused by excessive agrin cleavage. Also here, small differences 
at the beginning, could lead to a big alteration at the end. If initially type II motoneurons would, 
for example, have some small advantages, takeover events could result in a severe increase in 
the proportion of type II fibers. A possibility would be a lower neurotrypsin expression level in 
type II motoneurons, increasing their potential to build and maintain endplates. The reason for a 
lower expression level could be the insertion of the transgene in a region with a generally lower 
expression level in type II than in type I motoneurons. Such a region could be differentially 
regulated in females, not causing the same effect.
Together, the increase in proportion of type I fiber for the majority of lines could be explained by 
small differences in NMJ stability, which leads to the predominant denervation, atrophy and loss 
of type II fibers. Additionally, takeover of denervated type II fibers by type I motoneurons, which 
have a higher potential to build stable endplates, could further increase the proportion of type I 
fibers and lead to fiber type grouping. The additional supply with transgenic cleavable agrin may 
enhance takeover events and further increase the proportion of type I fibers without improving the 
overall muscle morphology. The opposite effect in males from line Nto1 seems to be an exception, 
whose reasons remain elusive.
Fiber type grouping146,198,241,267 and, at least for rodents, increase in proportion of type I 
fibers146,201,234,235,252,253,255,256 has been reported to be characteristic for sarcopenia. Indeed, we found 
a significant increase in type I fibers and fiber type grouping in aged animals. Speculations about 
the mechanism of age-associated increase in type I fiber proportion include greater stability of 
type I muscle fibers, motoneurons, or endplates. The lower mitochondrial volume of type II fibers 
could render them for example more susceptible to death via mitochondrial dysfunction after 
oxidative damages153. However, such a mechanism is not suitable for the transgenic situation, 
since there is no indication that neurotrypsin overexpression and enhanced agrin cleavage at the 
NMJ directly influence the stability of the muscle fibers. Neither does greater stability of type I 
motoneurons apply for the transgenic situation, since the number of motoneurons is not changed 
at all. Most likely, differences in NMJ stabilities induce differences in the fiber type composition 
in conditions with enhanced agrin cleavage. Since the NMJ has been identified as primary target 
of neurotrypsin overexpression and since deterioration of the NMJ may induce the muscle 
degeneration, susceptibility of the NMJ to agrin-mediated stabilization or neurotrypsin-induced 
dispersal could decide the fate of the corresponding muscle fiber. Whether a similar mechanism 
is also responsible for the age-associated relative increase in type I fibers is not known, but the 
striking similarities in the phenotypes of aged and transgenic animals and the greater stability of 
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type I endplates to age-associated fragmentation are clearly favoring this hypothesis. Alternatively, 
fiber type distribution appears to be influenced by the expression of myogenic regulatory factors 
(MRFs), such as myogenin611. Myogenin expression was, for example, maximally detected in 
slow-twitch muscles. Age-related increase in myogenin expression may contribute to the type I 
fiber preference seen in sarcopenia. However, myogenin expression is not changed in neurotrypsin 
transgenic animals, despite a similar type I fiber preference. Therefore, increased myogenin 
expression may not be an essential condition for the age-associated increase in type I fibers. 
The same accounts for decreasing testosterone concentrations, which are thought to influence the 
fiber type distribution (see above). A continuously high androgen level appears to be required to 
maintain the low proportion of type I fibers in male compared to female mice258. Whereas an age-
associated decrease in testosterone concentration has been found259-261, such a decrease is unlikely 
to occur in young adult neurotrypsin-overexpressing animals, and hence, may not be an essential 
condition for type I fiber preference in sarcopenia.
Interestingly, in aged animals, we found that grouping is more pronounced in type II than in 
type I fibers, reflected by the higher T2 than T1 value. It’s not completely clear whether this is 
indication of a biological process or just an artefact of the quantification method. The increase 
in type I fibers would rather suggest that reinnervation and reprogramming is more frequently 
accomplished by type I than by type II motoneurons. More frequent reinnervation of neighboring 
fibers then would result in more frequent grouping of type I and not type II fibers. Alternatively, 
if higher stability of type I NMJs in the aging process is assumed, denervation of type II fiber 
is more frequent. This process increases not only the amount of denervated type II fibers, but 
also the amount of unconnected type II motoneurons, which therefore could exhibit a higher 
potential for reinnervation. There might be reinnervation and reprogramming of type I fibers by 
type II motoneurons, although these connections might not be sustained for long time. Lexell and 
Downham267 studied age-associated type grouping in 24 human vastus lateralis muscle and found 
a similar pattern in T1 and T2 values. Muscles from subjects around 30 years of age exhibited 
slightly negative values for both type I and type II fibers, nicely corresponding to our result for 
young adult wild-type mice. Thereafter, the cubic regression line for T2 slowly increased between 
30 and 70 years of age, whereas T1 stayed constant until about 65 years of age. Thus, in muscles 
from subjects between 50 and 70 years of age, T2 was suspected to be greater than T1. The same 
pattern was observed in our study in mice in an analogical age range. However, a direct comparison 
of T1 and T2 values of the 24 individuals in the human study revealed a close agreement of T1 
and T2. Since we analyzed only two time points, the age-related change in T1 and T2 cannot 
be fully understood. Furthermore, it is important to keep in mind that, unlike for type I fibers, 
several subgroups of type II fibers exist. Therefore, a group of type II fiber may actually consist 
of type IIa, IIx, or IIb fibers, which are innervated by different motoneurons. Quantification of 
type II fiber grouping should be made separately for each subgroup to more thoroughly analyze 
this issue. However, some of these fiber types may not or only in small numbers be present in the 
soleus muscle, making the quantification impossible.
4.11 Reliability of the method of enclosed fibers as indication of fiber type 
grouping
We used a method based on the number of enclosed fibers to analyze the degree of fiber type 
grouping. The concept of enclosed fiber has been introduced by Jennekens et al.262 in order to 
collect data on the number of fibers in clusters. A muscle fiber was considered to be enclosed, if in 
a cross-section, it was completely surrounded by fibers of its own histochemical type. Most fibers 
are bordered by 4 or 5 other fibers, thus at least 5 or 6 fibers of one type have to occur together 
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to observe an enclosed fiber. Within large clusters the number of enclosed fibers is higher and the 
number of surrounding fibers is relatively lower than within small clusters. In general, fiber-type 
grouping is associated with an increase in the number of enclosed fibers. However, the number 
of enclosed fibers strongly depends on the relative amount of the fiber types. Thus, this method 
only leads to reliable results, if the proportion of the different fiber types stays constant. In our 
study, this was not the case. A relative increase in one fiber type necessarily increases the amount 
of enclosed fibers and a correction is needed. To study the statistical properties of the number of 
enclosed fibers, a model based upon hexagonal-shaped fibers was formulated265. In an empirical 
study, Downham et al.655 showed that the number of enclosed fibers closely follows a negative 
binomial distribution, entirely defined by the sample size and fiber type proportion. Knowledge 
of the underlying distribution for a single sample now permitted the calculation of a significance 
level and the formation of a measure of randomness. However, the applicability of the model 
depends upon how close its assumptions resemble the muscle sections studied. In particular, there 
are two aspects that could invalidate the results. First, one fiber type could be consistently differing 
in size from the other type, and second the proportion of the two fiber types could systematically 
vary within a muscle. It is known that the different fiber types can vary considerably in thickness 
according to numerous factors including muscle type, species studied, and age of the subjects. In 
the present study, we did not observe a consistent difference in CSA between the fiber types in 
the soleus muscle of young wild-type animals. Neurotrypsin overexpression and aging increased 
the heterogeneity of fiber size, but not in a type specific way. Hypertrophied and atrophied fibers 
could be found among both type I and type II fibers. Without a consistent difference in thickness 
of one fiber type, the model of enclosed fiber should be valid, despite the increased heterogeneity 
of fiber size. A systematic variation in the proportion of fibers within the muscle was observed 
along the boarders of the soleus muscle in our study. Type II fibers were much more frequent 
along the boarder of the muscle than type I fibers. However, Lexell and Downham267 formulated 
an alternative equation, which included a correction for the accumulation of one fiber type at the 
boarder of fascicles. This formula was used for the calculation of T values in this study. A further 
problem of the enclosed fiber method occurs, if one fiber type is much more frequent. In such a 
case, few, if any, enclosed fibers of one type can be expected, and so this count is unsuitable. Thus, 
the proportion of one fiber type should lie between 30 and 70% to generate reliable results. In this 
study, the fiber composition was in a reasonable range to use this quantification method. In most 
of the animals, the proportion of type I fibers was between 40 and 60%. There was only one case 
exceeding 70% of type I fibers and only three with more than 65%.
A major concern in our study was the high variation between individual animals in regard to T1 
and T2 and the low correlation between T1 and T2 of the same animal. T1 for example varied 
between 2.2 and -1.2 for adult wild-type animals and a low T1 value was not an indication for a 
low T2 value in the same muscle. Lexell and Downham267, in contrast, found a close correlation 
between T1 and T2 values. However, they used the human vastus lateralis muscle, which contains 
much more fibers than the mouse soleus muscle we analyzed. They assessed 18-60 fascicles with 
700-2000 muscle fibers per individual, whereas we were bound to the 900-1000 muscle fibers of 
the mouse soleus muscle. Thus, the T1 and T2 value per individual may be more accurate in the 
human study. The low accuracy of the individual T values could explain the absence of a clear 
correlation between T1 and T2 in the same muscle. To compensate for the variation between the 
individuals we used high number of animals in each age group.
Together, the results that were obtained with this method were reasonable. Nevertheless, variations 
between animals, between muscles from both legs, and even between different sections from the 
same muscle were considerable, which is reflected by the high standard deviations. Thus, high 
numbers of cross-sections have to be used to get significant differences and small differences may 
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not be registered. 
4.12 A model for neurotrypsin induced muscle wasting: the sequence of events
The overexpression of neurotrypsin in motoneurons leads to an excessive agrin cleavage at the 
NMJ. A 90 kDa middle fragment and a 22 kDa C-terminal fragment are produced. The C-terminal 
fragment of agrin, comprising the AChR aggregation activity, is diffusible and may leave the 
NMJ. The remaining agrin N-terminal part and the 90 kDa middle fragment, which might still 
be fixed at the basal lamina of the NMJ, are not capable to induce agrin signaling and protect 
the NMJ from dispersal. The presence of the nerve, releasing the dispersal factor acetylcholine, 
together with the absence of the protecting function of agrin leads to the loss of postsynaptic 
AChR aggregates. This results in dispersal of the presynaptic parts that are not directly opposed by 
postsynaptic sites. During this process, partial misalignment of the pre- and postsynaptic sites can 
be observed, although the alignment of pre- and postsynaptic sites is maintained in the majority 
of cases. The NMJs appear more and more fragmented. Eventually, the entire postsynapse of 
an NMJ is lost. Dispersal of all postsynaptic sites then is followed by the deterioration of the 
abandoned presynaptic nerve ending, which is not opposed to postsynaptic specialization and not 
supported by trophic factors from the muscle. The motoneuron itself is not affected and retains 
the ability for growth and innervation of other muscle fibers. Due to different stabilities, the 
majority of dispersed NMJs are of type II, leading to a higher proportion of type I endplates and 
consequentially type I fibers. The denervated muscle fiber is not supported by trophic factors 
and starts to atrophy, being angular and eventually to degenerate and get lost. The time a muscle 
fiber persists in a denervated state may be relatively short. A denervated muscle fiber can also be 
reinnervated by terminal sprouts of an adjacent motoneuron. However, in most of the cases this 
is not or only partially successful. Transient, unstable synapses are built rather than stable NMJs, 
which crucially depend on full-length agrin. Nevertheless, the takeover of denervated muscle 
fibers by sprouts from adjacent motoneurons, eventually leading to a type change, takes place, 
finally resulting in fiber type grouping. Whether it needs the formation of a complete NMJ or 
just some synaptic transmission is not clear. The potential of type I fibers to built endplates, 
regardless if stable or not, is higher, leading to a further increase in type I fibers. Agrin may play 
an important role in such reinnervation events, since additional supply of motoneurons with agrin 
increases their capability for synapse formation and takeover of fibers. Although some takeover of 
denervated fibers is possible, most of the muscle fibers, which looses their connection to the nerve 
are atrophied and subsequently lost. The loss of muscle fibers induces a regeneration reaction of 
the muscle. Satellite cells are activated and new, centrally nucleated fibers are added to the muscle. 
However, the innervation of these muscle fibers may not be successful in most of the cases, due to 
the lack of full-length agrin to form stable NMJs. Thus, the regeneration is ineffective and can’t 
counteract the loss of fibers. Another compensation mechanism is more successful. Normal, non-
fragmented endplates, capable of supporting myofibers, still exists in neurotrypsin-overexpressing 
animals, although their proportion is decreased. The healthy, correctly innervated fibers increase 
in thickness to compensate for the loss and atrophy of fibers. This is most likely a training effect, 
due to increased loading of the remaining fibers. Atrophy of denervated and compensatory 
hypertrophy of innervated fibers results in increased heterogeneity of fiber thickness. This process 
is highly dynamic; healthy endplates supporting hypertrophied fibers may also start to fragment 
and disappear, leading to atrophy of the corresponding fiber. Alternatively an atrophied fiber may 
become reinnervated and, when eventually a stable NMJ can be formed, hypertrophied. Due to 
this compensatory hypertrophy, the loss of muscle size and mass is relatively moderate, compared 
to the loss of muscle fibers. The reduction in muscle size leads to a loss of muscle strength of the 
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same magnitude. The de- and regenerating neuromuscular system complicates the control of the 
skeletal muscles and result in motor coordination impairment. 
The pathogenic mechanism underlying sarcopenia may be similar. Destabilization of the NMJ 
could be the start point to a final common pathway controlling the pathogenic processes resulting 
in sarcopenia. Whether the mechanism inducing NMJ destabilization in senescence is also the 
same remains an open question.
4.13 Neurotrypsin-overexpressing mice can serve as model for sarcopenia
There are striking similarities between the loss of muscle mass and function due to neurotrypsin 
overexpression and due to aging. Beside the more general hallmarks of muscle weakness - reduced 
muscle strength and size, and loss of muscle fibers – features, that are special for sarcopenia 
- greater heterogeneity of fiber thickness, centralized nuclei, angular fibers, fiber type grouping 
and the increase in type I fiber proportion - can be observed in both skeletal muscle from aged 
and neurotrypsin-overexpressing mice. Moreover and most importantly, the fragmentation and 
decay of the NMJs that may initiate the process resulting in sarcopenia occurs in both aged and 
neurotrypsin transgenic animals. Thus, the neurotrypsin-overexpressing mouse can serve as an 
animal model for sarcopenia. The transgenic neurotrypsin-overexpressing mouse lines exhibit 
aging-like neuromuscular features in a well-defined, easy-to-handle fashion, which could simplify 
the analysis of aging induced degenerations dramatically. Research on sarcopenia bears a lot of 
drawbacks that could be circumvented using the neurotrypsin-overexpressing model. First, it is 
time consuming and expensive to generate aged mice, and experiments have to be planed a long 
time in advance. Second, the severity of sarcopenia in aged mice can vary substantially, increasing 
the amount of animals necessary to get reliable and consistent data. Especially mice from inbred 
strains often develop a variety of pathological alterations in senescence that cannot always be 
recognized and may influence the results. Third, the morphological alterations due to sarcopenia 
are rather small in mice, again increasing the amount of animals needed. It could be difficult to 
detect subtle changes for example upon treatment. Fourth, a variety of age-dependent changes 
that may or may not influence sarcopenia make it difficult to distinguish between modulating 
influences and fundamental mechanisms that underlie sarcopenia. 
The neurotrypsin-overexpressing model provides an aging-like neuromuscular environment, in a 
consistent, well-defined way, and can be generated without extensive breeding time. Sarcopenia 
can be analyzed in young, otherwise healthy animals that do not exhibit other age-related changes, 
such as physical inactivity, reduced food uptake or endocrine alterations. A variety of influences 
that may modulate but not initially cause sarcopenia can be sorted out. Consequently, animals 
from the same mouse line exhibit a degree of sacropenia that is much more consistent than in 
naturally aged animals. Moreover, different mouse lines with distinct neurotrypsin expression 
levels provide a broad range of severities. Some transgenic mouse lines exhibit a phenotype, 
which is by far stronger than the naturally occurring. Thus, beneficial effects of a treatment could 
be detected much easier.
4.14 the neurotrypsin-overexpressing model provides insights into the 
pathogenesis of sarcopenia: NMJ stability is essential
Several hypotheses about the etiology of sarcopenia can be posted from the transgenic model: 
First, the deterioration of the NMJ is the essential factor triggering sarcopenia. Thereby agrin, as 
NMJ protecting and stabilizing agent, could play an important role. Second, a loss of motoneurons 
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does not precede the loss of fibers and may not primarily cause sarcopenia. Interestingly, fiber 
type grouping seen in sarcopenia does not necessarily indicate motoneuronal death, as it has 
been thought up to know. Instead, it may rather point to degeneration of the NMJs. Third, the 
potential of aged motoneurons to innervate denervated muscle fibers may be decreased due to the 
inability to form stable NMJs, which depend on agrin. The supply with full-length agrin might 
determine the success of reinnervation. And fourth, the preferential type II fiber loss is the result 
of a distinct type I and type II NMJ stability rather than the susceptibility of type I or II fibers to 
aging-induced processes152. Such processes, like the mitochondrial dysfunction, which arises from 
the accumulation, over time, of mitochondrial DNA damage as a result of oxidative stress, are not 
very likely to occur in neurotrypsin-overexpressing animals. 
Factors influencing the stability of the NMJ can play a critical role in the development of 
sarcopenia. The structure of the NMJ has to be adjusted on the fine line between having room for 
plasticity and being stable over a long time period. Together, our results suggest agrin cleavage, 
NMJ destabilization, and fiber denervation at the onset of a final common pathway leading to 
sarcopenia. The interplay between agrin and neurotrypsin greatly influences the NMJ structure, 
making them candidates for an involvement in the process leading to sarcopenia.
4.15 the absence of neurotrypsin and the overexpression of a neurotrypsin-
resistant agrin variant do not prevent sarcopenia
The induction of sarcopenia by overexpression of neurotrypsin in motoneurons prompted us to 
test for a role of enhanced neurotrypsin-dependent agrin cleavage as a pathogenic mechanism 
of age-dependent sarcopenia. We found that aged neurotrypsin-deficient mice suffered from 
sarcopenia as much as their wild type littermates. This indicates that neurotrypsin may not 
play an essential role in the pathogenesis of sarcopenia. However, the cleavage of agrin at the 
NMJ, and not the presence of neurotrypsin may be the important sarcopenia promoting process. 
Neurotrypsin overexpression could be regarded as a tool to induce extensive agrin cleavage at 
the NMJ, without actually playing a physiological role at this particular site. Recent results from 
our laboratory revealed that the overexpression of neurotrypsin-resistant agrin together with 
neurotrypsin results in a substantial delay, albeit not complete arrest, of NMJ maturation (Bolliger 
et al., in preparation). Because NMJ maturation was not delayed in Ntd mice we speculated that 
a distinct, but related protease, cleaving agrin at the same and possibly additional sites substitutes 
neurotrypsin as an agrin-cleaving protease at the NMJ. The hypothesized protease should not 
be expressed in the central nervous system due to the absence of cleavage fragments in Ntd 
mice. Such a protease might not exhibit as stringent site specificity as neurotrypsin. Neurotrypsin 
requires a highly restricted consensus sequence, with an acidic amino acid followed by a basic 
amino acid. Variances in P1 or P2 position completely abolish cleavage. Furthermore, neurotrypsin 
activity strongly depends on exosite interactions. Small peptide substrates with the consensus 
sequence are not cleaved. Consequently, only one substrate for neurotrypsin has been identified 
up to now. Most of the proteases are by far less specific, cleaving at multiple positions in a series 
of substrates. Therefore, it may well be that the proposed protease could process the neurotrypsin-
resistant agrin variant, possibly with a decreased rate. In agreement with this hypothesis, the 
endplate maturation was delayed upon overexpression of neurotrypsin and resistant agrin but not 
completely prevented. The NMJs reached the pretzel stadium in Nto1/rAg animals, indicating that 
a low level of agrin cleavage might occur. The mutation of agrin at the neurotrypsin cleavage sites 
could reduce the rate of cleavage by the alternative protease without preventing it completely. 
The availability of less cleavage sites or less preferred cleavage sites is likely to reduce the rate 
of proteolytic processing. Alternatively, another agrin degrading process that is slower than the 
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cleavage by neurotrypsin or a related protease might exist. This process might ensure a basal 
level of agrin degradation and hence, NMJ maturation in Nto1/rAg animals. In accordance with 
these hypotheses, we found here that co-overexpression of a neurotrypsin-resistant form of agrin 
with neurotrypsin did not prevent sarcopenia. In contrast, Nto1/rAg double transgenic animals 
appear to suffer slightly more from sarcopenia. The neurotrypsin-resistant agrin might be cleaved 
or degraded by neurotrypsin independent processes over the animal’s lifetime, leading to the 
destabilization of the NMJs that promotes sarcopenia. 
Alternatively to increased agrin cleavage, agrin expression might be reduced with age. Deposition 
of a lower amount of agrin in the NMJ could have a similar effect as increased agrin cleavage, 
as both result in a lesser availability of agrin’s signaling component. Indeed, Western blotting 
on aged spinal cord extract indicated, that the abundance of agrin might be lower in age. The 
upper part of the agrin signal, representing the most heavily glycanated variants, were absent 
in aged animals. Neurotrypsin can process these agrin variants, but might not or not alone be 
responsible for their absence in age, since they also disappeared in Ntd animals. In brain tissue, 
these variants have been shown to predominate at synapses. A lower amount of these, regardless 
whether due to increased degradation or decreased synthesis, could influence the stability of the 
NMJ and the development of sarcopenia. However, increased transgenic expression of agrin 
under the Thy-1 promoter (Ag and rAg mice) did not have a significant sarcopenia-preventing 
effect. Nevertheless, minor changes of several histological parameters have been noted. The age-
associated loss of fibers appears to be less severe in senescent agrin-overexpressing animals than 
in wild type littermates. Consequentially, the compensatory hypertrophy was less pronounced in 
these animals. Since hypertrophy is induced by the loss of muscle fibers, it is not surprising that 
these two morphological parameters correlate. Most striking, the number of centrally nucleated 
fibers was significantly reduced in aged agrin-overexpressing animals compared to their wild 
type littermates. This could have several reasons: A reduced loss of muscle fibers may induce 
the compensatory addition of new fibers to a lower extent. However, aged agrin-overexpressing 
animals also lose a substantial amount of their muscle fibers in comparison to young animals. 
Therfore, it is not very likely that the regeneration mechanism is not induced to the maximal 
extent. Alternatively, in some skeletal muscles, hypertrophy is accompanied by an increase 
in centralized nuclei, most likely due to the fusion of satellite cells to the myofibers656. Since 
compensatory hypertrophy is less pronounced in Ag- and rAg-overexpressing than in wild type 
muscles, the amount of fused satellite cells and consequentially, centralized nuclei could be lower 
in these muscles. However, central nucleation was not especially frequent in hypertrophied fibers, 
suggesting that hypertrophy is not accompanied by central nucleation in the soleus muscle. Finally, 
the beneficial influence of transgenic agrin could be attributable to increased regeneration and 
not to the prevention of fundamental sarcopenia-inducing processes. Because in young animals 
overexpressing of wild type agrin induces fiber type switching and, by inference, reinnervation, 
an increased rate of reinnervation could be responsible for the beneficial effects of trangenic 
agrin in senescence. Centralized nuclei are thought to be evidence of newly formed fibers and 
disappear after innervation of the fibers. Increased reinnervation of newly formed fibers in aged 
Ag and rAg transgenic animals may reduce the amount of centrally nucleated fibers. In agreement 
with this hypothesis, a tendency for increased proportion of type I fibers was observed in aged 
agrin-overexpressing animals, suggesting that fiber type switching may be more frequent in 
these animals. Agrin might increase the possibility of a motoneuron to innervate denervated or 
newly formed muscle fibers. Newly built connections might only transiently be stable, but such a 
process could increase fiber type switching. In aged animals, the agrin degrading process might be 
slower than in neurotrypsin-overexpressing animals, and agrin overexpression could have a small 
beneficial effect on fiber number due to increased reinnervation, without actually counteracting 
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the fundamental process causing sarcopenia.
Importantly, the beneficial effects of agrin were observed upon overexpression of both wild type 
and cleavage-resistant agrin. This finding suggests that the additional supply with agrin does not 
counteract or delay an agrin degrading process that involves cleavage at the neurotrypsin –specific 
sites. If there is a sarcopenia-promoting decrease in full-length agrin, it might not result from 
increased cleavage at the neurotrypsin-specific position. 
Together, two processes could result in decreased amounts of full-length agrin and, hence, in 
destabilization of NMJs and the propagation of sarcopenia. First, agrin could be locally cleaved 
at the NMJ by a protease with a proteolytic spectrum including but not limited to the α and 
β cleavage sites. Over an animal’s lifetime, resistant agrin can’t counteract the continuous 
degradation, which finally results in sarcopenia. Beneficial influence of transgenic agrin might 
rather indicate increased reinnervation of denervated or newly formed fibers than counteraction 
to the fundamental sarcopenia promoting process. Differences in cleavage rates between wild 
type and resistant agrin might be too small to observe a difference in the reinnervation-promoting 
effect. Second, decreased amounts of full-length agrin could be attributable to either reduced 
agrin synthesis or an agrin degradation process that is independent of cleavage at the α and β 
cleavage sites. This hypothesis would explain the beneficial effects of the overexpression of both 
neurotrypsin-resistant and wild type agrin. Since these effects are very small, agrin overexpression 
might not be sufficient to counteract the age-associated reduction. This would imply, either a low 
level of overexpression or a subsantial decrease in full-length agrin.
However, the evidence for an involvement of agrin cleavage in the pathogenesis of sarcopenia 
is rather weak. Other components of the NMJ could influence its stability. Age-dependent 
downregulation or decay of these components could similarly induce NMJ dispersal and activate 
a common pathway leading to sarcopenia. Oxidative damages due to age-associated increase in 
production of ROS could for example induce the degradation of stabilizing proteins. It has been 
shown that increased generation of ROS in superoxide dismutase (sod1)-deficient mice leads to 
fragmentation and denervation of the NMJs finally resulting in muscle fiber atrophy460.
4.16 Could agrin be involved in age-related excitation-contraction 
uncoupling?
Another possibility of an influence of agrin cleavage on sarcopenia comes from the involvement 
of agrin in excitation-contraction coupling (ECC). It has been recently shown that neural agrin 
controls the maturation of the ECC mechanism in human myotubes in vitro116. Treatment of 
myotubes with agrin mimicks the effect of spinal cord explants in regard to the fraction of muscle 
cells showing a functional excitation-contraction mechanism. The promotion of ECC by agrin 
treatment involves the increase of functional ryanodine receptors and dihydropyridine-sensitive 
L-type Ca2+ channels. It has been shown that aging is associated with excitation-contraction 
uncoupling (ECU), which is mediated by an age-related decrease in expression of ryanodine 
receptors and dihydropyridine-sensitive L-type Ca2+ channels155,156. Enhanced agrin cleavage might 
potentially inactivate its function in controlling ECC. However, at the moment, there is no further 
evidence for such a connection. It is for example not known, which part of agrin is responsible for 
the control of ECC. Furthermore, agrin’s effect on ECC has only been found in human and not in 
mouse muscle cells, whereas age-associated ECU has been found in mice. Further experiments 
would be needed to examine a possible role of agrin in age-related ECU.
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